Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Flu

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44352   clinical trials with a EudraCT protocol, of which   7379   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    Study title: Long-term results of laser treatment for retinal angiomatosis in von Hippel-Lindau disease. Schmidt D, Natt E, Neumann HP. Eur J Med Res. 2000 Feb 28;5(2):47-58.
    Active substance: FLUORESCEIN
    Study summary document link (including results): Long-term results of laser treatment for retinal angiomatosi.pdf
    View full study record
    Document reference: 28245
    Study title: Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. [No authors listed] Pediatrics. 2000 Feb;105(2):295-310.
    Active substance: FLUORESCEIN
    Study summary document link (including results): Supplemental therapeutic oxygen for prethreshold retinopathy.pdf
    View full study record
    Document reference: 28246
    Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG O.D. IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27785
    Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG/DAY IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27589
    Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG/DAY IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27952
    Study title: TO EVALUATE THE EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF DISSEMINATED CANDIDIASIS AND CRYPTOCOCCAL MENINGITIS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27623
    Study title: TO EVALUATE THE EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF DISSEMINATED CANDIDIASIS AND CRYPTOCOCCAL MENINGITIS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27985
    Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF A SINGLE 400 MG ORAL/IV DOSE OF FLUCONAZOLE IN PATIENTS SUFFERING FROM CANDIDAL ESOPHAGITIS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27394
    Study title: Chirurg. 2001 Sep;72(9):1071-7. [Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft tissue tumors. 3rd Interdisciplinary Consensus Conference "PET in Oncology": results of the Bone and Soft Tissue Study Group] [Article in German] Franzius C, Schulte M, Hillmann A, Winkelmann W, Jürgens H, Bockisch A, Schober O.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28166
    Study title: Clin Nucl Med. 2002 Aug;27(8):572-7. F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease. Rini JN, Manalili EY, Hoffman MA, Karayalcin G, Mehrotra B, Tomas MB, Palestro CJ.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28156
    Study title: Clin Nucl Med. 2003 Aug;28(8):648-51. Thymic uptake of radiopharmaceuticals. Connolly LP, Connolly SA.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28143
    Study title: Clin Nucl Med. 2005 Mar;30(3):170-6. Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors. Uchida Y, Minoshima S, Kawata T, Motoori K, Nakano K, Kazama T, Uno T, Okamoto Y, Ito H.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28109
    Study title: Diabetes Care. 2001 Mar;24(3):555-60. Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Oxford Regional Prospective Study Group. Schultz CJ, Neil HA, Dalton RN, Konopelska Bahu T, Dunger DB; Oxford Regional Prospective Study Group.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28171
    Study title: Endocr Pract. 2003 Jul-Aug;9(4):273-9. Comment in: Endocr Pract. 2003 Jul-Aug;9(4):324-6. [18F]fluorodeoxyglucose triple-head coincidence imaging as an adjunct to 131I scanning for follow-up of papillary thyroid carcinoma. Gonzalo IT, Itti E, Mlikotic A, Pham le H, Cesar RB, Meignan M, Mishkin FS.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28140
    Study title: Epilepsia. 2006;47 Suppl 2:71-5. Neuropsychological findings in Rolandic epilepsy and Landau-Kleffner syndrome. Metz-Lutz MN, Filippini M.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28072
    Study title: Eur J Appl Physiol Occup Physiol. 1995;70(5):442-50. Pulmonary gas exchange and ventilatory responses to brief intense intermittent exercise in young trained and untrained adults. Chamari K, Ahmaidi S, Fabre C, Ramonatxo M, Préfaut C.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28202
    Study title: Eur J Haematol. 2007 Mar;78(3):206-12. Epub 2007 Jan 23. Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma. Hutchings M, Loft A, Hansen M, Berthelsen AK, Specht L.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28069
    Study title: Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):346-50. CT vs 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current. Kamel E, Hany TF, Burger C, Treyer V, Lonn AH, von Schulthess GK, Buck A.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28158
    Study title: Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):581-7. Epub 2003 Jan 30. Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy. Choi JY, Kim SJ, Hong SB, Seo DW, Hong SC, Kim BT, Kim SE.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28152
    Study title: Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):396-402. Epub 2003 Jan 9. Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours. Lassen U, Daugaard G, Eigtved A, Højgaard L, Damgaard K, Rørth M.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28149
    Study title: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1064-72. Epub 2004 Mar 11. Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors. Tian M, Zhang H, Oriuchi N, Higuchi T, Endo K.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28131
    Study title: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1073-80. Epub 2004 Mar 9. Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. Ng SH, Chang JT, Chan SC, Ko SF, Wang HM, Liao CT, Chang YC, Yen TC.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28133
    Study title: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1105-13. Epub 2004 Mar 9. Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT. Bar-Shalom R, Gaitini D, Keidar Z, Israel O.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28132
    Study title: Eur J Nucl Med Mol Imaging. 2004 Jun;31(6):811-9. Epub 2004 Feb 5. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology. Amthauer H, Denecke T, Rau B, Hildebrandt B, Hünerbein M, Ruf J, Schneider U, Gutberlet M, Schlag PM, Felix R, Wust P.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28135
    Study title: Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1422-8. Epub 2005 Aug 31. Respiratory motion artefact in the liver dome on FDG PET/CT: comparison of attenuation correction with CT and a caesium external source. Papathanassiou D, Becker S, Amir R, Menéroux B, Liehn JC.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28098
    Study title: J Pediatr Hematol Oncol. 2006 Aug;28(8):501-12. Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease. Furth C, Denecke T, Steffen I, Ruf J, Voelker T, Misch D, Vondran F, Plotkin M, StÃver B, Henze G, Lemke AJ, Amthauer H.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28078
    Study title: Jpn Circ J. 1997 Mar;61(3):201-10. Myocardial blood flow and metabolism in patients with hypertrophic cardiomyopathy--a study with carbon-11 acetate and positron emission tomography. Ishiwata S, Maruno H, Senda M, Toyama H, Nishiyama S, Seki A.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28195
    Study title: Klin Padiatr. 2003 May-Jun;215(3):146-50. [18-FDG-PET-findings in children and adolescents with Hodgkin's disease: retrospective evaluation of the correlation to other imaging procedures in initial staging and to the predictive value of follow up examinations] [Article in German] Wickmann L, Lüders H, DÃrffel W.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28146
    Study title: Leuk Lymphoma. 1999 Aug;34(5-6):545-51. Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease. Wiedmann E, Baican B, Hertel A, Baum RP, Chow KU, Knupp B, Adams S, HÃr G, Hoelzer D, Mitrou PS.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28184
    Study title: Leuk Lymphoma. 2004 Jan;45(1):85-92. FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison. Friedberg JW, Fischman A, Neuberg D, Kim H, Takvorian T, Ng AK, Mauch PM, Canellos GP, van den Abbeele AD.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28129
    Study title: Leuk Lymphoma. 2007 Sep;48(9):1721-7. Comment in:Leuk Lymphoma. 2007 Sep;48(9):1667-9. Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans. Picardi M, De Renzo A, Pane F, Nicolai E, Pacelli R, Salvatore M, Rotoli B. Leuk Lymphoma. 2007 Sep;48(9):1721-7. Comment in:Leuk Lymphoma. 2007 Sep;48(9):1667-9. Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans. Picardi M, De Renzo A, Pane F, Nicolai E, Pacelli R, Salvatore M, Rotoli B.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28063
    Study title: Lung Cancer. 2004 May;44(2):175-81. FDG-PET in staging lung cancer: how does it change the algorithm? Verhagen AF, Bootsma GP, Tjan-Heijnen VC, van der Wilt GJ, Cox AL, Brouwer MH, Corstens FH, Oyen WJ.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28127
    Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF A SINGLE 400 MG ORAL/IV DOSE OF FLUCONAZOLE IN PATIENTS SUFFERING FROM CANDIDAL ESOPHAGITIS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27759
    Study title: TO EVALUATE THE PHARMACOKINETIC PARAMETERS AFTER IV FLUCONAZOLE IN PATIENTS WITH EITHER 1. AIDS WITHOUT LIVER DISEASE OR 2. LIVER CIRRHOSIS OR SEVERE HEPATIC DISEASE IN COMPARISON WITH HEALTHY SUBJECTS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27427
    Study title: TO EVALUATE THE PHARMACOKINETIC PARAMETERS AFTER IV FLUCONAZOLE IN PATIENTS WITH EITHER 1. AIDS WITHOUT LIVER DISEASE OR 2. LIVER CIRRHOSIS OR SEVERE HEPATIC DISEASE IN COMPARISON WITH HEALTHY SUBJECTS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27792
    Study title: TO EVALUATE THE SAFETY AND EFFICACY OF FLUCONAZOLE CAPSULES VS. NYSTATIN SUSPENSION IN THE PREVENTION OF CANDIDIASIS IN LEUKEMIC PATIENTS UNDERGOING CHEMOTHERAPY.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27593
    Study title: TO EVALUATE THE SAFETY AND EFFICACY OF FLUCONAZOLE CAPSULES VS. NYSTATIN SUSPENSION IN THE PREVENTION OF CANDIDIASIS IN LEUKEMIC PATIENTS UNDERGOING CHEMOTHERAPY.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27956
    Study title: TO GATHER ADDITIONAL DATA ON THE SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS CRYPTOCOCCAL MENINGITIS. TO MAKE FLUCONAZOLE AVAILABLE FOR USE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO IN THE INVESTIGATOR JUDGEMENT WOULD BENEFIT FROM TREATMENT WITH THIS AGENT
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27594
    Study title: TO GATHER ADDITIONAL DATA ON THE SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS CRYPTOCOCCAL MENINGITIS. TO MAKE FLUCONAZOLE AVAILABLE FOR USE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO IN THE INVESTIGATOR JUDGEMENT WOULD BENEFIT FROM TREATMENT WITH THIS AGENT
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27957
    Study title: TO INVESTIGATE THE SAFETY AND EFFICACY OF A SINGLE ORAL DOSE OF FCA 150 MG CAPS FOR THE TX OF WOMEN WITH VAGINAL CANDIDIASIS
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27683
    Study title: Warts in children: Treatment with 5-fluorouracil 5% cream and other painless alternatives. Cunningham B.B. Cosmetic Dermatology ( Cosmet. Dermatol. ) (United States) , May 1, 2004 , 17/5 SUPPL. 1 (9-12) Warts in children: Treatment with 5-fluorouracil 5% cream and other painless alternatives. Cunningham B.B. Cosmetic Dermatology ( Cosmet. Dermatol. ) (United States) , May 1, 2004 , 17/5 SUPPL. 1 (9-12)
    Active substance: FLUOROURACIL
    Study summary document link (including results):
    View full study record
    Document reference: 28262
    Study title: Young patient trabeculectomy: Assessment of risk factors for failure. Sturmer J. Ophthalmology. June 18, 1993, 928-39
    Active substance: FLUOROURACIL
    Study summary document link (including results):
    View full study record
    Document reference: 28292
    Study title: A Double-Blind Placebo-Controlled Study of Fluoxetine and Clomipramine in the Treatment of Panic Disorder
    Active substance: FLUOXETINE
    Study summary document link (including results): Fluoxetine - B1Y-EW-HCHQ Synopsis.pdf
    View full study record
    Document reference: 28335
    Study title: Discontinuation Of Fluoxetine In Ocd
    Active substance: FLUOXETINE
    Study summary document link (including results): Fluoxetine - B1Y-SZ-IS38 Synopsis.pdf
    View full study record
    Document reference: 28331
    Study title: "Fluox20mg V Fluox40mg V Clomip75mg Out Pt. Maj. Depression
    Active substance: FLUOXETINE
    Study summary document link (including results):
    View full study record
    Document reference: 28339
    Study title: Fluoxetine hydrocloride with enteric cover
    Active substance: FLUOXETINE
    Study summary document link (including results):
    View full study record
    Document reference: 28342
    Study title: A comparison of Fucidin tablets and Flucloxacillin in skin and soft-tissue infections
    Active substance: FUSIDIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 28694
    Study title: Open clinical study to evaluate the reactogenicity of SmithKline Beecham Biologicals' Hib conjugate vaccine mixed with SmithKline Beecham Biologicals' DTPa vaccine when given as a booster dose to children at 15 to 18 months of age, previously primed with SB Bio's Hib tetanus conjugate and DTPa vaccines in study HIB-012.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41133
    Study title: Open label, randomised comparative assessment of the immunogenicity and reactogenicity of SmithKline Beecham's (SB's) diphteria/tetanus/acellular pertussis (DTPa) vaccine and SB's Hib with commercially available diphtheria/tetanus/whole cell pertussis (DTPw) and SB's Hib. Vaccines to be combined in the same syringe and administered to healthy infants as three consecutive doses at 2, 3 and 4 months of age.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41137
    Study title: Open randomised clinical study to evaluate the immunogenicity and reactogenicity of SB Biologicals' Hib tetanus conjugate vaccine, co-administered with SB Biologicals' DTPa vaccine either mixed in one syringe, or in two separate injections into opposite limbs, to healthy children around two years of age.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41141
    Study title: Open study to assess the immunogenicity and reactogenicity of a three-dose primary vaccination course against Haemophilus influenzae type b, diphtheria, tetanus, pertussis and hepatitis B in healthy infants at 6, 10 and 14 weeks of age.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41155
    Study title: Open, phase II clinical trial to assess long-term antibody persistence, before Td booster vaccination, in healthy children 5 to 6 years old, previously vaccinated with 4 doses of SB Biologicals¿ DTPa vaccine mixed with SB Biologicals¿ Hib conjugate vaccine in primary vaccination study Hib-006 (208108/005) and in booster vaccination study Hib-017 (208108/017).
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41156
    Study title: Kokki H. et al.: Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in Children;PEDIATRICS Volume 120, Number 4, October 2007.
    Active substance: IBUPROFEN
    Study summary document link (including results):
    View full study record
    Document reference: 29545
    Study title: The influence of locally implanted high doses of gentamicin on hearing and renal function of newborns treated for acute hematogenous osteomyelitis.The influence of locally implanted high doses of gentamicin on hearing and renal function of newborns treated for acute hematogenous osteomyelitis.
    Active substance: GENTAMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 28886
    Study title: A phase IIb randomised, multi-site clinical study to assess the immunogenicity and reactogenicity of formulation B of SB Biologicals¿ Hib conjugate vaccine administered mixed as single injection with SB Biologicals¿ DTPa vaccine versus formulation A of SB Biologicals¿ Hib conjugate vaccine administered either mixed as single injection or separately into opposite thighs with SB Biologicals¿ DTPa vaccine as a three-dose primary vaccination course in healthy infants at 3, 4, and 5 months of age.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41147
    Study title: A post-marketing surveillance study of GlaxoSmithKline Biologicals¿ Haemophilus influenzae type b (Hib) tetanus conjugate vaccine in 3,000 Filipino subjects. Phase IV single-blind randomised study to assess the feasibility of syringe mixing of combined diphtheria, tetanus, whole cell Bordetella pertussis (DTPw) vaccine and Haemophilus influenzae type b (Hib) conjugate vaccine as a three dose primary vaccination course in healthy infants.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41151
    Study title: An open multicentric post marketing surveillance study of SmithKline Beecham haemophilus influenzae type B tetanus conjugate vaccine-Hiberix- administered according to local recommendations in infants and children up to the age of 5 years. Only Korean version-English title to be provided.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41157
    Study title: An open, parallel, randomised clinical study to assess the reactogenicity of SB Biologicals¿ Hib conjugate vaccine mixed with SB Biologicals¿ DTPa vaccine in comparison to the Pasteur-Mérieux´s Hib conjugate vaccine mixed with Pasteur-Mérieux´s DTPw vaccine as a booster vaccination to healthy children at 15 to 20 months, previously primed with three doses of commercially available DTPw and Hib conjugate vaccines.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41154
    Study title: An open, parallel, randomized clinical study to assess the reactogenicity of SmithKline Beecham (SB) Biologicals¿ Hib conjugate vaccine mixed with SB Biologicals¿ DTPa vaccine in comparison to Pasteur-Mérieux Connaught¿s (PMC) Hib conjugate vaccine mixed with PMCs¿ DTPw vaccine, as a three-dose primary vaccination course to healthy infants at 2, 4 and 6 months of age.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41153
    Study title: An open, randomised clinical study to assess the reactogenicity of SB Biologicals¿ Hib conjugate vaccine administered mixed as single injection with SB Biologicals¿ DTPa vaccine in comparison to commercially available Hib conjugate vaccine and DTPw vaccine administered separately into opposite limbs as a booster vaccination in healthy infants at 18 months of age, previously primed with three doses of DTPw and Hib conjugate vaccines.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41149
    Study title: Dadamyan Z.S. Aflubin in the treatment and prophylaxis of influenza and other ARVIs in children, Moscow
    Active substance: Gentiana D1, Aconitum D6, Bryonia D6, Ferrum phosphoricum D12, Acidum sarcolacticum D12
    Study summary document link (including results):
    View full study record
    Document reference: 40008
    Study title: Petukhova Z.N., Yablonskaya L.V., Burakhova S.V. Clinical effectiveness of Aflubin in the treatment of ARVI and influenza in children with joint diseases, Novosibirsk
    Active substance: Gentiana D1, Aconitum D6, Bryonia D6, Ferrum phosphoricum D12, Acidum sarcolacticum D12
    Study summary document link (including results):
    View full study record
    Document reference: 40011
    Study title: Sitnikow I., Kisseljow W., Fjodeorow W., Alexandrowa E., Kremnowa N., Sitnikowa E., Marenko E. The pathogenic mechanisms of Aflubin in children with ARVI, Jaroslawl, 1999
    Active substance: Gentiana D1, Aconitum D6, Bryonia D6, Ferrum phosphoricum D12, Acidum sarcolacticum D12
    Study summary document link (including results):
    View full study record
    Document reference: 40010
    Study title: Utschajkin W.F., Charlamowa F.S., Sawenkowa M.S., Afanassjewa A.A. Aflubin in the treatment of ARVI associated with stenosing laryngotracheitis in children, Moscow, 2000
    Active substance: Gentiana D1, Aconitum D6, Bryonia D6, Ferrum phosphoricum D12, Acidum sarcolacticum D12
    Study summary document link (including results):
    View full study record
    Document reference: 40009
    Study title: An open, randomised post-marketing clinical trial to assess the safety and reactogenicity of GlaxoSmithKline Biologicals¿ Haemophilus influenzae type b (Hib) tetanus conjugate vaccine (Hiberix¿) co-administered with Chinese local DTPw vaccine when compared to Chinese local DTPw vaccine administered alone, in healthy infants at 3, 4 and 5 months of age.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41128
    Study title: Clinical study to assess the immunogenicity and reactogenicity of a booster dose of formulation B of SB Biologicals¿ Hib conjugate vaccine administered either mixed as a single injection or separate into opposite sites with SB Biologicals¿ DTPa vaccine, or formulation A of SB Biologicals¿ Hib conjugate vaccine separately into opposite sites with SB Biologicals¿ DTPa vaccine at 13 months of age in infants primed in study 208108/032 (Hib-032).
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41150
    Study title: Clinical study to assess the immunological memory induced by a primary course using different formulations of Hib conjugate vaccines in several combinations with acellular pertussis vaccines by giving one dose of unconjugated PRP co-administered with SB Biologicals¿ DTPa-HBV combined vaccine at 12-24 months of age in infants primed in study DTPa-HBV-037.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41146
    Study title: Open, randomised, clinical study to evaluate the interference on the immunogenicity of vaccine antigens, when Haemophilus influenzae type b tetanus conjugate and combined diphtheria, tetanus, acellular pertussis vaccines are co-administered, either in one single or two separate injections as a primary vaccination course to healthy infants at 2, 4 and 6 months of age.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41136
    Study title: Open, randomized clinical study of the immunogenicity and reactogenicity of the SB Biologicals¿ DTPa and Hib conjugate vaccines, either mixed in one syringe or given in two separate injections, to healthy infants at the age of 2, 4, 6 and 18 months, or the administration of a dose of plain PRP at the age of 12 months in infants primed with Hib conjugate vaccine.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41135
    Study title: Phase II open randomized primary vaccination study to assess the immunogenicity and reactogenicity of GlaxoSmithKline Biologicals (GSK) Haemophilus influenzae type b (Hib) conjugate vaccine administered either mixed or in two separated injections with commercially available DTPw vaccine (Government Pharmaceutical Organization: GPO) as compared to GSK Biologicals¿ Hib administered mixed with GSK Biologicals¿ DTPw vaccine in healthy infants, aged 2, 4 and 6 months.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41158
    Study title: Phase IV primary vaccination study to assess the immunogenicity and reactogenicity of concomitant administration of Haemophilus influenzae type b (Hib) vaccine with either diphtheria-tetanus-whole cell pertussis vaccine and hepatitis B vaccine or with quadrivalent diphtheria-tetanus-whole cell pertussis-hepatitis B vaccine
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41152
    Study title: Kraemer C. und Evers S.: Eine randomisierte, doppelblinde, placebokontrollierte, Crossover Studie zur Wirksamkeit von Ibuprofen und Zolmitriptan akuten Migräneattacke bei Kindern; Neurology 2006;67;497-499; original published online Jun 14, 2006. Lewis D. et al.: Children`s Ibuprofen Suspension for the Acute Treatment of Pediatirc Migraine; Headache September 2002. pp:780-786.St. Charles CS et al.: A comparison of ibuprofen versus acetaminophen with codein in the young tonsillectomy. PubMed. Bennie RE et al.: Postoperative analgesia with preoperative oral ibuprofen or acetaminophen in children undergoing myringotomy. PubMed. Kokki H. et al.: Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in Children;PEDIATRICS Volume 120, Number 4, October 2007. Clark E....
    Active substance: IBUPROFEN
    Study summary document link (including results):
    View full study record
    Document reference: 29609
    Study title: A PHASE IV RANDOMIZED STUDY OF THE USE OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY VERSUS EPISODIC THERAPY IN HIV POSITIVE SUBJECTS WITH RECURRENT OROPHARYNGEAL CANDIDIASIS.
    Active substance: FOSPHENYTOIN
    Study summary document link (including results):
    View full study record
    Document reference: 28603
    Study title: A RANDOMIZED, DOUBLE-BLIND COMPARATIVE MULTICENTER STUDY OF FLUCONAZOLE PLUS AMPHOTERICIN B VERSUS FLUCONAZOLE PLUS PLACEBO IN THE TREATMENT OF CANDIDEMIA AND ITS CONSEQUENCES IN NON-NEUTROPENIC PATIENTS
    Active substance: FOSPHENYTOIN
    Study summary document link (including results):
    View full study record
    Document reference: 28602
    Study title: PILOT STUDY TO DETERMINE THE FEASIBILITY OF FLUCONAZOLE FOR INDUCTION TREATMENT AND SUPPRESSION OF RELAPSE OF HISTOPLASMOSIS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME
    Active substance: FOSPHENYTOIN
    Study summary document link (including results):
    View full study record
    Document reference: 28601
    Study title: Double-blind, randomised clinical study to evaluate the consistency of the immunogenicity and reactogenicity of three consecutive production lots of SB Biologicals¿ Hib formulation B vaccine, co-administered with SB Biologicals¿ DTPa vaccine into opposite limbs, and in comparison to the SB Biologicals¿ Hib formulation A vaccine co-administered with SB Biologicals¿ DTPa vaccine into opposite limbs, as a primary vaccination course to healthy infants at 3, 4 and 5 months of age.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41140
    Study title: Double-blind, randomised clinical study to evaluate the immunogenicity and reactogenicity of four different lots of SB Biologicals' Hib vaccine co-administered with SB Biologicals¿ DTPa vaccine into opposite limbs, as a primary vaccination course to healthy infants at the age of 3, 4½ and 6 months.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41138
    Study title: Double-blind, randomised, comparative, multicentre, clinical study to assess the immunogenicity and reactogenicity of three lots of SmithKline Beecham Biologicals' Haemophilus influenzae type b (Hib) tetanus conjugate vaccine when administered simultaneously with SmithKline Beecham Biologicals' tricomponent DTPa vaccine, reconstituted in one single injection, as a primary vaccination course in healthy infants at the age of 3 and 5 months (referred to in this report as Hib-10).
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41131
    Study title: Open clinical study to assess the immunogenicity and reactogenicity of a booster dose of formulation B of SB Biologicals¿ Hib conjugate vaccine mixed with SB Biologicals¿ DTPa vaccine as a single injection at 12 or 15-18 months of age in healthy children primed with SB Biologicals¿ Hib conjugate vaccines co-administrated with DTPa-HBV vaccine in study DTPa-HBV-038
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41144
    Study title: Open clinical study to assess the immunogenicity and reactogenicity of a dose of SB Biologicals¿ plain PRP vaccine at 12 months of age followed by SB Biologicals¿ DTPa-HBV vaccine at 15 to 18 months of age in children primed with a new formulation of SB Biologicals¿ Hib conjugate vaccine mixed with DTPa-HBV combined vaccine as a single injection (group 5 of study DTPa-HBV-023).
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41143
    Study title: Open clinical study to assess the safety of SmithKline Beecham Biologicals' Haemophilus influenzae type b conjugate vaccine mixed with SmithKline Beecham Biologicals' diphtheria, tetanus, tricomponent acellular pertussis vaccine and administered in one single injection, given as a primary vaccination course to healthy infants at 3, 4 and 5 months of age.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41132
    Study title: Open clinical study to evaluate persistence of antibodies induced by a primary vaccination course using SmithKline Beecham Biologicals¿ Hib vaccine mixed with SmithKline Beecham Biologicals' DTPa vaccine, and to assess immunogenicity and reactogenicity of a booster dose of the same vaccines at 15-20 months of age (referred to in this report as Hib-21).
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41134
    Study title: Open clinical study to evaluate the immunogenicity and reactogenicity of SB Biologicals' Hib vaccine, co-administered with routine DTPw vaccine into opposite limbs, as a primary vaccination course to healthy infants at the age of 2, 4 and 6 months.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41142
    Study title: Open clinical study to evaluate the priming, in terms of antibody persistence and immunological memory, induced by the administration of SB Biologicals¿ Hib conjugate vaccine administered with DTPa-HBV vaccine in study DTPa-HBV-039 and to evaluate the immunogenicity and reactogenicity of a booster dose of SB Biologicals¿ Hib conjugate vaccine when administered mixed with DTPa-HBV combined vaccine.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41145
    Study title: Open clinical study to evaluate the priming, in terms of antibody persistence and immunological memory, induced by the administration of SB Biologicals¿ Hib conjugate vaccine administered with DTPa-HBV vaccine in study DTPa-HBV-043 and to evaluate the immunogenicity and reactogenicity of a booster dose of SB Biologicals¿ Hib conjugate vaccine when administered either mixed or separately with DTPa-HBV combined vaccine.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41148
    Study title: A multi-centre, randomised, double-blind, double-dummy, parallel-group study to determine the clinical equivalence between fluticasone propionate 50μg twice daily delivered via a multidose powder inhaler (MDPI) and the Diskhaler™ in children aged 4-11 years with reversible airways disease
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FMDT01-ICHE3.pdf
    View full study record
    Document reference: 28432
    Study title: A multi-centre, randomised, double-blind, parallel group study to validate the changes in tidal breathing lung function parameters versus FEV1 and PD20 assessments due to anti-inflammatory treatment in 5 to 10 years old mild to moderately symptomatic children with asthma. Extensive searching has revealed that no clinical report is available for this study. The clinical trial results were reported via publications; see citation below.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FMS30002-ICHE3.pdf
    View full study record
    Document reference: 28397
    Study title: A Multi-centre, Randomised, Parallel-Group, Open-Label Study to Assess the Long-Term Safety (Including Growth) of Fluticasone Propionate 100mcg bd via the Metered-Dose Inhaler and BabyhalerTM Spacer Device Compared With Sodium Cromoglycate 5mg qds Delivered via Metered Dose Inhaler and NebuhalerTM Spacer Device in Children aged 12-47 Months With Documented Evidence of Recurrent/Persistent Asthma-Like Symptoms over a 52-Week Treatment Period
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FAS30009-ICHE3.pdf
    View full study record
    Document reference: 28394
    Study title: A multicenter, randomized, double-blind, parallel group vehicle-controlled study of the efficacy and safety of fluticasone propionate lotion 0.05% applied once daily for four weeks in the treatment of adult and pediatric subjects with moderate to severe atopic dermatitis Report No. NI1999/00008/00
    Active substance: FLUTICASONE
    Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FPL30003.pdf
    View full study record
    Document reference: 45116
    Study title: A multicentre, blinded, parallel group, randomized study to compare the efficacy and tolerability of nebulised Fluticasone propionate 0.25mg administered twice daily versus nebulised Budesonide 0.5mg administered twice daily in children with mild asthma..
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FLIC12-ICHE3.pdf
    View full study record
    Document reference: 28419
    Study title: A multicentre, randomised, double-blind, parallel group clinical trial to determine the safety and efficacy of nebulised fluticasone propionate 1mg twice daily compared with oral soluble prednisolone administered for 7 days to children aged 4 to 16 years with an acute asthma exacerbation.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FLTB3002-ICHE3.pdf
    View full study record
    Document reference: 28420
    Study title: A multicentre, randomised, double-blinded, parallel-group comparison of the efficacy and tolerability of fluticasone propionate 100mcg bid with nedocromil MDI 4mg bid in mild-moderate asthmatic children
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FLIC16-ICHE3.pdf
    View full study record
    Document reference: 28374
    Study title: A multiple-dose, open-label, 2-way crossover study in pediatric subjects with asthma aged 1 to < 4 years to compare the systemic exposure of fluticasone propionate 88mcg administered via the hydrofluoroalkane metered-dose inhaler using the valved holding chambers, Aerochamber Plus™ and Babyhaler™, with face-masks
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FAS10002-ICHE3.pdf
    View full study record
    Document reference: 28438
    Study title: A phase III multicentre, open, parallel-group, randomised study to compare the efficacy and tolerability of fluticasone propionate 50 micrograms bd via the Diskhaler™ with inhaled sodium cromoglycate (Intal) 20 milligrams qds via the Spinhaler in asthmatic children with a clinic requirement for inhaled prophylactic therapy.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FLUPD-AH90-N081-ICHE3.pdf
    View full study record
    Document reference: 28383
    Study title: A phase III, randomised, double-blind, parallel group study to compare the efficacy of inhaled fluticasone propionate 100μg given once daily and fluticasone propionate 50μg given twice daily, both delivered via the multi-dose powder inhaler, in children aged 4–16 years with mild to moderate, stable asthma.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FLTB3049-ICHE3.pdf
    View full study record
    Document reference: 28379
    Study title: Summary of the efficacy and safety and safety of salmeterol 50mcg and fluticasone propionate 100mcg administered in Diskus Dry Powder Inhaler twice daily in steroid experienced children with reversible airways obstruction
    Active substance: FLUTICASONE AND SALMETEROL
    Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAM40121-ICHE3.pdf
    View full study record
    Document reference: 28449
    Study title: A prospective dose titration study of the efficay and safety (fluvastatin sodium) in the treatment of children with heterozygous familial hypercholesterolemia
    Active substance: FLUVASTATIN
    Study summary document link (including results):
    View full study record
    Document reference: 28455
    Study title: "Open label, phase III, dose titration, multicenter study to assess the efficacy and safety of fluvastatin sodium capsules and fluvastatin sodium extended-release tablets (20, 40 and 80 mg) given orally at bedtime for 114 weeks in pediatric patiens with heterozygous familial hypercholesterolemia"
    Active substance: FLUVASTATIN
    Study summary document link (including results):
    View full study record
    Document reference: 28456
    Study title: Fluvoxamine for Children and Adolescents With Obsessive-Compulsive Disorder: A Randomized, Controlled, Multicenter Trial.(Statistical Data Included) Article from: Journal of the American Academy of Child and Adolescent Psychiatry,2001 | RIDDLE, MARK A.; REEVE, ELIZABETH A.; YARYURA-TOBIAS,JOSE A.; YANG, HWA MING; CLAGHORN, JAMES L.; GAFFNEY, GARY; GREIST,JOHN H.; HOLLAND, DONNA; McCONVILLE, BRIAN J.; PIGOTT, TERESA; WALKUP, JOHN T.
    Active substance: FLUVOXAMINE
    Study summary document link (including results): Bayer Pharma_Fluvoxamine Maleate_Riddle MA_2001_publication.pdf
    View full study record
    Document reference: 28457
    Study title: FLUVOXAMINE IN THE TREATMENT OF OBSESSIVE COMPULSIVE DISORDER: A MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED STUDY IN OUTPATIENT CHILDREN AND ADOLESCENTS
    Active substance: FLUVOXAMINE
    Study summary document link (including results): Fluvoxamine-RH.114.02.01.pdf
    View full study record
    Document reference: 47713
    Study title: Multiple-Dose Pharmacokinetics of Fluvoxamine in Children and Adolescents;J . AM. ACAD. CHILD ADOLESC. PSYCHIATRY, 43:12, DECEMBER 2004
    Active substance: FLUVOXAMINE
    Study summary document link (including results): A9R1546.pdf
    View full study record
    Document reference: 28458
    Study title: The Multiple-Dose Pharmacokinetics of Fluvoxamine in Children and Adolescents
    Active substance: FLUVOXAMINE
    Study summary document link (including results): Fluvoxamine-S114.1.102.pdf
    View full study record
    Document reference: 47714
    Study title: Randomised comparative assessment of the immunogenicity and reactogenicity of three different lots of SmithKline Beecham Biologicals' Haemophilus influenzae type b vaccine and the Pasteur/Mérieux Haemophilus influenzae type b vaccine. The vaccines were administered to healthy infants as a primary vaccination course of three consecutive doses at 2, 4 and 6 months of age.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41130
    Study title: Randomised, double-blind clinical study to evaluate and compare the immunogenicity and reactogenicity of a booster dose of two formulations of SB Biologicals' Hib conjugate vaccine, when administered mixed in one syringe with SB Biologicals' DTPa vaccine to healthy children in their 2nd year of life.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41139
    Study title: Placebo controlled randomised study of Haemophilus lnfluenzae type b capsular polysaccharide tetanus conjugate vaccine (PRP-T) associated with Diphtheria-Tetanus-Pertussis and Inactivated Poliomyelitis vaccine (DTP-IPV).
    Active substance: HaemophilusType b Vaccine Conjugated to Tetanus Protein
    Study summary document link (including results):
    View full study record
    Document reference: 47493
    Study title: Placebo controlled randomized study of Haemophilus influenzae type b capsular polysaccharide tetanus conjugate vaccine (PRP-T) combined with Diphtheria-Tetanus-Pertussis and Inactivated Poliomyelitis vaccine (DTP-IPV).
    Active substance: HaemophilusType b Vaccine Conjugated to Tetanus Protein
    Study summary document link (including results):
    View full study record
    Document reference: 47492
    Study title: McCoy KS, Castile RG, Allen ED, Filbrun DA, Flucke RL, Bar-Yishay E. Functional residual capacity (FRC) measurements by plethysmography and helium dilution in normal infants. Pediatric pulmonology. 1995;19(5):282-90.McCoy KS, Castile RG, Allen ED, Filbrun DA, Flucke RL, Bar-Yishay E. Functional residual capacity (FRC) measurements by plethysmography and helium dilution in normal infants. Pediatric pulmonology. 1995;19(5):282-90.
    Active substance: HELIUM AND OXYGEN
    Study summary document link (including results):
    View full study record
    Document reference: 29095
    Study title: Fucidin versus flucloxacillin in skin and soft tissue infection
    Active substance: FUSIDIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 28715
    Study title: DuRant RH, Dyken PR, Swift AV. J Pediatr Aug 1982;101(2):288-93 [Abstract]. The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitisDuRant RH, Dyken PR, Swift AV. J Pediatr Aug 1982;101(2):288-93 [Abstract]. The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitis
    Active substance: INOSINE
    Study summary document link (including results):
    View full study record
    Document reference: 30100
    Study title: Effect of topically applied fluorides in dental caries experiences on children residing in fluoride areas1951-Downs
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1951-Downs-Effect of topically applied fluorides in dental caries experiences on children residing in fluoride areas.pdf
    View full study record
    Document reference: 49131
    Study title: Enamel opacities in the incisors of school children in a community in the canton of ZurichSteiner 1984
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Steiner 1984 Enamel opacities in the incisors of school children.pdf
    View full study record
    Document reference: 49180
    Study title: Evaluation of a practise based preventative programme for adolescentsBlinkhorn et. al. Community Dent. Oral Epidemiol. 1981: 9: 275-279
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1981-blinkhorn-Evaluation of a Practice Basedpreventive programme for adolescents.pdf
    View full study record
    Document reference: 48771
    Study title: Fluoride - Ten year prospective study of deciduous and permanent dentitionFrederick J Margolis, Harold R Reames, Ernest Freshman, John C Macauley, Howard Mehaffey. Am J Dis Child - Vol 129. July 1975
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1975-margolis-Fluoride-tenyear prospective study of decidous and permanent dentition.pdf
    View full study record
    Document reference: 48768
    Study title: Fluoride absorption after the local applicationEinwag 1987
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Einwag 1987 Fluoride absorption after the local application.pdf
    View full study record
    Document reference: 49162
    Study title: Fluoride excretion in the urine of childrenFeuerle 1989
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Feuerle 1989 Fluoride excretion in the urine of children.pdf
    View full study record
    Document reference: 49164
    Study title: Fluoride level in surface enamelHotz 1987
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Hotz 1987 Fluoride level in surface enamel.pdf
    View full study record
    Document reference: 49168
    Study title: A functional magnetic resonance imaging study of the long-term influences of early indomethacin exposure on language processing in the brains of prematurely born children.
    Active substance: INDOMETHACIN
    Study summary document link (including results):
    View full study record
    Document reference: 29804
    Study title: Plasma and cerebrospinal fluid concentrations of indomethacin in children after intravenous administration.
    Active substance: INDOMETHACIN
    Study summary document link (including results):
    View full study record
    Document reference: 29985
    Study title: PROPHYLAXIS OF FUNGAL INFECTION WITH DIFLUCAN IN PATIENTS WITH COLLAGEN DISEASE ON THE LONG TERM, AND LARGE-DOSAGE STEROID THERAPY.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27865
    Study title: Prophylaxis, costs and effectiveness of gram positive therapy in neatropenic children
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27454
    Study title: Prophylaxis, costs and effectiveness of gram positive therapy in neatropenic children
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27818
    Study title: PROSPECTIVE COMPARATIVE TRIAL OF AMPHOTERICIN B VS. FCA IN NEONATAL SYSTEMIC FUNGAL INFECTIONS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27643
    Study title: PROSPECTIVE COMPARATIVE TRIAL OF AMPHOTERICIN B VS. FCA IN NEONATAL SYSTEMIC FUNGAL INFECTIONS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 28005
    Study title: PROSPECTIVE OPEN PILOT COMPARATIVE STUDY OF SAFETY & EFFICACY OF FCA PARENTERAL/ORAL VS STANDARD PROPHYLACTIC REGIMEN IN PREVENTION OF FUNGAL INFECTIONS IN PTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY OR IN PTS SUFFERING FROM APLASTIC ANEMIA
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27396
    Study title: PROSPECTIVE OPEN PILOT COMPARATIVE STUDY OF SAFETY & EFFICACY OF FCA PARENTERAL/ORAL VS STANDARD PROPHYLACTIC REGIMEN IN PREVENTION OF FUNGAL INFECTIONS IN PTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY OR IN PTS SUFFERING FROM APLASTIC ANEMIA
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27761
    Study title: RANDOMIZED CONTROLLED STUDY COMPARING ORAL FLUCONAZOLE TO TOPICAL CLOTRIMAZOLE IN THE TREATMENT OF VAGINAL CANDIDIASIS
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27648
    Study title: RANDOMIZED CONTROLLED STUDY COMPARING ORAL FLUCONAZOLE TO TOPICAL CLOTRIMAZOLE IN THE TREATMENT OF VAGINAL CANDIDIASIS
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 28010
    Study title: RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF THE EFFICACY OF FLUCONAZOLE PARENTERAL/ORAL IN THE PREVENTION OF FUNGAL INFECTIONS IN PATIENTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML).
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27397
    Study title: RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF THE EFFICACY OF FLUCONAZOLE PARENTERAL/ORAL IN THE PREVENTION OF FUNGAL INFECTIONS IN PATIENTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML).
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27762
    Study title: RETROSPECTIVE CONTROLLED ANALYSIS OF FLUCONAZOLE PROPHYLAXIS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27619
    Study title: RETROSPECTIVE CONTROLLED ANALYSIS OF FLUCONAZOLE PROPHYLAXIS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27981
    Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN CRYPTOCOCCAL MENINGITIS IN PATIENTS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27677
    Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN CRYPTOCOCCAL MENINGITIS IN PATIENTS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 28039
    Study title: A phase III double-blind, randomized, multicentric, comparative vaccination study of the immunogenicity and reactogenicity of a thiomersal-free formulation of Influsplit SSW® 2003/2004 versus the standard formulation of Influsplit SSW® 2003/2004 in children aged from 6 months to <6 years.
    Active substance: Influenza Vaccine (Split Virion, Inactivated)
    Study summary document link (including results): 100351 (FLU-056) synopsis.pdf
    View full study record
    Document reference: 48371
    Study title: A phase III, open-label, multi-centre study to evaluate the safety, tolerability an immunogenicity of CSL´s influenza vaccine in two paediatric populations, Group A (≥ 6 month to ≥ 3 years) and Group B (≥ 3 years to < 9 years).
    Active substance: Influenza Vaccine (Split Virion, Inactivated)
    Study summary document link (including results):
    View full study record
    Document reference: 47149
    Study title: A phase III, open-label, multi-centre study to evaluate the safety, tolerability and immunogenicity of CSL´s influenza vaccine in two paediatric populations, Group A (≥ 6 month to ≥ 3 years) and Group B (≥ 3 years to < 9 years).
    Active substance: Influenza Vaccine (Split Virion, Inactivated)
    Study summary document link (including results):
    View full study record
    Document reference: 47150
    Study title: Concomitant administration of a Haemophilus influenzae type b - Hepatitis b vaccine with a diphtheria, tetanus, acellular pertussis, inactivated polio combination vaccine in healthy infants
    Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32)
    Study summary document link (including results):
    View full study record
    Document reference: 41191
    Study title: Diminution of the anti-polyribosylribito phosphate response to a combined diphtheria-tetanus-acellular pertussis/Haemophilus influenzae Type b vaccine by concurrent inactivated poliovirus vaccination
    Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32)
    Study summary document link (including results):
    View full study record
    Document reference: 41205
    Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN LIFE THREATENING DEEP MYCOSES
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27674
    Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN LIFE THREATENING DEEP MYCOSES
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 28036
    Study title: A phase IV, open study to evaluate the reactogenicity and immunogenicity of SmithKline Beecham Biologicals' influenza split vaccine in children aged 6-36 months
    Active substance: Influenza Vaccine (Split Virion, Inactivated)
    Study summary document link (including results): 218352-003 (FLUARIX-003) synopsis.pdf
    View full study record
    Document reference: 48372
    Study title: Clinical Analysis of Influsplit SSW® 94 1 Fluarix in children of the ages of 3-6 years
    Active substance: Influenza Vaccine (Split Virion, Inactivated)
    Study summary document link (including results): Influ 02 94 _Synopsis.pdf
    View full study record
    Document reference: 48375
    Study title: Clinical Trial of the Reactogenicity and Immunogenicity of INFLUSPLIT SSW®92 in children aged from 1 to 4 years
    Active substance: Influenza Vaccine (Split Virion, Inactivated)
    Study summary document link (including results): INFLU 03 92 INFLU 04 92 synopsis.pdf
    View full study record
    Document reference: 48376
    Study title: Open immunization study to determine the reactogenicity and immunogenicity of Influsplit SSW® 2000/2001 in children aged from 6 month to <6 years
    Active substance: Influenza Vaccine (Split Virion, Inactivated)
    Study summary document link (including results): 218352-044 (Influ 03-2000) synopsis.pdf
    View full study record
    Document reference: 48374
    Study title: Open immunization study to determine the reactogenicity and immunogenicity of Influsplit SSW® 98/99 in children upon completion of 6 month of live till completion of 18 years
    Active substance: Influenza Vaccine (Split Virion, Inactivated)
    Study summary document link (including results): 218352-031 (Influ 02-98) synopsis.pdf
    View full study record
    Document reference: 48373
    Study title: A Randomized, Endpoint-blind, Parallel Group Study to Demonstrate the Non-inferiority of the Subunit Influenza Vaccine Influvac® to the Subunit Influenza Vaccine Agrippal® in Healthy Children, Adults and Elderly in China
    Active substance: influenza vaccine (subunit, inactivated)
    Study summary document link (including results):
    View full study record
    Document reference: 47501
    Study title: Reactogenicity and Immunogenicity of InfluvacR in high-risk children between 6 months and 4 years of age.
    Active substance: influenza vaccine (subunit, inactivated)
    Study summary document link (including results):
    View full study record
    Document reference: 47502
    Study title: Factors influencing successful closure with indomethacin of the patent ductus arteriosus in premature infants.
    Active substance: INDOMETHACIN
    Study summary document link (including results):
    View full study record
    Document reference: 29903
    Study title: Flurbiprofen in the treatment of ankylosing spondylitis. A comparison with indomethacin.
    Active substance: INDOMETHACIN
    Study summary document link (including results):
    View full study record
    Document reference: 29905
    Study title: High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus.
    Active substance: INDOMETHACIN
    Study summary document link (including results):
    View full study record
    Document reference: 29909
    Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH NON-LIFE THREATENING MYCOSIS WHO CANNOT BE TREATED ADEQUATELY TREATED WITH AVAILABLE AGENTS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27676
    Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH NON-LIFE THREATENING MYCOSIS WHO CANNOT BE TREATED ADEQUATELY TREATED WITH AVAILABLE AGENTS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 28038
    Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN CANCER PATIENTS WITH OROPHARYNGEAL AND OESOPHAGEAL CANDIDIASIS
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27651
    Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN CANCER PATIENTS WITH OROPHARYNGEAL AND OESOPHAGEAL CANDIDIASIS
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 28013
    Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE THREATENING DEEP MYCOSES.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27675
    Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE THREATENING DEEP MYCOSES.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 28037
    Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE-THREATENING DEEP MYCOSES, WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27449
    Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE-THREATENING DEEP MYCOSES, WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27813
    Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27426
    Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27791
    Study title: SAFETY AND EFFICACY OF FLUCONAZOLE PO VS. AMPHOTERICIN B SUSPENSION IN PREVENTION OF CANDIDIASIS IN LEUKEMIC PATIENTS UNDERGOING CHEMOTHERAPY.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27961
    Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH GASTRO-INTESTINAL CANDIDIASIS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27419
    Study title: Fluoride tablets in prevention of tooth decayG. Stolte, Aus dem Gesundheitsamt der Stadt SolingenM.Hoskova 1968. Ceskoslovenska pediatrie praha
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1968-hoscowa-Fluoride tablets in prevertion od tooth decay.pdf
    View full study record
    Document reference: 48784
    Study title: Fluoride toothpastes for preventing dental caries in children and adolescents2009-marinho, the cochrane collaboration
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 2009-marinho-fluoride toothpastes for preventing dental caries in children and adolescents.pdf
    View full study record
    Document reference: 49091
    Study title: Schöneberger Einfluß der immunstimulierenden Wirkung von Preßsaft aus Herba Echinaceae purpureae auf Verlauf und Schweregrad von Erkältungskrankheiten (EC31J0.05)Z. für Immunbiologie in der Praxis, 2 (8), 1992, 18-22
    Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1, 85 %
    Study summary document link (including results):
    View full study record
    Document reference: 39721
    Study title: Fluoride tablets in pre-school age - effect on primary and permanent teethRoland Andersson, Hans Grahnen. Swed Dent J69 137 - 143
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1969-anderesson-Fluoride Tablets in Preschool Age - Effect on Primary and Permanent Teeth.pdf
    View full study record
    Document reference: 48767
    Study title: Evaluation of safety and immunogenicity of inactivated flu vaccine in children with underlying disease
    Active substance: INACTIVATED INFLUENZA SPLIT VIRION VACCINE (TRITON X 100)
    Study summary document link (including results):
    View full study record
    Document reference: 41289
    Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 3 to 8 years
    Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100)
    Study summary document link (including results):
    View full study record
    Document reference: 41221
    Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 3 to 8 years
    Active substance: INACTIVATED INFLUENZA SPLIT VIRION VACCINE (TRITON X 100)
    Study summary document link (including results):
    View full study record
    Document reference: 41290
    Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 6 to 35 months
    Active substance: INACTIVATED INFLUENZA SPLIT VIRION VACCINE (TRITON X 100)
    Study summary document link (including results):
    View full study record
    Document reference: 41291
    Study title: Evaluation of safety and immunogenicity of inactivated flu vaccine in children with underlying disease
    Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal
    Study summary document link (including results):
    View full study record
    Document reference: 41217
    Study title: Comparison between fluproquazone and indomethacin in treatment of primary dysmenorrhoea.
    Active substance: INDOMETHACIN
    Study summary document link (including results):
    View full study record
    Document reference: 29843
    Study title: Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children, 2002
    Active substance: HYPERTONIC SOLUTIONS
    Study summary document link (including results):
    View full study record
    Document reference: 29378
    Study title: Reduced Advanced Glycation Endproduct (AGE) Levels in Children on Automated Peritoneal Dialysis (PD) with PD-Fluids Containing Less Glucose Degradation Products (GDPs), 2003
    Active substance: HYPERTONIC SOLUTIONS
    Study summary document link (including results):
    View full study record
    Document reference: 29379
    Study title: Immunogenicity and safety of P.M.sv, inactivated split influenza vaccine in children between 6 months and 3 years old
    Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal
    Study summary document link (including results):
    View full study record
    Document reference: 41477
    Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 3 to 8 years
    Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal
    Study summary document link (including results):
    View full study record
    Document reference: 41474
    Study title: Immunogenicity and tolerability of the Aventis Pasteur inactivated flu vaccine (IMOVAX GRIPE) in high risk and healthy children aged from 6 to 35 months
    Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal
    Study summary document link (including results):
    View full study record
    Document reference: 41476
    Study title: Safety of inactivated split-virion influenza vaccine administered by the intradermal route in healthy children
    Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal
    Study summary document link (including results):
    View full study record
    Document reference: 45254
    Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 6 to 35 months
    Active substance: Inactivated Influenzae Split Virion Vaccine
    Study summary document link (including results):
    View full study record
    Document reference: 41475
    Study title: Large scale safety study of the DTacP-IPV {acellular TETRACOQ®) vaccine, administered in combination (one injection site) or in assocation two injection sites) with Haemophilus influenzae Type b vaccine (Act-HIB®) for primary and booster immunisation
    Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32)
    Study summary document link (including results):
    View full study record
    Document reference: 41203
    Study title: Randomised open trial of the safety and the immunogenicity of a combined dihtheria, tetanus, acellular pertussis and inactivated polio vaccine (DTacP-IPV) mixed with Haemophilus influenzae type b vaccine (Act-HIB®) given either at 3-5 and 12 or 2-4-6 and 13 months of age
    Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32)
    Study summary document link (including results):
    View full study record
    Document reference: 41190
    Study title: Safety and immunogenicity of a diphteria, tetanus, acellular pertussis, enhanced inactivated trivalent poliovirus vaccine administered separately or combined with Haemophilus influenzae type b vaccine, to healthy Chilean infants
    Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32)
    Study summary document link (including results):
    View full study record
    Document reference: 41188
    Study title: A Stratified, Multicenter, Randomized, Double-Blind, Parallel Group, 4-Week Comparison of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID versus Fluticasone Propionate DISKUS 100mcg in Pediatric and in Adolescent Subjects with Activity-Induced Bronchospasm. Report No. RM2005/00345/00
    Active substance: SALMETEROL
    Study summary document link (including results):
    View full study record
    Document reference: 35593
    Study title: Interaction between flurbiprofen and indomethacin in rheumatoid arthritis.
    Active substance: INDOMETHACIN
    Study summary document link (including results):
    View full study record
    Document reference: 29948
    Study title: Fluoride varnish for community based caries prevention in children1997-peterson
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1997-peterson-Fluoride varnish for community based caries prevention in children.pdf
    View full study record
    Document reference: 49124
    Study title: Fluoride varnish versus acidulated phosphate fluoride gel1995-seppa
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1995-seppa-Fluoride varnish versus acidulated phosphate fluoride gel.pdf
    View full study record
    Document reference: 49120
    Study title: Fluoride varnishes in caries prevention.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42420
    Study title: Double-blind cross-over comparison of flurbiprofen and indomethacin in osteoarthritis of the knee and hip
    Active substance: INDOMETHACIN
    Study summary document link (including results):
    View full study record
    Document reference: 29862
    Study title: Safety and immunogenicity of PMSV diphtheria, tetanus, acellular pertussis, polio (DTacP-IPV) vaccine given mixed or separately with Haemophilus influenzae type b (Act-HIB®) vaccine, as a primary series. Comparison of three lots of DTacP-IPV vaccine given combined or separately with Act-HIB®
    Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32)
    Study summary document link (including results):
    View full study record
    Document reference: 41189
    Study title: A double-blind cross-over study of niflumic acid and indomethacin in rheumatoid arthritis.
    Active substance: INDOMETHACIN
    Study summary document link (including results):
    View full study record
    Document reference: 29802
    Study title: Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children, 2002 Reduced Advanced Glycation Endproduct (AGE) Levels in Children on Automated Peritoneal Dialysis (PD) with PD-Fluids Containing Less Glucose Degradation Products (GDPs), 2003
    Active substance: ISOTONIC SOLUTIONS
    Study summary document link (including results):
    View full study record
    Document reference: 30758
    Study title: Duraphat varnish a 2 year clinical trial in 5 year old childeren1977-murray, Brit. Dental J
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1977-murray-Duraphat varnish a 2 year clinical trial in 5 year old childeren.pdf
    View full study record
    Document reference: 49103
    Study title: Effect of a partial substitution of invert sugar for surcose in combination with Duraphat treatment in caries development in pre-school children1991-frostell
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1991-frostell-Effect of a partial substitution of invert sugar for surcose in combination with Duraphat treatment in caries development in pre-scho...
    View full study record
    Document reference: 49116
    Study title: Effect of fluoride varnish (Duraphat) treatment every 6 months compared with weekly mouthrinsing with 02 percent NaF solution on dental caries1979-koch
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1979-koch-Effect of fluoride varnish (Duraphat) treatment every 6 months compared with weekly mouthrinsing with 02 percent NaF solution on dental c...
    View full study record
    Document reference: 49105
    Study title: Effect of topical applied stannous fluoride on dental caries experience children1955-Howell
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1955-Howell-Effect of topical applied stannous fluoride on dental caries experience children.pdf
    View full study record
    Document reference: 49132
    Study title: Procedure Guideline for Tumor Imaging Using Fluorine- 1 8-FDGJ Nucl Med 1998; 3&13&1305. Heinrich R. Schelbert, Carl K. Hoh, Henry D. Royal, Manuel Brown, Magnus N. Dahlbom, Farrokh Dehdashti and Richard L. Wahl
    Active substance: Steripet
    Study summary document link (including results): schelbert-1998.pdf
    View full study record
    Document reference: 48744
    Study title: The dental caries experience of 12 year old children in England and Wales2002-Pitts, Community Dental Health 2002 19, 46-53
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 2002-Pitts-the dental caries experience of 12 year old children in England and Wales.pdf
    View full study record
    Document reference: 49089
    Study title: The effect of a fluoride gel used for supervising toothbrushing 15 to 30 times per yearMarthaler 1970
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Marthaler 1970 The effect of a fluoride gel.pdf
    View full study record
    Document reference: 49172
    Study title: The effect on human dental caries of weekly oral rinsing with a sodium fluoride mouth wash duraphat rinse clinical1971-Horowitz
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1971-Horowitz-the effect on human dental caries of weekly oral rinsing with a sodium fluoride mouthwashduraphat rinse clinical.pdf
    View full study record
    Document reference: 49127
    Study title: The effects of aminfluoride on nibition of caries in pre-school children and school children in rijekaOstric 1977
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Ostric 1977 The effects of aminfluoride.pdf
    View full study record
    Document reference: 49173
    Study title: The rationale for the administration of a NaF tablet supplement during pregnancy and postnatally in a private practice setting.Frances B. Glenn 1981, Journal of Dentistry for Children
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1981-Glenn-The Rationale for the Administration od a NaF Tablet Supple,ment during Pregnancy and Postnatally in a private practice setting.pdf
    View full study record
    Document reference: 48778
    Study title: The reduction of dental caries through use of a sodium fluoride mouthwash1960-Weisz
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1960-Weisz-the reduction of deental caries through use of a sodium fluoride mouthwash.pdf
    View full study record
    Document reference: 49125
    Study title: The relative anticaries effectiveness of three fluoride-containing dentifrices in Puerto Rico2004-stookey, caries research
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 2004-stookey-the relative anticaries effectiveness of three fluoride-containing dentifrices in Puerto Rico.pdf
    View full study record
    Document reference: 49090
    Study title: The results of 3 year prophylaxis of caries through fluoride preparations in a solinger kindergarden G. Stolte, Aus dem Gesundheitsamt der Stadt Solingen
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1968-stolte-Ergebnisse dreijähriger Kariesprophylaxe durch orale Fluoridgaben in Solinger Kindergarten.pdf
    View full study record
    Document reference: 48783
    Study title: Use of fluorides by Finnish adolescentsHonkala ., Nyssonen V, Rimpela A, Scand J Dent Res 1984; 92: 517-23
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1984-honkala-Use of fluoride by finnish adolescents.pdf
    View full study record
    Document reference: 48769
    Study title: use of professionally administered flouride among Danish children1992-ambjerg
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1992-ambjerg-use of professionally administered flouride among Danish children.pdf
    View full study record
    Document reference: 49118
    Study title: Variation in caries prevalence related to combinations of dietary andoral hygiene habits and chewing fluoride tablets in 4 year old childrenLars-Eric Granath, Holger Rootzen, Elso Liljegren, Kerstin Hoist, Lennart Kohler 1978. Caries Res 12: 83-92
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1978-granath-Caries prevalence related to combinations of dietary and oral hygiene habits and chewing fluoride tablets in 4 years old children.pdf
    View full study record
    Document reference: 48781
    Study title:
    Active substance: LEFLUNOMIDE
    Study summary document link (including results):
    View full study record
    Document reference: 47352
    Study title: The superiority of topical application of stannous fluoride on primary teeth1957-McDonald
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1957-McDonald-the superiority of topical application of stannous fluoride on primary teeth.pdf
    View full study record
    Document reference: 49135
    Study title: The use of a sodium fluoride mouthwash in reducing the dental caries increment in eleven year old english school children1972-Brandt
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1972-Brandt-the use of a sodium fluoride mouthwash in reducing the dental caries increment in eleven year old english school children.pdf
    View full study record
    Document reference: 49128
    Study title: Three year report on caries prevention using I fluoride varnish for caries risk children in a community with fluoridated water1982-seppa
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1982-seppa-Three year report on caries prevention using I fluoride varnish for caries risk children in a community with fluoridated water.pdf
    View full study record
    Document reference: 49109
    Study title: Topical application of a fluoride protective varnish for caries prophylaxis1973-maiwald
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1973-maiwald-Topical application of a fluoride protective varnish for caries prophylaxis.pdf
    View full study record
    Document reference: 49101
    Study title: Trends in total caries experience2000-Brown
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 2000-Brown-trends in total caries experience.pdf
    View full study record
    Document reference: 49097
    Study title: Two-year clinical tests with different methods of local caries-preventive fluorine application in swedish school-children1965-Torell
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1965-Torell-two-year clinical tests with different methods of local caries-preventive fluorine application in swedish school-children.pdf
    View full study record
    Document reference: 49126
    Study title: Fluorine concentration in primary tooth enamel in 6 year olds after 3 years of daily intake of fluoride-containing tablets.J. Widenheim, Lars G Petersson, Goran Koch 1984, Swed Dent J
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1984-widenheim-Fluoide concentration in primary tooth enamel in 6 years oldy after 3 years of daily intake of fluoridecontaining tablets.pdf
    View full study record
    Document reference: 48777
    Study title: Fluroide in the prevention of caries in the pre-school childRugg 19990. J. Dent
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1990-Rugg_Gunn-Fluoride in the Prevention of Caries in the Pre-school Child.pdf
    View full study record
    Document reference: 48774
    Study title: Four year study of caries inhibition of intensive Duraphat application in 11-15 year old children1994-skold, Community Dent. Oral Epidemiol. 1994 22:18-24
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1994-skold-Four year study of caries inhibition of intensive Duraphat application in 11-15 year old children.pdf
    View full study record
    Document reference: 49119
    Study title: Gingival recession and wedge-shaped defects with regular use of an amine fluoride-containing gel applied with a toothbrushSchiffner 1995
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Schiffner 1995 Gingival recession and wedge-shaped.pdf
    View full study record
    Document reference: 49177
    Study title: High-fluoride toothpaste and no post-brushing water rinsing on enamel demineralization using an in-sit caries model with orthodontic bands2010-AlMulla
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 2010-AlMulla-high-fluoride toothpaste and no post-brushing water rinsing on enamel demineralization using an in-sit caries model with orthodontic b...
    View full study record
    Document reference: 49098
    Study title:
    Active substance: LEFLUNOMIDE
    Study summary document link (including results):
    View full study record
    Document reference: 47353
    Study title:
    Active substance: LEFLUNOMIDE
    Study summary document link (including results):
    View full study record
    Document reference: 47354
    Study title: Double-blind, eight-month extension study to collect durability of efficacy data and additional safety data in patients with juvenile rheumatoid arthritis completing the double-blind comparison study HWA486/3503 of leflunomide versus methotrexate
    Active substance: LEFLUNOMIDE
    Study summary document link (including results): Leflunomide-Study 3.pdf
    View full study record
    Document reference: 47350
    Study title: Efficacy and safety of leflunomide versus methotrexate in the treatment of pediatric patients with juvenile rheumatoid arthritis (JRA)
    Active substance: LEFLUNOMIDE
    Study summary document link (including results): Leflunomide-Study 2.pdf
    View full study record
    Document reference: 47349
    Study title: Phase IB Trial of Leflunomide in Pediatric Subjects with Polyarticular Course Juvenile Rheumatoid Arthritis (JRA)
    Active substance: LEFLUNOMIDE
    Study summary document link (including results): Leflunomide-Study 1.pdf
    View full study record
    Document reference: 47348
    Study title: Population pharmacokinetics of A77 1726 (M1) after oral administration of leflunomide in pediatric subjects with polyarticular course juvenile rheumatoid arthritis
    Active substance: LEFLUNOMIDE
    Study summary document link (including results): Leflunomide-Study 4.pdf
    View full study record
    Document reference: 47351
    Study title: Q Clinical impact of fluorine-18fluorodeoxyglucose positron emission tomography in cancer patients. A comparative study between dedicated camera and dual-head coincidence gamma camera.JNucl Med Mol Imaging. 2006 Mar;50(1):68-77. Andrieux A 2006
    Active substance: SteriPET
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48624
    Study title: Schmitz A, Risse JH, Grünwald F, Gassel F, Biersack HJ, Schmitt O.. Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary results. [schmitz-2001]Eur Spine J. 2001 Dec;10(6):534-9. Schmitz A 2001
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48696
    Study title: Shulkin BL, Goodin GS, McCarville MB, Kaste SC, Krasin MJ, Hudson MM, Metzger M.. Bone and [18F]fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults. [shulkin-2009 Leuk Lymphoma. 2009 Nov;50(11):1794-802. Shulkin BL 2009
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48698
    Study title: Shulkin BL, Hutchinson RJ, Castle VP, Yanik GA, Shapiro B, Sisson JC.. Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy. [shulkin-1996]Radiology. 1996 Jun;199(3):743-50. Shulkin BL 1996
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48697
    Study title: Incremental rates of dental caries after repeated topical sodium fluoride applications in children with lifelong consumption of fluoridated water1971-Englander
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1971-Englander-incremental rates of dental caries after repeated topical sodium fluoride applications in children with lifelong consumption of fluo...
    View full study record
    Document reference: 49093
    Study title: Jarman underproveleged area scores, tooth decay and the effect of water fluoridation1997-jones
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1997-jones-Jarman underproveleged area scores, tooth decay and the effect of water fluoridation.pdf
    View full study record
    Document reference: 49123
    Study title: Kollective Karies pravention in Vorchulatter unter Verwendung eines Fluoridhaltingen lackes1980-treide
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1980-treide-Kollective Karies pravention in Vorchulatter unter Verwendung eines Fluoridhaltingen lackes.pdf
    View full study record
    Document reference: 49107
    Study title: Kollektive VorbeugungsprogrammeMagri 1986
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Magri 1986 Kollektive Vorbeugungsprogramme.pdf
    View full study record
    Document reference: 49169
    Study title: Long term evaluation of a SnF2 gel for control of gingivitis and decalcification in adolescent orthodontic patients1994-boyd
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1994-boyd - long term evaluation of a SnF2 gel for control of gingivitis and decalcification in adolescent orthodontic patients.pdf
    View full study record
    Document reference: 49157
    Study title: NHS dental epidemology programme for England2010-Rooney
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 2010-Rooney-NHS dental epidemology programme for England.pdf
    View full study record
    Document reference: 49092
    Study title: Perspectives on the use of Prenatal Fluoride Administration for Prevention of Dental Caries: a reactors comments1981-Stamm. Journal of Dentistry for Children, March - April, 1951
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1981-Stamm-Perspectives on the use of Prenatal Fluoride Administration for Prevention of Dental Caries.pdf
    View full study record
    Document reference: 48772
    Study title: Pharmacokinetics of Fluoride gelsEkstrand 1981, Caries Res 15:213 - 220 (1981)
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Ekstrand 1981 Pharmacokinetics of Fluoride gels.pdf
    View full study record
    Document reference: 49163
    Study title: Pilot caries prevention- Modellversuch der KariesprophylaxeStöhr 1979
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Steiner 1984 Enamel opacities in the incisors of school children.pdf
    View full study record
    Document reference: 49181
    Study title: Plasma fluoride concentration and urinary fluoride excretion in children following application of the fluoride containing varnish Duraphat1980-ekstrand, Caries Res, 14: 185-189 1980
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1980-ekstrand-Plasma fluoride concentration and urinary fluoride excretion in children following application of the fluoride containing varnish Dur...
    View full study record
    Document reference: 49106
    Study title: Pre-eruptive effect of NaF tablets on caries in children from 12 to 17 years of ageJ. Widenheim, Dowen Birked, Lars Granath, Georg Lindgren 1986. Community Dent Oral Epidemiol
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1986-Widenheim-Preeruptive effect of NaF Tablets on Caries in Children from 12 to 17 years of age.pdf
    View full study record
    Document reference: 48776
    Study title: Pretreatment of teeth with sodium fluoride prior to stannous fluoride applications1959-Abdul-Gaffar, J DENT RES 1959 38: 901 H. Abdul-Ghaffar and Joseph C. Muhler
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1959-Abdul-Gaffar- Pretreatment of teeth with sodium fluoride prior to stannous fluoride applications.pdf
    View full study record
    Document reference: 49136
    Study title: Prevention of caries progress in xerostomic patients by topical fluoride applicationsMarkitziu 1982
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Markitziu 1982 Prevention of caries progress.pdf
    View full study record
    Document reference: 49171
    Study title: Bastiaannet E, Oyen WJ, Meijer S, Hoekstra OS, Wobbes T, Jager PL, et al.. Impact of 18F] fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients. [bastiaannet-2006]Br J Surg. 2006 Feb;93(2):243-9. Bastiaannet E 2006
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48631
    Study title: Borgwardt L, Højgaard L, Carstensen H, Laursen H, Nowak M, Thomsen C, et al.. Increased fluorine-18 2-fluoro-2-deoxy-Dglucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion. [borgwardt-2005]J Clin Oncol. 2005 May 1;23(13):3030-7. Borgwardt L 2005
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48634
    Study title: Buchmann I, Reinhardt M, Elsner K, Bunjes D, Altehoefer C, Finke J, et al.. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. [buchmann-2001]Cancer. 2001 Mar 1;91(5):889-99. Buchmann I, 2001
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48636
    Study title: Prevention of decalcification in orthodontic patients by daily self treatment with 0.4 percent SnF2 gel1979-shannon
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1979-shannon - prevention of decalcification in orthodontic patients by daily self treatment with 0.4 percent SnF2 gel.pdf
    View full study record
    Document reference: 49154
    Study title: Preventive effect of high-fluoride dentifrice in caries-active adolescents2010-Nordstrom
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 2010-Nordstrom-preventive effect of high-fluoride dentifrice in caries-active adolescents.pdf
    View full study record
    Document reference: 49099
    Study title: Reduction in dental caries with four concentrations of sodium fluoride in a dentifrice: a meta-analysis evaluation2001-Bartizek, The journal of clinical dentistry
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 2001-Bartizek-reduction in dental caries with four concentrations of sodium fluoride in a dentifrice.pdf
    View full study record
    Document reference: 49087
    Study title: Relative anti-caries efficacy of 1100, 1700, 2200 and 2800 ppm fluoride ion in a sodium fluoride dentifrice over 1 year2001-Biesbrock, Community dentistry and oral epidemiology
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 2001-Biesbrock-relative anti-caries efficacy of 1100, 1700, 2200 and 2800 ppm fluoride ion in a sodium fluoride dentifrice over 1 year.pdf
    View full study record
    Document reference: 49088
    Study title: Results of a 3-year oral hygiene programmeDénes 1991, european Journal of Orthodontics 13 (1991) 129-133
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Dénes 1991 Results of a 3-year oral hygiene programme.pdf
    View full study record
    Document reference: 49161
    Study title: Results of a group prophylaxis programmeBüttner 1985
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Büttner 1985 Results of a group prophylaxis programme.pdf
    View full study record
    Document reference: 49158
    Study title: Results of a three-year investigation about Zahneputzen with an amine fluoride gels - Ergebnisse einer dreijährigen untersuchung uber Zahneputzen mit einem Aminfluorid-geleSzöke 1989
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Szöke 1989 Ergebnisse einer dreijährigen.pdf
    View full study record
    Document reference: 49182
    Study title: Results of the Sherbrooke-Lac Megtanic fluoride varnish study after 20 months1985-clark
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1985-clark-Results of the Sherbrooke-Lac Megtanic fluoride varnish study after 20 months.pdf
    View full study record
    Document reference: 49112
    Study title: Sodium fluoride tablets for childrenFrancis A. Arnold, F.J. McClure, Carl. L. White. Dental Vol 1. No. 1. October 1960
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1960-Arnold-Sodium fluoride tablets for children.pdf
    View full study record
    Document reference: 48766
    Study title: stannous fluoride topically applied os effective-data at the end of a five years study1965-Rothhaar
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1965-Gish-Effect on dental caries in children in a natural fluoride area of combined use of three agents containing stannous fluoride.pdf
    View full study record
    Document reference: 49148
    Study title: Stannous fluoride versus sodium fluoride in preventive treatment of orthodontic patients1977-shannon
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1977-shannon - stannous fluoride versus sodium fluoride in preventive treatment of orthodontic patients.pdf
    View full study record
    Document reference: 49153
    Study title: Benefit of fluoroscopically guided intraarticular, long-acting corticosteroid injection for subtalar arthritis in juvenile idiopathic arthritis.; CAHILL AM; Pediatr. Radiol.; 2007 vol.37 p544 548Benefit of fluoroscopically guided intraarticular, long-acting corticosteroid injection for subtalar arthritis in juvenile idiopathic arthritis.; CAHILL AM; Pediatr. Radiol.; 2007 vol.37 p544 548
    Active substance: IOVERSOL
    Study summary document link (including results):
    View full study record
    Document reference: 30397
    Study title: Acta Radiol. 1989 Nov-Dec;30(6):643-6 Influence of urography on renal function in children. A double blind study with metrizoate and iohexol. Stake G, Monn E, Rootwelt K, Golman K, Monclair T Acta Radiol. 1989 Nov-Dec;30(6):643-6 Influence of urography on renal function in children. A double blind study with metrizoate and iohexol. Stake G, Monn E, Rootwelt K, Golman K, Monclair T
    Active substance: IOHEXOL
    Study summary document link (including results):
    View full study record
    Document reference: 30362
    Study title: Choi SJ, Kim JS, Kim JH, Oh SJ, Lee JG, Kim CJ, et al.. Epub 2005 Feb 15. [18F]3'-deoxy-3'- fluorothymidine PET for the diagnosis and grading of brain tumors. [choi-2005]Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):653-9. Choi SJ 2005
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48637
    Study title: Fluorides in community programms-A study of four years of various fluorides applied topically to the teeth of children in fluoridated communities1972-Swejda
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1972-Swejda-Fluorides in community programms-A study of four years of various fluorides applied topically to the teeth of children in fluoridated c...
    View full study record
    Document reference: 49150
    Study title: Fluorine concentration in primary tooth enamel in 6 year old after 3 years of daily intake1984-Widenheim
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1984-Widenheim-Fluorine concentration in primary tooth enamel in 6 year old after 3 years of daily intake.pdf
    View full study record
    Document reference: 49155
    Study title: Effect on a 30 second topical stannous fluoride treatement on dental caries reductions in children1964-Mercer
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1964-Mercer-Effect on a 30 second topical stannous fluoride treatement on dental caries reductions in children.pdf
    View full study record
    Document reference: 49146
    Study title: Effect on dental caries in children in a natural fluoride area of combined use of three agents containing stannous fluoride1965-Gish
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1965-Gish-Effect on dental caries in children in a natural fluoride area of combined use of three agents containing stannous fluoride.pdf
    View full study record
    Document reference: 49147
    Study title: Effect on dental caries in children in a non fluoride area of combined use of three agents containing stannous fluoride1964-Bixler
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1964-Bixler-Effect on dental caries in children in a non fluoride ares of combined use of three agents containing stannous fluoride.pdf
    View full study record
    Document reference: 49145
    Study title: Effectiveness of fornightly tooth brushing with amine fluorides in caries-prone subjectsRan 1991
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Ran 1991 Effectiveness of fornightly tooth brushing.pdf
    View full study record
    Document reference: 49176
    Study title: Effectiveness of visible light fissure sealant (Delton) versus fluoride varnish (Duraphat) 24 month clinical trial1996-bravo, Community Dent. Oral Epidemiol. 1996: 24: 42-6
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1995-seppa-Fluoride varnish versus acidulated phosphate fluoride gel.pdf
    View full study record
    Document reference: 49121
    Study title: Influence of urography on renal function in children. A double blind study with metrizoate and iohexol. Acta Radiol. 1989 Nov-Dec; 30(6):643-6 Stake G 1989
    Active substance: IOHEXOL
    Study summary document link (including results): Stake G 1989.pdf
    View full study record
    Document reference: 48872
    Study title: Dietlein M, Krug B, Groth W, Smolarz K, Scheidhauer K, Psaras T, et al.. Positron emission tomography using 18Ffluorodeoxyglucose in advanced stages of malignant melanoma: a comparison of ultrasonographic and radiological methods of diagnosis. [dietlein-1999]Nucl Med Commun. 1999 Mar;20(3):255-61. Dietlein M 1999
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48640
    Study title: Open Study to determine the concentration of telithromycin in middle ear fluid and plasma in infants/children with acute otitis media or otitis media with effusion after single oral administration of 20mg/kg or 30mg/kg of a telithromycin pediatric suspension
    Active substance: telithromycin
    Study summary document link (including results):
    View full study record
    Document reference: 41566
    Study title: Furth C, Steffen IG, Amthauer H, Ruf J, Misch D, Schönberger S, Kobe C, Denecke T, Stöver B, Hautzel H, Henze G, Hundsdoerfer P.. Epub 2009 Aug 10.Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial. [furth-2009]J Clin Oncol. 2009 Sep 10;27(26):4385-91. Furth C 2009
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48651
    Study title: effects of self-applied topical fluoride preparations in orthodontic patients2000-alexander
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 2000-alexander-effects of self-applied topical fluoride preparations in orthodontic patients.pdf
    View full study record
    Document reference: 49096
    Study title: Enamel changes and dental caries in 7 years old children given fluoride tablets from shortly after birthA. Thylstrup, O. Fejerskov, C. Brunn, J. Kann 1979. Brit Dent.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1979-thylstrup-Enamel Changes and Dental Caries in 7-Year-Old children fiven fluoride tablets from shortly after birth.pdf
    View full study record
    Document reference: 48779
    Study title: A 3 year oral health dose response study of sodium monofluorophosphate dentifrices with and without zinc citrate1988-Stephen, Community Dent Oral Epidemiology 16:321-5
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1988-Stephen-a 3 year oral health dose response study of sodium monofluorophosphate dentifrices with and without zinc citrate.pdf
    View full study record
    Document reference: 49085
    Study title: A 48-month survival analysis comparing sealant (Delton) with fluoride varnish (Duraphat) in 6-8 year old children1997-bravo
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1996-bravo-Effectiveness of visible light fissure sealant (Delton) versus fluoride varnish (Duraphat) 24 month clinical trial.pdf
    View full study record
    Document reference: 49122
    Study title: A Community Study of Fluoride Tablets for School Children in Portsmouth1982-Allmark. Br Dent J 1982: 153: 426
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1982-Allmark-A Community Study od Fluoride Tablets for School Children in Portsmouth.pdf
    View full study record
    Document reference: 48773
    Study title: A home care program of chemical preventive dentistry for orthodontic patients1973-landry
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1973-landry-a home care program of chemical preventive dentistry for orthodontic patients.pdf
    View full study record
    Document reference: 49151
    Study title: a new approach to the topical application of fluorides for the reduction od dental caries in children-results at the end of five years1962-Gish
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1962-Gish-a new approach to the topical application of fluorides for the reduction od dental caries in children-results at the end of five years.pdf
    View full study record
    Document reference: 49143
    Study title: A new approach to the topical application of fluorides for the reduction of dental caries in children1957-gish
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1957-gish-a new approach to the topical application of fluorides for the reduction of dental caries in children.pdf
    View full study record
    Document reference: 49133
    Study title: A new approach to the topical application of fluorides in children with results at the end of four years1959-Gish
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1959-Gish-A new approach to the topical application of fluorides in children with results at the end of four years.pdf
    View full study record
    Document reference: 49137
    Study title: A newapproach to the topical application of fluorides in children with results at the end of two years1957-gish
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1957-Gish-A newapproach to the topical application of fluorides in children with results at the end of two years.pdf
    View full study record
    Document reference: 49134
    Study title: A study of a single application of eight persent stannous fluoride1959-Jordan
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1959-Jordan-A study of a single application of eight persent stannous fluoride.pdf
    View full study record
    Document reference: 49138
    Study title: A three year clinical comparison of a sodium monofluorophosphate dentifrice with sodium fluoride dentifrices on dental caries in children1987-Lu, Journal of dentistry for children, July-August 1987
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1987-Lu-a three year clinical comparison of a sodium monofluorophosphate dentifrice with sodium fluoride dentifrices on dental caries in children.pdf
    View full study record
    Document reference: 49083
    Study title: Influence of iodine supplementation on serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) levels in severe iodine deficiency. ;Özön-A. Turkish Journal of Pediatrics, 2004, Vol/Iss/Pg. 46/4 (303-308)Influence of iodine supplementation on serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) levels in severe iodine deficiency. ;Özön-A. Turkish Journal of Pediatrics, 2004, Vol/Iss/Pg. 46/4 (303-308)
    Active substance: IODINE
    Study summary document link (including results):
    View full study record
    Document reference: 30265
    Study title: Influence of nutritional state on the disposal of orally and intramuscularly administered iodized oil to iodine repleted older children and adult women. Fierro-Benitez-R. Journal of Endocrinological Investigation, 1989, Vol/Iss/Pg. 12/6 (405-407)Influence of nutritional state on the disposal of orally and intramuscularly administered iodized oil to iodine repleted older children and adult women. Fierro-Benitez-R. Journal of Endocrinological Investigation, 1989, Vol/Iss/Pg. 12/6 (405-407)
    Active substance: IODINE
    Study summary document link (including results):
    View full study record
    Document reference: 30266
    Study title: Amounts of fluorides in self administered dental products: safety considerations for childrenStanley B Heifetz, Herschel S Horowitz. Pediatrics Vol 77No. 6 June 1986
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1986-heifetz-Amounts of fluoride in self-administered dental products-safety consideration for children.pdf
    View full study record
    Document reference: 48770
    Study title: An assessment of two dental health education programmes for school children in the Lothian region of ScotlandC. Wight, A.S. Blinkhorn 1988. Journal of Pediatric Dentistry
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1988-wight-An Assessment of Two Dental Health Education programmes for school children in the lothian region of scotland.pdf
    View full study record
    Document reference: 48775
    Study title: An open study to investigate what happens with a lozenge that is given to a 3-5 year old child that are told to leave it be in their mouth.Mejàre et al. (1987-09-23)
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 48943
    Study title: Assessment of the effectiveness of supervised oral hygiene programmes by means of different indicesMaiwald 1993
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Maiwald 1993 Assessment of the effectiveness.pdf
    View full study record
    Document reference: 49170
    Study title: Caries epidemiological studies- Kariesepidemiologische UntersuchungenBüttner 1995
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Büttner 1995 Kariesepidemiologische Untersuchungen.pdf
    View full study record
    Document reference: 49160
    Study title: Caries increment in primary teeth after application of Duraphat fluoride varnish1982-grogzka
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1982-grogzka-Caries increment in primary teeth after application of Duraphat fluoride varnish.pdf
    View full study record
    Document reference: 49108
    Study title: Pediatr cardiol. 2005 Jul-Aug: 26(4):413-7: Safety and Efficacy of Itravenous Contrast Imaging in Pediatrich Echocardiography.Pediatr cardiol. 2005 Jul-Aug: 26(4):413-7: Safety and Efficacy of Itravenous Contrast Imaging in Pediatrich Echocardiography.
    Active substance: Perflutren
    Study summary document link (including results):
    View full study record
    Document reference: 41585
    Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Lamioflur (drops) [AWB-AT]
    Active substance: Lamioflur
    Study summary document link (including results):
    View full study record
    Document reference: 40045
    Study title: Caries increments-tooth discoloration-and state of oral hygiene in children1965-Wellock
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1965-Wellock-Caries increments-tooth discoloration-and state of oral hygiene in children.pdf
    View full study record
    Document reference: 49149
    Study title: Caries inhibiting effect of different modes of Duraphat reapplication-A three year radiographic study1991-peterson, Caries Res. 1991:25:70-73
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1991-peterson-Caries inhibiting effect of different modes of Duraphat reapplication-A three year radiographic study.pdf
    View full study record
    Document reference: 49117
    Study title: Caries inhibition of mixed NaF-Na2PO3F dentifrices containing 1000 and 2500 ppmF1988-Ripa- JADA Volume 116, January 1988
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1988-Ripa-caries inhibition of mixed NaF-Na2PO3F dentifrices containing 1000 and 2500 ppmF.pdf
    View full study record
    Document reference: 49084
    Study title: Caries prevention by daily fluoride mouthrinsingRugg-Gunn 1973
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Rugg-Gunn 1973 Caries prevention by daily fluoride mouthrinsing.pdf
    View full study record
    Document reference: 49129
    Study title: Caries preventive effect of Duraphat Varnish versus fluoride mouthrinses-5 year data1986-kirkegaard
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1986-kirkegaard-Caries preventive effect of Duraphat Varnish versus fluoride mouthrinses-5 year data.pdf
    View full study record
    Document reference: 49113
    Study title: Caries preventive effect of fluoride varnish application performed two or four times a year1990-seppa
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1990-seppa-Caries preventive effect of fluoride varnish application performed two or four times a year.pdf
    View full study record
    Document reference: 49115
    Study title: Guidelines for paediatric bone scanning with 99mTc-labelled radiopharmaceuticals and 18F-fluoride. Stauss J, Hahn K, Mann M, De Palma D. Eur J Nucl Med Mol Imaging. (8 pages) Published online: www.eanm.org/scientific_info/guidelines/EJNMMI_Bone_Scintigraphy_in_Children.pdf
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 48759
    Study title: Reflux of nasopharyngeal content into middle ear through the eustachian tube Eur Arch Otorhinolaryngol. 2004 Sep;261(8):439-44. Epub 2003 Nov 18. Ayanoglu E 2003
    Active substance: TECHNETIUM (99m)
    Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc
    View full study record
    Document reference: 48794
    Study title: Hain SF, O'Doherty MJ, Lucas JD, Smith MA. Nucl Med Commun. 1999 Sep;20(9):845-8. Fluorodeoxyglucose PET in the evaluation of amputations for soft tissue sarcoma. [hain-1999] Hain SF, O'Doherty MJ, Timothy AR, Leslie MD, Harper PG,. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse. [hain-2000]Huddart RA. Br J Cancer. 2000 Oct;83(7):863-9. Hain SF 2000
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48656
    Study title: Hoegerle S, Juengling F, Otte A, Altehoefer C, Moser EA, Nitzsche EU.. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging? [hoegerle 1998]Radiology. 1998 Oct;209(1):253-8. Hoegerle S 1998
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48658
    Study title: Caries preventive effect of high fluoride and xylitol containing dentifrices1992-Cutress-
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1992-Cutress-caries preventive effect of high fluoride and xylitol containing dentifrices.pdf
    View full study record
    Document reference: 49094
    Study title: Caries preventive effect of three topical fluorides_1% years clinical trial in Chandigarh schoolchildren of North India1984-tewari-
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1984-tewari-Caries preventive effect of three topical fluorides_1% years clinical trial in Chandigarh schoolchildren of North India.pdf
    View full study record
    Document reference: 49111
    Study title: Caries preventive effect of two fluoride varnishes and a fluoride mouthrinse1987-seppa, Caries Res. 1987:21: 375-379
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1987-seppa-Caries preventive effect of two fluoride varnishes and a fluoride mouthrinse.pdf
    View full study record
    Document reference: 49114
    Study title: Caries preventive effort of a fluoride-containing varnish (Duraphat) after 1 year s study1975-koch, Community Dentl Oral Epidemiol, 1975: 3: 262-266
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1975-koch-Cariespreventive effort of a fluoride-containing varnish (Duraphat) after 1 year s study.pdf
    View full study record
    Document reference: 49102
    Study title: Caries rate, enamel fluoride concentration after fortnightly brushing with aminfluoride gelRan 1987
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Ran 1987 Caries rate, enamel fluoride concentration.pdf
    View full study record
    Document reference: 49175
    Study title: Caries reduction and cost benefit after 3 years of sucking fluoride tablets daily at schoolK.W. Stephen, D. Campbell 1978. Brit Dent J 1978 144, 202
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1978-stephen-Caries Reduction and Cost Benefit After 3 Years of Sucking Fluoride Tablets Daily at school.pdf
    View full study record
    Document reference: 48780
    Study title: Kostakoglu L, Leonard JP, Kuji I, Coleman M, Vallabhajosula S, Goldsmith SJ.. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. [kostakaglu-2002]Cancer. 2002 Feb 15;94(4):879-88. Kostakoglu L 2002
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48670
    Study title: Clinical assessment of the latrogenicGatto 1988
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Gatto 1988 Clinical assessment of the latrogenic.pdf
    View full study record
    Document reference: 49166
    Study title: Clinical evaluations on the biocompatibility- Valutazioni cliniche sulla biocompatibilitaGatto 1989
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Gatto 1989 Valutazioni cliniche sulla biocompatibilita.pdf
    View full study record
    Document reference: 49167
    Study title: Clinical study of an amine fluoride gel and acidulated phosphate fluoride gelShern 1976
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Shern 1976 Clinical study of an amine fluoride.pdf
    View full study record
    Document reference: 49178
    Study title: Collective preschool caries prevention using a fluoride-containing varnish] [Article in German]
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42543
    Study title: Comments on the biocompatibility - Osservazioni sulla biocompatibilitaGallusi 1988
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Gallusi 1988 Osservazioni sulla biocompatibilita.pdf
    View full study record
    Document reference: 49165
    Study title: Comparision of a single application of stannous fluoride with a single application of sodium fluoride or two applications of stannous fluoride1961-Mercer
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1961-Mercer-Comparision of a single application of stannous fluoride with a single application of sodium fluoride or two applications of stannous f...
    View full study record
    Document reference: 49141
    Study title: Comparision of three self applied topical fluoride preparationsfor control of decalcification1993-boyd
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1993-boyd - comparision of three self applied topical fluoride preparationsfor control of decalcification.pdf
    View full study record
    Document reference: 49156
    Study title: Comparison of three prevention programs -Vergleich dreier Prophylaxe ProgrammeBüttner 1987
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Büttner 1987 Vergleich dreier Prophylaxe Programme.pdf
    View full study record
    Document reference: 49159
    Study title: A phase II, two-centre, open-label study in patients aged 3 months to 13 years with endoscopically-proven reflux oesophagitis.
    Active substance: LANSOPRAZOLE
    Study summary document link (including results): Lansoprazole_AG-II-95-028-Synopsis.pdf
    View full study record
    Document reference: 47610
    Study title: Investigate how absorption is influenced by volume, composition and food intake.Forsman et al
    Active substance: PHENOXYMETHYLPENICILLIN
    Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_1.xlsx
    View full study record
    Document reference: 49031
    Study title: Investigate how absorption is influenced by volume, composition and food intake.Forsman et al
    Active substance: PHENOXYMETHYLPENICILLIN
    Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_1.xlsx
    View full study record
    Document reference: 49032
    Study title: Levivier M, Goldman S, Pirotte B, Brucher JM, Balériaux D, Luxen A, et al.. Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. [levivier-1995]J Neurosurg. 1995 Mar;82(3):445-52. Levivier M 1995
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48675
    Study title: Moll AC, Hoekstra OS, Imhof SM, Comans EF, Schouten-van Meeteren AY, van der Valk P, et al. Ophthalmic Genet. 2004 Mar;25(1):31-5. Fluorine-18 fluorodeoxyglucose positron emission tomography (PET) to detect vital retinoblastoma in the eye: preliminary experience. [moll-2004]Moll AC 2004
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48679
    Study title: Control of decalcification in orthodontic patients by daily self administered application of a water free 0.4 percent stannous fluoride gel1974-stratemann
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1974-stratemann - control of decalcification in orthodontic patients by daily self administered application of a water free 0.4 percent stannous fl...
    View full study record
    Document reference: 49152
    Study title: Controlled trial of fluoride in vitamin drops for prevention of caries in childrenLars-Eric Granath, Holger Rootzen, Elso Liljegren, Kerstin Hoist, Lennart Kohler 1978. Caries Res 12: 83-92lENNART hAMBERG 1971, THE LANCET, February 27
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1971-hamberg-Controlled trial of Fluoride in Vitamins Drops for Prevention od Caries in Children.pdf
    View full study record
    Document reference: 48782
    Study title: Djelovanje aminofluorida - elmex gelee na: Effect of amine fluorideRajic 1977
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Rajic 1977 Djelovanje aminofluorida - elmex gelee na.pdf
    View full study record
    Document reference: 49174
    Study title: Decrease in DMF tooth numbersSigrist 1975
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): Sigrist 1975 Decrease in DMF tooth numbers.pdf
    View full study record
    Document reference: 49179
    Study title: The anticariogenic effectiveness od a single application of stannous fluoride in children residing in an optimum fluoride area1960-Muhler
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1960-Muhler-The anticariogenic effectiveness od a single application of stannous fluoride in children residing in an optimum fluoride area.pdf
    View full study record
    Document reference: 49140
    Study title: the anticariogenic effects of one and two X application of stannous fluoride on the deciduous and permanent teeth of children1962-Salter
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 49144
    Study title: The caries inhibitory effect of a fluoride gel (PreviDent) ina self-brushing home based programm for shoolchildren1994-DePaola
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1994-DePaola-the caries inhibitory effect of a fluoride gel (PreviDent) ina self-brushing home based programm for shoolchildren.pdf
    View full study record
    Document reference: 49095
    Study title: The caries preventing effect of mouthrinsing with 0.025 percent sodium fluoride solution in Swedish children. Forsman B. Community Dent Oral Epidemiol. 1974;2(2):58-65.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 48944
    Study title: The caries preventive effect of a fluoride varnish in the fissures of the first permanent molar1984-holm
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1984-holm-The caries preventive effect of a fluoride varnish in the fissures of the first permanent molar.pdf
    View full study record
    Document reference: 49110
    Study title: The caries prophylactic effect of Fluorlack after years of use in paediatric/adolescent dental care: Karies prophylaktische Wirkung von Fluorlack nach mehrjahriger Anwendung in der Jugendzahnpflege1978-leiser
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1978-leiser-Karies prophylaktische Wirkung von Fluorlack nach mehrjahriger Anwendung in der Jugendzahnpflege.pdf
    View full study record
    Document reference: 49104
    Study title: The caries-preventive effect of a fluoride varnish in the fissures of the first permanent molar.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42369
    Study title: The clinical anticariogenic effectiveness of supplementary fluoride vitamin preparations - result at the end of four yearsDavid K. Hennon, Georg K Stookey, Joseph C Muhler 1967. Journal of dentistry for children.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1967-hennon-Ciinical Anticariogenic Effectivenoss of Supplementary Fluoride-Vitamin Preparations-Results at the end of four years.pdf
    View full study record
    Document reference: 48785
    Study title: The combined antocariogenic effeccts of a single stannous fluoride treatement and the unsupervised use of stannous fluoride dentifrice1959-Muhler, J DENT RES 1959 38: 994
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1959-Muhler-The combined antocariogenic effeccts of a single stannous fluoride treatement and the unsupervised use of stannous fluoride dentifrice.pdf
    View full study record
    Document reference: 49139
    Study title: Novak L, Emri M, Molnar P, Balkay L, Lengyel Z. Subcortical [18F]fluorodeoxyglucose uptake in lesional epilepsy in patients with intracranial tumour. [novak-2004]Tron L. Nucl Med Commun. 2004 Feb;25(2):123-8. Novak L 2004
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48685
    Study title: O'Connell MT, Seal A, Nortje J, Al-Rawi PG, Coles JP, Fryer TD, et al.. Glucose metabolism in traumatic brain injury: a combined microdialysis and [18F]-2-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET) study. [oconnell-2005]Acta Neurochir Suppl. 2005;95:165-8. O'Connell MT 2005
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48686
    Study title: A randomized, double-blind, double dummy, parallel group comparison of fluticasone propionate inhalation powder (50mcg BID) via DiskusTM with oral montelukast (5mg QD) chewable tablets in children 6–12 years of age with persistent asthma
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FPD40013-ICHE3.pdf
    View full study record
    Document reference: 28428
    Study title: A Randomized, Double-Blind, Double-Dummy, Parallel-Group Trial Assessing the Efficacy and Safety of Fluticasone Propionate 50 or 100mcg BID via the Multi-Dose Powder Inhaler, Fluticasone Propionate 50 or 100mcg BID via the Diskhaler and Placebo in Subjects Aged 4 to 11 Years with Chronic Asthma
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FLTA2006-ICHE3.pdf
    View full study record
    Document reference: 28423
    Study title: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, 12-Week Trial of Inhaled Fluticasone Propionate 88mcg BID versus Placebo in Propellant GR106642X in Pediatric Subjects 4 to 11 Years of Age With Asthma
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FAP30010-ICHE3.pdf
    View full study record
    Document reference: 28391
    Study title: A randomized, double-blind, placebo-controlled study examining the effect of fluticasone propionate aqueous nasal spray in antibiotic therapy in the treatment of chronic rhinosinusitis in paediatric patients.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FNS30003-ICHE3.pdf
    View full study record
    Document reference: 28368
    Study title: A Randomized, Open-Label, 2-Way Crossover, Repeat-Dose Study in Pediatric Subjects with Asthma, Age 4-11 Years, to Compare Systemic Exposure of Fluticasone Propionate 2x44mcg Following Administration by Metered-Dose Inhalers Containing Hydrofluoroalkane or Chlorofluorocarbon Propellants
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FAP10006-ICHE3.pdf
    View full study record
    Document reference: 28417
    Study title: A Randomized, Open-Label, 2-Way Crossover, Repeat-Dose Study in Pediatric Subjects with Asthma, Age 4-11 Years, to Compare Systemic Exposure of Fluticasone Propionate 2x44mcg Following Administration by Metered-Dose Inhalers Containing Hydrofluoroalkane or Chlorofluorocarbon Propellants
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FAP10006-ICHE3.pdf
    View full study record
    Document reference: 28441
    Study title: A single centre, randomised, double blind, cross over study to investigate longitudinal growth using knemometry in children with seasonal and perennial rhinitis during treatment with fluticasone propionate aqueous nasal spray (FPANS) 100mcg/day and placebo.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FNM40181-ICHE3.pdf
    View full study record
    Document reference: 28415
    Study title: A Study to Determine the Systemic Activity of a Single Dose of Fluticasone Propionate via the Diskus in Asthmatic Children Inhaling at Different Inspiratory Flows
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FLTB4009-ICHE3.pdf
    View full study record
    Document reference: 28382
    Study title: Comparison of fluticasone powder 1mg/day to budesonide powder 1mg/day in deterioration of severe asthma in children: a double-blind, randomised, multicentre study with parallel groups.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone -Propionate-FLPB0145-ICHE3.pdf
    View full study record
    Document reference: 28404
    Study title: Specific or superfluous? Doubtful clinical value of granulocyte scintigraphy in osteomyelitis in children. Kaiser S, Jacobsson H, Hirsch G. J Pediatr Orthop B. 2001 Apr;10(2):109-12.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43453
    Study title: INFLUENCE ON BRONCHIAL HYPERRESPONSIVENESS USING A LONG ACTING (FORMOTEROL) AND A SHORT ACTING (SALBUTAMOL) BETA-2 SYMPATHOMIMETIC IN CHILDREN WITH BRONCHIAL ASTHMA
    Active substance: FORMOTEROL
    Study summary document link (including results):
    View full study record
    Document reference: 45268
    Study title: INFLUENCE ON BRONCHIAL HYPERRESPONSIVENESS USING A LONG ACTING (FORMOTEROL) AND A SHORT ACTING (SALBUTAMOL) BETA-2 SYMPATHOMIMETIC IN CHILDREN WITH BRONCHIAL ASTHMA
    Active substance: FORMOTEROL
    Study summary document link (including results): FOR258 DFORD2 Art45 listing 2011.xls
    View full study record
    Document reference: 47845
    Study title: Report on an Open Cross-Over Comparison of Flurbiprofen and Naproxen in Juvenile Spondylitis, Definite and Probable
    Active substance: FLURBIPROFEN
    Study summary document link (including results): Flurbiprofen-M84-121.pdf
    View full study record
    Document reference: 47461
    Study title: Serum Concentrations of Flurbiprofen in Children After a Single Oral Dose of 22.5 mg or 27 mg of the Drug, following a Multidose Regime
    Active substance: FLURBIPROFEN
    Study summary document link (including results): flurbiprofen-dm7620.pdf
    View full study record
    Document reference: 48075
    Study title:
    Active substance: FLURIBUPROFEN
    Study summary document link (including results):
    View full study record
    Document reference: 28346
    Study title:
    Active substance: FLURIBUPROFEN
    Study summary document link (including results):
    View full study record
    Document reference: 28347
    Study title: Open comparative trial to evaluate the effectiveness of gonorrhae in males.Fluker
    Active substance: AMOXICILLIN
    Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Amoxillin_9.xlsx
    View full study record
    Document reference: 48999
    Study title:
    Active substance: FLURIBUPROFEN
    Study summary document link (including results):
    View full study record
    Document reference: 28348
    Study title:
    Active substance: FLURIBUPROFEN
    Study summary document link (including results):
    View full study record
    Document reference: 28349
    Study title:
    Active substance: FLURIBUPROFEN
    Study summary document link (including results):
    View full study record
    Document reference: 28350
    Study title:
    Active substance: FLURIBUPROFEN
    Study summary document link (including results):
    View full study record
    Document reference: 28351
    Study title:
    Active substance: FLURIBUPROFEN
    Study summary document link (including results):
    View full study record
    Document reference: 28352
    Study title:
    Active substance: FLURIBUPROFEN
    Study summary document link (including results):
    View full study record
    Document reference: 28353
    Study title:
    Active substance: FLURIBUPROFEN
    Study summary document link (including results):
    View full study record
    Document reference: 28354
    Study title:
    Active substance: FLURIBUPROFEN
    Study summary document link (including results):
    View full study record
    Document reference: 28355
    Study title:
    Active substance: FLURIBUPROFEN
    Study summary document link (including results):
    View full study record
    Document reference: 28356
    Study title:
    Active substance: FLURIBUPROFEN
    Study summary document link (including results):
    View full study record
    Document reference: 28357
    Study title:
    Active substance: FLURIBUPROFEN
    Study summary document link (including results):
    View full study record
    Document reference: 28358
    Study title:
    Active substance: FLURIBUPROFEN
    Study summary document link (including results):
    View full study record
    Document reference: 28359
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results):
    View full study record
    Document reference: 28360
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results):
    View full study record
    Document reference: 28361
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FPO40003.pdf
    View full study record
    Document reference: 28362
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-DENB4016-ICHE3.pdf
    View full study record
    Document reference: 28369
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Study FAD101-Fluticasone Propionate-Flixotide Diskus.xls
    View full study record
    Document reference: 28370
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Study FAD102-Fluticasone Propionate-Flixotide Diskus.xls
    View full study record
    Document reference: 28371
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FAS30006-ICHE3.pdf
    View full study record
    Document reference: 28372
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FAS40019-ICHE3.pdf
    View full study record
    Document reference: 28373
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Study Fluticasone_Propionate-PED-FLTA2008.xlsx
    View full study record
    Document reference: 28377
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results):
    View full study record
    Document reference: 28378
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results):
    View full study record
    Document reference: 28381
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Study FMS40016-Fluticasone.xls
    View full study record
    Document reference: 28385
    Study title: Due to the lack of good diagnostic techniques it can be difficult to diagnose asthma in young children. The symptoms can be such that anti-inflammatory medication is given as test medication; however there is a lack of clinical data in a large group of wheezy infants using objective endpoints. The aim of this study was to evaluate the effects of fluticasone propionate on lung function and symptom scores in infants with recurrent and persistent wheeze.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FMS30060-ICHE3.pdf
    View full study record
    Document reference: 28398
    Study title: Effect of long-term treatment with fluticasone propionate on bone density, growth and lung function in childhood asthma.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FMS40175-ICHE3.pdf
    View full study record
    Document reference: 28388
    Study title: Efficacy of treatment with inhaled fluticasone and the effect of priming and activation of PMN cells in children with allergy and asthma.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FMS40229-ICHE3.pdf
    View full study record
    Document reference: 28405
    Study title: FLU9705: a multi-centre, parallel group, randomised, double-blind study to investigate the efficacy of fluticasone propionate 100 mcg MDI bd versus placebo MDI bd both via Babyhaler™ spacer in 1 to 5 year old children with asthma or asthma-like symptoms during a 6 months study period.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FMS40256-ICHE3.pdf
    View full study record
    Document reference: 28395
    Study title: Nebulised Fluticasone propionate in an upper respiratory tract inflammatory disorder (rhinopharyngitis): a multicentre, randomised, blinded, parallel group study of the efficacy and safety of nebulised fluticasone propionate 0.5mg daily compared with nebulised beclomethasone dipropionate 0.8mg daily in children suffering from acute rhinopharyngitis.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FLIC09-ICHE3.pdf
    View full study record
    Document reference: 28422
    Study title: Pharmacodynamics of the 88mcg BID dose of the Hydrofluoroalkane propellant formulation of inhaled Fluticasone Propionate following Administration via the Metered-dose Inhaler in Pediatric Subjects 4 to 11 years of age with Asthma
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FAP19052-ICHE3.pdf
    View full study record
    Document reference: 28390
    Study title: Prevention of Otitis media in children." 6) "A randomized, double-blind, placebo-controlled study examining the effect of fluticasone propionate aqueous nasal spray in antibiotic therapy in the treatment of chronic rhinosinusitis in paediatric patients."
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FNM40083-ICHE3.pdf
    View full study record
    Document reference: 28367
    Study title: Report on a multicentre, randomised, double-blind, parallel-group clinical trial to compare the efficacy and safety of the dry powder formulation of fluticasone proprionate (FP) 200μg/day with fluticasone proprionate 400μg/day administered for 6 weeks from a multidose powder device (Diskus™) to paediatric patients with chronic asthma.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FLTB3051-ICHE3.pdf
    View full study record
    Document reference: 28380
    Study title: Systemic exposure of the fluticasone propionate from the hydrofluoroalkane propellant formulation via the metered-dose inhaler with and without a spacer in pediatric subjects 4 to 11 years of age with asthma.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FAP19058-ICHE3.pdf
    View full study record
    Document reference: 28418
    Study title: Treatment with inhaled corticosteroids in wheezing pre-school children: is there a predictable effect?
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone -Propionate-FMS40257-ICHE3.pdf
    View full study record
    Document reference: 28396
    Study title: A multi-centre, randomised, open-label, parallel group clinical trial to assess the efficacy and safety of Salmeterol/Fluticasone Propionate combination product (2x 25/125μg/actuation, bd) via a hydrofluoroalkane metereddose inhaler compared with Salmeterol/Fluticasone Propionate Accuhaler™ (50/250μg bd) in adult Chinese patients with mild to moderate asthma.
    Active substance: FLUTICASONE AND SALMETEROL
    Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAS30021-ICHE3.pdf
    View full study record
    Document reference: 28452
    Study title: Investigate the relationship between relapses in H. influenzae meningitis and the ability of ampicillin to penetrate to the CSF.Coleman et al. (The journal of pediatrics May 1969)
    Active substance: AMPICILLIN
    Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_7.xlsx
    View full study record
    Document reference: 49008
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results):
    View full study record
    Document reference: 28386
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results):
    View full study record
    Document reference: 28387
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results):
    View full study record
    Document reference: 28392
    Study title: Influence of age and gender on quantitative sacroiliac joint scintigraphy. Lin WY, Wang SJ. J Nucl Med. 1998 Jul;39(7):1269-72.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43531
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone -Propionate-FAS30007-ICHE3.pdf
    View full study record
    Document reference: 28393
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results):
    View full study record
    Document reference: 28400
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results):
    View full study record
    Document reference: 28401
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Study FLIC22 Fluticasone Propionate Fixotide nebules.xls
    View full study record
    Document reference: 28402
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Study FMDT08-Fluticasone Propionate-Flixotide Diskus.xls
    View full study record
    Document reference: 28403
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Study FPC40002-Fluticasone propionate-Cutivate - approved.xls
    View full study record
    Document reference: 28406
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Study FLNT52-Fluticasone_Flixonase.xls
    View full study record
    Document reference: 28410
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Study FLNT59-Fluticasone_Flixonase.xls
    View full study record
    Document reference: 28411
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Study FLNT60-FNM30026-Fluticasone_Flixonase.xls
    View full study record
    Document reference: 28412
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Study FPC40001-Fluticasone propionate-Cutivate - approved.xls
    View full study record
    Document reference: 28427
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results):
    View full study record
    Document reference: 28429
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FLT411.pdf
    View full study record
    Document reference: 28430
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results):
    View full study record
    Document reference: 28431
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FLT412.pdf
    View full study record
    Document reference: 28433
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results):
    View full study record
    Document reference: 28439
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results):
    View full study record
    Document reference: 28440
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FPL10005.pdf
    View full study record
    Document reference: 47739
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FPL30004.pdf
    View full study record
    Document reference: 47740
    Study title: A multicentre, randomised, double-blind, double-dummy, parallel group comparison of three treatments : 1) salmeterol/fluticasone propionate (SFC) (50/100mcg strength) bd via DISKUS/ACCUHALER inhaler, 2) fluticasone propionate 200mcg bd via DISKUS/ACCUHALER inhaler, 3) fluticasone propionate 100mcg bd via DISKUS/ACCUHALER inhaler in children aged 4-11 years with asthma
    Active substance: FLUTICASONE AND SALMETEROL
    Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAM40012-ICHE3.pdf
    View full study record
    Document reference: 28443
    Study title: A pilot single centre, randomised, double-blind, crossover study to demonstrate the superiority of Salmeterol/fluticasone propionate combination product 50/100mcg bd versus fluticasone propionate 100mcg bd when treated for two weeks with respect to activity levels in children aged 7-15 years.
    Active substance: FLUTICASONE AND SALMETEROL
    Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAM40101-ICHE3.pdf
    View full study record
    Document reference: 28448
    Study title: A Randomized, Double-Blind, 12-Week Trial Evaluating the Safety of the Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID Versus Fluticasone Propionate DISKUS 100mcg BID in Symptomatic Pediatric Subjects (4-11 Years) With Asthma
    Active substance: FLUTICASONE AND SALMETEROL
    Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAS30031-ICHE3.pdf
    View full study record
    Document reference: 28453
    Study title: A Stratified, Multicenter, Randomized, Double-Blind, Parallel Group, 4-Week Comparison of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID versus Fluticasone Propionate DISKUS 100mcg BID in Pediatric and in Adolescent Subjects with Activity-Induced Bronchospasm
    Active substance: FLUTICASONE AND SALMETEROL
    Study summary document link (including results): Fluticasone-Propionate-Sameterol-SFA100314-ICHE3.pdf
    View full study record
    Document reference: 28454
    Study title: A Stratified, Multicenter, Randomized, Double-Blind, Parallel Group, 4-Week Comparison of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID versus Fluticasone Propionate DISKUS 100mcg BID in Pediatric and in Adolescent Subjects with Activity-Induced Bronchospasm
    Active substance: FLUTICASONE AND SALMETEROL
    Study summary document link (including results): Fluticasone-Propionate-Sameterol-SFA100316-ICHE3.pdf
    View full study record
    Document reference: 47594
    Study title: An observational study to assess the health related quality of life impact of treating poorly controlled asthmatic children with Seretide(tm) 50/100mcg
    Active substance: FLUTICASONE AND SALMETEROL
    Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAM3802-ICHE3.pdf
    View full study record
    Document reference: 28442
    Study title: Comparison of stepwise treatment of asthmatic children with salmeterol/fluticasone propionate (FP) combination product (Seretide) and/or fluticasone propionate (Flixotide) based on PD20 methacholine plus symptoms or based on symptoms only (Children Asthma Therapy Optimal”)
    Active substance: FLUTICASONE AND SALMETEROL
    Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAS30018-ICHE3.pdf
    View full study record
    Document reference: 28451
    Study title: Prospective, parallel-group, randomized, open label study to evaluate the impact of additional guidance from the health professionals team on treatment compliance of children aged between 6 and 14 years old with persistent moderate or severe asthma, receiving the combination salmeterol/fluticasone propionate 50/250 mcg (Seretide) twice a day. ADERE PROJECT (Pediatric)
    Active substance: FLUTICASONE AND SALMETEROL
    Study summary document link (including results): Fluticasone-Propionate-Sameterol-ADERE-PEDIATRIC-1-ICHE3.pdf
    View full study record
    Document reference: 28444
    Study title: Randomised, double-blind, comparator study to demonstrate the superiority of salmeterol/fluticasone propionate combination DISKUS™ 50/100mcg bd over fluticasone propionate DISKUS™/ACCUHALER™ 200mcg bd with respect to airway physiology in asthmatic children treated for 6 weeks.
    Active substance: FLUTICASONE AND SALMETEROL
    Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAM40100-ICHE3.pdf
    View full study record
    Document reference: 28447
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Study FLU-KI-4186-Fluticasone propionate-Cutivate - approved.xls
    View full study record
    Document reference: 47741
    Study title: A double blind, double dummy, crossover study to compare the systemic pharmacodynamic effects and safety of inhaled fluticasone propionate Nebules™ 1mg bd with oral prednisolone administered for 7 days to children aged 4 to 16 years with asthma
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FLTB3055-ICHE3.pdf
    View full study record
    Document reference: 28421
    Study title: A double blind, double dummy, placebo controlled trial of Fluticasone propionate aqueous nasal spray and oral Ketotifen in children with perennial rhinitis aged between 2 and 4 years.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FLNQ12-ICHE3.pdf
    View full study record
    Document reference: 28364
    Study title: A double-blind, 2x2 Factohal Study to evaluate the effects of treatment with intranasal fluticasone propionate and use of Otovent mechanical ventilation of the middle ear on the need for surgery in children aged 4-8 with chronic or recurrent otitis media.
    Active substance: FLUTICASONE
    Study summary document link (including results): Study FLNL45-Fluticasone_Flixonase.xls
    View full study record
    Document reference: 28363
    Study title: A Double-Blind, Double-Dummy, Placebo-Controlled, Crossover Study to Compare the Potential Short-Term Growth Effect of Fluticasone Propionate Aqueous Nasal Spray, Beclomethasone Dipropionate Aqueous Nasal Spray, and Placebo in Adolescents with Perennial Allergic Rhinitis.
    Active substance: FLUTICASONE
    Study summary document link (including results): Study FNM40007-Fluticasone_Flixonase.xls
    View full study record
    Document reference: 28365
    Study title: A double-blind, randomized, placebo-controlled study of the efficacy and safety of aqueous fluticasone propionate given once- versus twice-daily versus placebo for two weeks in adolescent patients with seasonal allergic rhinitis
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FLN-305-ICHE3.pdf
    View full study record
    Document reference: 28407
    Study title: A double-blind, randomized, placebo-controlled study of the efficacy and safety of aqueous fluticasone propionate given once daily versus placebo for two weeks in pediatric patients with seasonal allergic rhinitis
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FLN-320-ICHE3.pdf
    View full study record
    Document reference: 28408
    Study title: A double-blind, randomized, placebo-controlled study of the efficacy and safety of aqueous fluticasone propionate versus placebo for four weeks in pediatric patients with seasonal allergic rhinitis
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FNM30008-ICHE3.pdf
    View full study record
    Document reference: 28409
    Study title: A Multi-Center, Randomized, Double-Blind, Parallel-Group Study to Assess the Potential Growth Effects of a One-Year Course of Fluticasone Propionate Aqueous Nasal Spray (200mcg QD) Versus Placebo in Prepubescent, Pediatric Subjects with Perennial Allergic Rhinitis
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FNM40017-ICHE3.pdf
    View full study record
    Document reference: 28414
    Study title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Potential Effects of a Six-Week Course of Fluticasone Propionate Aqueous Nasal Spray (200mcg QD) on the HPA-Axis in ≥2 and <4 Year Old Subjects with Allergic Rhinitis.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FNM40183-ICHE3.pdf
    View full study record
    Document reference: 28416
    Study title: A multi-centre, randomised, double-blind, double-dummy, parallel-group study to compare the efficacy and safety of fluticasone propionate 400μg daily with budesonide 400μg daily in children with asthma.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FMS30037-ICHE3.pdf
    View full study record
    Document reference: 28426
    Study title: A multi-centre, randomised, double-blind, double-dummy, parallel-group study to determine the clinical equivalence between fluticasone propionate 100μg twice daily delivered via a multidose powder inhaler (MDPI) and the Diskhaler™ in adult and paediatric patients with reversible airways disease.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-propionate-FMDT02-ICHE3.pdf
    View full study record
    Document reference: 28424
    Study title: Describing three children, two with meningitis and one with septicemia, from whom ampicillin-resistant Haemophilus influenzae type B were isolated from the CSF, blood or both. At least one case represents ampicillin failure in the treatment of H. influenzae meningitis because of resistence of the organism to the drug.Ousama et al. (JAMA, July 15 1974, Vol 229, No 3)
    Active substance: AMPICILLIN
    Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_7.xlsx
    View full study record
    Document reference: 49007
    Study title:
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41161
    Study title: A phase II, double-blind, randomized study to compare the immunogenicity, safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals¿ Tritanrix¿-HepBlow thio/Hib2.5 Gödöllö to GSK Biologicals¿ Tritanrix¿-HepB/Hiberix¿Gödöllö when administered as a three-dose primary vaccination course to healthy infants at 6, 10 and 14 weeks of age. A dose of unconjugated Hib vaccine (plain PRP booster) will be administered at the age of 10 months to 50% of the subjects. Note: This report presents the results pertaining to the plain PRP challenge at 10 months of age.
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41159
    Study title: "Fluoxetine Vs Placebo In Obsessive Compulsive "
    Active substance: FLUOXETINE
    Study summary document link (including results):
    View full study record
    Document reference: 28337
    Study title: Fluoxetine Vs Placebo In Ocd Relapse Prevention
    Active substance: FLUOXETINE
    Study summary document link (including results):
    View full study record
    Document reference: 28328
    Study title: Fluoxetine Vs Placebo In Post Natal Depression
    Active substance: FLUOXETINE
    Study summary document link (including results):
    View full study record
    Document reference: 28326
    Study title: "Fluoxetine vs. Placebo in the Acute Treatment of Major Depressive Disorder in Children and Adolescents
    Active substance: FLUOXETINE
    Study summary document link (including results): fluoxetine B1Y-MC-X065 Clinical Study Synopsis.pdf
    View full study record
    Document reference: 28343
    Study title: Fluoxetine: In Depression And Ocd (Compassionate Use)
    Active substance: FLUOXETINE
    Study summary document link (including results):
    View full study record
    Document reference: 28332
    Study title: Fluoxetine/Placebo In Panic Disorder
    Active substance: FLUOXETINE
    Study summary document link (including results):
    View full study record
    Document reference: 28338
    Study title: Impact Of Fluoxetine On Growth In Children And Adolescents
    Active substance: FLUOXETINE
    Study summary document link (including results):
    View full study record
    Document reference: 28330
    Study title: Pharmacokinetic Assessment of Fluoxetine and Norfluoxetine in Preadolescent and Adolescent Patients
    Active substance: FLUOXETINE
    Study summary document link (including results): fluoxetine B1Y-MC-HCIU Clinical Study Summary.pdf
    View full study record
    Document reference: 47357
    Study title: "Prozac.Epidemiological Study In Obsessional Compulsive Disorder "
    Active substance: FLUOXETINE
    Study summary document link (including results):
    View full study record
    Document reference: 28336
    Study title: Tomoxetine + fluoxetine for Poor Metabolizer exposures
    Active substance: FLUOXETINE
    Study summary document link (including results): fluoxetine B4Z-MC-LYAQ Clinical Study Summary.pdf
    View full study record
    Document reference: 28333
    Study title: Reimão R, Lefévre AB.: Evaluation of flurazepam and placebo on sleep disorders in childhood. Arq Neuropsiquiatr. 1982 Mar;40(1):1-13.
    Active substance: FLURAZEPAM
    Study summary document link (including results):
    View full study record
    Document reference: 28345
    Study title: VALUTAZIONE IN PEDIATRIA DELL'ATTIVITA' IPNOINDUCENTE DEL FLURAZEPAM GOCCE (VAL 779) Rapisarda V.; Germana B. Formazione Psichiatrica, December 1, 1980 , No. 4/- (181-190) Evaluation of flurazepam and placebo on sleep disorders in childhood. Reimão R, Lefévre AB. Arq Neuropsiquiatr. 1982 Mar;40(1):1-13.
    Active substance: FLURAZEPAM
    Study summary document link (including results):
    View full study record
    Document reference: 28344
    Study title:
    Active substance: FLURBIPROFEN
    Study summary document link (including results): Flurbiprofen-M87-097.pdf
    View full study record
    Document reference: 47460
    Study title: Flurbiprofen in the Tretment of Juvenile Rheumatoid Arhtritis
    Active substance: FLURBIPROFEN
    Study summary document link (including results): flurbiprofen-m86055-bass.xls
    View full study record
    Document reference: 48078
    Study title: Pharmacokinetics of Oral and Rectal Flurbiprofen in Childrene
    Active substance: FLURBIPROFEN
    Study summary document link (including results): flurbiprofen-m84016-scaroni.xls
    View full study record
    Document reference: 48076
    Study title: Post-Tonsillectomy Treatment with Flurbiprofen and Phenylprenazone in Children
    Active substance: FLURBIPROFEN
    Study summary document link (including results): flurbiprofen-m84017-catalano.xls
    View full study record
    Document reference: 48077
    Study title: A placebo controlled trial during the pollen season comparing the effects of intranasal Beclomethasone dipropionate and intranasal Fluticasone propionate in children and young adults with asthma and allergic rhinitis.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FNM40054-ICHE3.pdf
    View full study record
    Document reference: 28366
    Study title: A randomised, double-blind, double-dummy, parallel group, multicentre study to compare the effect on growth measured by stadiometry of fluticasone propionate (100μg bd) administered via DISKUS™ with budesonide (200μg bd) administered via Turbuhaler in prepubescent children.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FMS40001-ICHE3.pdf
    View full study record
    Document reference: 28384
    Study title: A Randomized, Double-Blind, Double Dummy, Parallel Group Comparison of Fluticasone Propionate Inhalation Powder (50mcg BID) via DiskusTM with Oral Montelukast (5mg QD) Chewable Tablets in Children 6–12 years of Age with Persistent Asthma
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FPD40012-ICHE3.pdf
    View full study record
    Document reference: 28389
    Study title: A randomized, stratified, double blind trial to compare safety and efficacy of the Fluvirin® Vaccine (a purified surface antigen vaccine) with Connaught Inactivated Influenza Vaccine Fluzone® (a split virion vaccine) in healthy children aged 6 to 47 months of age.Nicolay 1999, Vaccine 17 (1999) 2223-2228
    Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed)
    Study summary document link (including results): MPL-318-01.xlsx
    View full study record
    Document reference: 49190
    Study title: Controlled study on the efficacy of Flour-Vigantoletten 1000 in prophylaxis of rachitis -Kontrollierte Studie zur rachitisprophylaktischen Wirkung von Flour-Vigantoletten 1000.Ther d Gegenw 1976; 115: 2076-2087 Pohlandt F., 1976
    Active substance: COLECALCIFEROL AND SODIUM FLUORIDE
    Study summary document link (including results): 20140709_Art 45 Studies.xlsx
    View full study record
    Document reference: 48990
    Study title: open uncontrolled study to evaluate the acceptance and tolerance of flucloxacillin suspension.Lidgren. Clinical trial on flucloxacillin suspension in children.
    Active substance: FLUCLOXACILLIN
    Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Flukloxacillin_2.xlsx
    View full study record
    Document reference: 49075
    Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IV FCA IN THE TREATMENT OF CANDIDIASIS IN THE LEUKEMIC PATIENTS
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27941
    Study title: EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF FUNGAL INFECTIONS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27663
    Study title: Anticancer Res. 2003 Jul-Aug;23(4):3513-6. Differentiating recurrent or residual nasopharyngeal carcinomas from post-radiotherapy changes with 18-fluoro-2-deoxyglucose positron emission tomography and thallium-201 single photon emission computed tomography in patients with indeterminate computed tomography findings. Tsai MH, Huang WS, Tsai JJ, Chen YK, Changlai SP, Kao CH.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28141
    Study title: Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidismJ Pediatr 2000; 136: 292-297 Bongers-Schokking JJ., 2000
    Active substance: LEVOTHYROXINE
    Study summary document link (including results): 20140709_Art 45 Studies.xlsx
    View full study record
    Document reference: 48982
    Study title: Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitis. Clinical and Experimental Allergy 29, p. 1367-1 377, 1999Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitis. Clinical and Experimental Allergy 29, p. 1367-1 377, 1999
    Active substance: LEVOCABASTINE
    Study summary document link (including results):
    View full study record
    Document reference: 31137
    Study title: Comparison of bisoprolol and verapamil in hypertension: influence on left ventricular mass and function−−a pilot study.Ostman−Smith I, Wettrell G, Riesenfeld T. Journal of the American College of Cardiology, 15 Nov 1999, vol. 34, no. 6, p.1813−22, Comparison of bisoprolol and verapamil in hypertension: influence on left ventricular mass and function−−a pilot study.Ostman−Smith I, Wettrell G, Riesenfeld T. Journal of the American College of Cardiology, 15 Nov 1999, vol. 34, no. 6, p.1813−22,
    Active substance: VERAPAMIL
    Study summary document link (including results):
    View full study record
    Document reference: 45541
    Study title: Factors influencing the prediction of steady state concentrations of digoxin.Nakamura T, Kakumoto M, Yamashita K, Takara K, Tanigawara Y, Sakaeda T, Okumura K. Biological & pharmaceutical bulletin, Apr 2001, vol. 24, no. 4, p. 403−8,Factors influencing the prediction of steady state concentrations of digoxin.Nakamura T, Kakumoto M, Yamashita K, Takara K, Tanigawara Y, Sakaeda T, Okumura K. Biological & pharmaceutical bulletin, Apr 2001, vol. 24, no. 4, p. 403−8,
    Active substance: VERAPAMIL
    Study summary document link (including results):
    View full study record
    Document reference: 45538
    Study title: Valutazione degli effetti indotti dall'uso di verapamile, flunarizina, diltiazem, nimodipina e placebo nella profilassi dell'emicrania. Studio a doppio cieco randomizzato cross−over. (Evaluation of the effects of verapamil, flunarizine, diltiazem, nimodipine and placebo in the prevention of hemicrania. A double−blind randomized cross−over study).Paterna S, Martino SG, Campisi D, Cascio IN, Marsala BA. La Clinica terapeutica, 31 Jul 1990, vol. 134, no. 2, p. 119−25, Valutazione degli effetti indotti dall'uso di verapamile, flunarizina, diltiazem, nimodipina e placebo nella profilassi dell'emicrania. Studio a doppio cieco randomizzato cross−over. (Evaluation of the effects of verapamil, flunarizine, diltiazem, nimodipine and placebo in the prevention of hemicrania. A double−blind random...
    Active substance: VERAPAMIL
    Study summary document link (including results):
    View full study record
    Document reference: 45557
    Study title: In vitro generation of cytotoxic effectors activated by interleukin 2 (IL-2): Comparison of autologous peripheral blood stem cells (PBSC) from adults and children. Valteau-Couanet D et al. Bone Marrow Transplant June. 13, 2001, 869-75
    Active substance: FLUOROURACIL
    Study summary document link (including results):
    View full study record
    Document reference: 28274
    Study title: A fluoride dose response evaluation in an anticaries clinical trial1992-Marks, J Dent Res(71)6:1286-1291, June 1992
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1992-Marks-a fluoride dose response evaluation in an anticaries clinical trial.pdf
    View full study record
    Document reference: 49086
    Study title: Topical stannous fluoride as a caries preventive for preschool children1962-Burgess
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results): 1962-Burgess-Topical stannous fluoride as a caries preventive for preschool children.pdf
    View full study record
    Document reference: 49142
    Study title: Assessment of Efficacy and Systemic Safety of a New Chlorofluorocarbon-Free Formulation of Inhaled Beclomethasone Dipropionate in Asthmatic ChildrenPEDIATRIC ASTHMA, ALLERGY & IMMUNOLOGY, Volume 15, Number 3, 2002
    Active substance: BECLAMETHASONE
    Study summary document link (including results): DM-RS-3303-05-00 pubblication.pdf
    View full study record
    Document reference: 49208
    Study title: Efficacy and tolerability of morniflumate in the treatment of acute pharyngotonsillitis in children. Clinica,anno XXIX, 77-84, gennaio-giugno 1990R.Riondino et al, 1990. Clinica Europea 1990, Riondino
    Active substance: MORNIFLUMATE
    Study summary document link (including results): Clinica Europea 1990, Riondino.pdf
    View full study record
    Document reference: 48878
    Study title: Treatment of acute bronchitis in childhood with morniflumate. Clinica,anno XXIX, 77-84, gennaio-giugno 1990L.Longo et al , 1990. Clinica Europea 1990 Longo
    Active substance: MORNIFLUMATE
    Study summary document link (including results): Clinica Europea 1990 Longo.pdf
    View full study record
    Document reference: 48877
    Study title:
    Active substance: FLUTICASONE
    Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FLD40004.pdf
    View full study record
    Document reference: 28434
    Study title: Neurology. 1995 Jan;45(1):123-6. FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy. Gaillard WD, Bhatia S, Bookheimer SY, Fazilat S, Sato S, Theodore WH.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28201
    Study title: Bericht über die klinische Prüfung von 9alpha-Fluorhydrocortison zur Behandlung hypotoner und orthostatischerKreislaufregulationsstörungen, Arzneim Forsch (Drug Research) 1971; 21: 1144-1149, Legeler HJ. , 1971
    Active substance: FLUDOCORTISONE
    Study summary document link (including results): 20140709_Art 45 Studies.xlsx
    View full study record
    Document reference: 48904
    Study title: Corticosteroids administered by nebulization to children with bronchial asthma.Terzano C, Barkai L, Cremonesi G., Adv Ther. 2001 Nov-Dec;18:253-60.
    Active substance: FLUNISOLIDE
    Study summary document link (including results): MC-PR-3502-001-99 publication.pdf
    View full study record
    Document reference: 49211
    Study title: Double-blind evaluation of effectiveness and safety of flunisolide aerosol for treatment of bronchial asthma in children.Piacentini G.L. et al, Allergy 1990,45, 612-616
    Active substance: FLUNISOLIDE
    Study summary document link (including results): Published paper (Piacentini).pdf
    View full study record
    Document reference: 49212
    Study title: Mitomycin C and 5-fluorouracil antimetabolite therapy for pediatric glaucoma filtration surgery. Snir M et al. Ophthalmic Surg Lasers. January 1, 2000, 31-7
    Active substance: FLUOROURACIL
    Study summary document link (including results):
    View full study record
    Document reference: 28277
    Study title: A PROSPECTIVE SURVEY OF OPPORTUNISTIC INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIAS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27481
    Study title: CLINICAL EVALUATION OF FLUCONAZOLE (UK-49,858) IN IV DRIP ENJECTION FROM EFFICACY AND SAFETY IN PEDIATRIC SYSTEMIC MYCOSIS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27933
    Study title: ONCE-WEEKLY ORAL FCA VS. PLACEBO IN THE PREVENTION OF MUCOCUTANEOUS FUNGAL INFECTIONS IN PATIENTS DISCHARGED FROM THE HOSPITAL AFTER BONE MARROW TRANSPLANTATION.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27611
    Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN HOSPITALIZED PATIENTS ON IVH
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27520
    Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH GASTRO-INTESTINAL CANDIDIASIS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27784
    Study title: An open uncontrolled study to evaluate the effect of treatment and tolerance of a flucloxacillin nsyrup.Price et al Flucloxacillin in the treatment of infectious conditions in children.
    Active substance: FLUCLOXACILLIN
    Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Flukloxacillin_1.xlsx
    View full study record
    Document reference: 49076
    Study title: Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitis. Clinical and Experimental Allergy 29, p. 1367-1 377, 1999Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitis. Clinical and Experimental Allergy 29, p. 1367-1 377, 1999
    Active substance: LEVOCABASTINE
    Study summary document link (including results):
    View full study record
    Document reference: 31118
    Study title: Safety and Efficacy of Rabeprazole in the Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Subjects
    Active substance: RABEPRAZOLE
    Study summary document link (including results): Rabeprazole-E3810-A001-202 (synopsis).pdf
    View full study record
    Document reference: 35258
    Study title: Eiermann B, Sommer N, Winne D, Schumm F, Maier U, Breyer-Pfaff U. Renal clearance of pyridostigmine in myasthenic patients and volunteers under the influence of ranitidine and pirenzepine. Xenobiotica. 1993 Nov;23(11):1263-75.Eiermann B, Sommer N, Winne D, Schumm F, Maier U, Breyer-Pfaff U. Renal clearance of pyridostigmine in myasthenic patients and volunteers under the influence of ranitidine and pirenzepine. Xenobiotica. 1993 Nov;23(11):1263-75.
    Active substance: PYRIDOSTIGMINE
    Study summary document link (including results):
    View full study record
    Document reference: 35222
    Study title: Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial. Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial.
    Active substance: PYRITINOL
    Study summary document link (including results):
    View full study record
    Document reference: 35235
    Study title: Mehta PD, Kulczycki J, Patrick BA, Sobczyk W, Wisniewski HM. J Neurol Sci. 1992 May;109(1):64-8. Effect of treatment on oligoclonal IgG bands and intrathecal IgG synthesis in sequential cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis.Mehta PD, Kulczycki J, Patrick BA, Sobczyk W, Wisniewski HM. J Neurol Sci. 1992 May;109(1):64-8. Effect of treatment on oligoclonal IgG bands and intrathecal IgG synthesis in sequential cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis.
    Active substance: INOSINE
    Study summary document link (including results):
    View full study record
    Document reference: 30147
    Study title: Spectrophotofluorometric assay for Isoniazid and Acetyl Isoniazid in Plasma adapted tp pediatric studies - Clin. Chem., 23(4), 745 - Olson W.A. Et al (1977) Spectrophotofluorometric assay for Isoniazid and Acetyl Isoniazid in Plasma adapted tp pediatric studies - Clin. Chem., 23(4), 745 - Olson W.A. Et al (1977)
    Active substance: RIFAMPICIN/ISONIAZID/PYRAZINAMIDE
    Study summary document link (including results):
    View full study record
    Document reference: 45141
    Study title: Glikson M et al. The influence of pyridostigmine administration on human neuromuscular functions--studies in healthy human subjects. Fundam Appl Toxicol. 1991 Feb;16(2):288-98Glikson M et al. The influence of pyridostigmine administration on human neuromuscular functions--studies in healthy human subjects. Fundam Appl Toxicol. 1991 Feb;16(2):288-98
    Active substance: PYRIDOSTIGMINE
    Study summary document link (including results):
    View full study record
    Document reference: 35209
    Study title: J Nucl Med Technol. 2007 Mar;35(1):21-6.Reproducibility of a standardized quantitative analysis using fixed regions of interest to differentiate movement disorders on 123I-FP-CIT SPECT. Stokkel MP, Dibbets-Schneider P, Koestering E, Dragoiescu C, Blokland KA. J Nucl Med Technol. 2007 Mar;35(1):21-6.Reproducibility of a standardized quantitative analysis using fixed regions of interest to differentiate movement disorders on 123I-FP-CIT SPECT. Stokkel MP, Dibbets-Schneider P, Koestering E, Dragoiescu C, Blokland KA.
    Active substance: ioflupane (123l)
    Study summary document link (including results):
    View full study record
    Document reference: 41498
    Study title: Neurology. 2001 Jan 23;56(2):266-7. SPECT imaging of the dopamine transporter in juvenile-onset dystonia. O'Sullivan JD, Costa DC, Gacinovic S, Lees AJ.Neurology. 2001 Jan 23;56(2):266-7. SPECT imaging of the dopamine transporter in juvenile-onset dystonia. O'Sullivan JD, Costa DC, Gacinovic S, Lees AJ.
    Active substance: ioflupane (123l)
    Study summary document link (including results):
    View full study record
    Document reference: 41501
    Study title: Neurology. 2004 Dec 14;63(11):2097-103. Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease. Varrone A, Pellecchia MT, Amboni M, Sansone V, Salvatore E, Ghezzi D, Garavaglia B, Brice A, Brunetti A, Bonavita V, De Michele G, Salvatore M, Pappatà S, Barone P. Neurology. 2004 Dec 14;63(11):2097-103. Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease. Varrone A, Pellecchia MT, Amboni M, Sansone V, Salvatore E, Ghezzi D, Garavaglia B, Brice A, Brunetti A, Bonavita V, De Michele G, Salvatore M, Pappatà S, Barone P.
    Active substance: ioflupane (123l)
    Study summary document link (including results):
    View full study record
    Document reference: 41499
    Study title: Acta Radiol. 1989 Nov-Dec;30(6):643-6 Influence of urography on renal function in children. A double blind study with metrizoate and iohexol. Stake G, Monn E, Rootwelt K, Golman K, Monclair T Acta Radiol. 1989 Nov-Dec;30(6):643-6 Influence of urography on renal function in children. A double blind study with metrizoate and iohexol. Stake G, Monn E, Rootwelt K, Golman K, Monclair T
    Active substance: IOHEXOL
    Study summary document link (including results):
    View full study record
    Document reference: 30361
    Study title: Cappa M et al. The growth hormone response to pyridostigmine plus growth hormone releasing hormone is not influenced by pubertal maturation. J Endocrinol Invest. 1991 Jan;14(1):41-5Cappa M et al. The growth hormone response to pyridostigmine plus growth hormone releasing hormone is not influenced by pubertal maturation. J Endocrinol Invest. 1991 Jan;14(1):41-5
    Active substance: PYRIDOSTIGMINE
    Study summary document link (including results):
    View full study record
    Document reference: 35210
    Study title: Remifentanil/Propofol versus Desflurane/N2O in general surgery, opthalmic surgery and ENT surgery in children
    Active substance: REMIFENTANIL
    Study summary document link (including results):
    View full study record
    Document reference: 35286
    Study title: Remifentanil/propofol versus remifentanil/sevoflurane in- and outpatient paediatric surgery
    Active substance: REMIFENTANIL
    Study summary document link (including results):
    View full study record
    Document reference: 35288
    Study title: Remifentanil/Propofol versus Sevofluran/N2O für allgemeinchirurgische und HNO-Eingriffe bei Kindern: Ein Vergleich der Hämodynamik, des Einschlaf- und Aufwachverhaltens sowie der anästhesierelevanten Zeiten
    Active substance: REMIFENTANIL
    Study summary document link (including results):
    View full study record
    Document reference: 35287
    Study title: Oh AY, Kim SD, Kim CS. Early and late reversal of rocuronium with pyridostigmine during sevoflurane anaesthesia in children. Anaesth Intensive Care. 2004 Oct;32(5):649-52Oh AY, Kim SD, Kim CS. Early and late reversal of rocuronium with pyridostigmine during sevoflurane anaesthesia in children. Anaesth Intensive Care. 2004 Oct;32(5):649-52
    Active substance: PYRIDOSTIGMINE
    Study summary document link (including results):
    View full study record
    Document reference: 35184
    Study title: A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. Allergy 54, p.1173-1180, 1999A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. Allergy 54, p.1173-1180, 1999
    Active substance: LEVOCABASTINE
    Study summary document link (including results):
    View full study record
    Document reference: 31138
    Study title: Dr. Benezis Essai contrôle en double aveugle etablissant l'efficacité et la tolerance de l'acide niflumique gélule par rapport au placébo et au diclofenac dans les tendinites du membre inférieur.
    Active substance: NIFLUMIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 32637
    Study title: Dr. M. Chelly.Essai controle en ouvert evaluant l'efficacitè et la tolèrance du morniflumate suppositoire enfant versus alpha-amylase sirop dans les angines.
    Active substance: NIFLUMIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 32638
    Study title: Bortone L, Picetti E, Mergoni M. Anaesthesia with sevoflurane in children: Nitrous oxide does not increase postoperative vomiting. Paediatric Anaesthesia. 2002; 12(9):775-9. Bortone L, Picetti E, Mergoni M. Anaesthesia with sevoflurane in children: Nitrous oxide does not increase postoperative vomiting. Paediatric Anaesthesia. 2002; 12(9):775-9.
    Active substance: NITROUS OXIDE
    Study summary document link (including results):
    View full study record
    Document reference: 32663
    Study title: Byhahn C, Strouhal U, Westphal K. The anaesthesiologist's occupational exposure to sevoflurane and nitrous oxide during inhalation mask induction and general anaesthesia in paediatric anaesthesia. Anaesthesiologie und Reanimation. 2000; 25(1):12-6. Byhahn C, Strouhal U, Westphal K. The anaesthesiologist's occupational exposure to sevoflurane and nitrous oxide during inhalation mask induction and general anaesthesia in paediatric anaesthesia. Anaesthesiologie und Reanimation. 2000; 25(1):12-6.
    Active substance: NITROUS OXIDE
    Study summary document link (including results):
    View full study record
    Document reference: 32664
    Study title: Goldman LJ. Anesthetic uptake of sevoflurane and nitrous oxide during an inhaled induction in children. Anesthesia and Analgesia. 2003; 96(2):400-6 Goldman LJ. Anesthetic uptake of sevoflurane and nitrous oxide during an inhaled induction in children. Anesthesia and Analgesia. 2003; 96(2):400-6
    Active substance: NITROUS OXIDE
    Study summary document link (including results):
    View full study record
    Document reference: 32666
    Study title: PA Averley, NM Girdler, S Bond, N Steen, J Steele. A randomised controlled trial of paediatric conscious sedation for dental treatment using intravenous midazolam combined with inhaled nitrous oxide or nitrous oxide⁄sevoflurane. Anaesthesia, 2004, 59, pages 844–852 PA Averley, NM Girdler, S Bond, N Steen, J Steele. A randomised controlled trial of paediatric conscious sedation for dental treatment using intravenous midazolam combined with inhaled nitrous oxide or nitrous oxide⁄sevoflurane. Anaesthesia, 2004, 59, pages 844–852
    Active substance: NITROUS OXIDE
    Study summary document link (including results):
    View full study record
    Document reference: 32669
    Study title: Minimal inhibittory concentrations of telithromycin (Ketek) against Streptococcus pneumoniae, Heamophilus influenzae and Moraxella catarrhalis strains isolated from specimen of young patients (17 years old or less) and from specimen of adults (18 years old and older)
    Active substance: telithromycin
    Study summary document link (including results):
    View full study record
    Document reference: 41557
    Study title: Open Study to determine the concentration of telithromycin in middle ear fluid and plasma in infants/children with otitis media with effusion after multiple oral administration of 20mg/kg, once daily for 5 days or 15mg/kg twice daily for 4.5/5 days of telithromycin pediatric suspension
    Active substance: telithromycin
    Study summary document link (including results):
    View full study record
    Document reference: 41568
    Study title: Open Study to determine the concentration of telithromycin in the extracellular and intracellular compartments of middle ear fluid in children with acute otitis media or otitis media with spontaneous effusion after single oral administration of a telithromycin pediatric suspension
    Active substance: telithromycin
    Study summary document link (including results):
    View full study record
    Document reference: 41567
    Study title: The effect of Bricanyl Turbuhaler and Bricanyl chlorofluorocarbon (CFC) inhaler on exercise-induced asthma in children.
    Active substance: TERBUTALINE
    Study summary document link (including results): Terbutaline Bricanyl 01-2178 interventional.xls
    View full study record
    Document reference: 44414
    Study title: Evaluation of the role of acidic and non-acidic reflux in recurrent respiratory and chronic ear, nose,and throat (ENT) diseases in children by using multichannel intraluminal impedance (MII) apparatus
    Active substance: OMEPRAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 32778
    Study title: Omeprazole in children with reflux esophagitis-an open dose finding study and an evaluation of the safety and efficacy during maintenance treatment. Interim report 1996
    Active substance: OMEPRAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 32794
    Study title: PK/PD study on omeprazole in children with gastro-esophageal reflux
    Active substance: OMEPRAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 32771
    Study title: Use of magnesium omeprazole (MOPRAL) for treating pathological gastroesophagael reflux in children (Mexico)
    Active substance: OMEPRAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 32775
    Study title: Arguelles-Martin F. Sucralfate versus cimetidine in the treatment of reflux oesophagitis in children. Am J Med 1989; 86 (suppl 6A): 73-76. Arguelles-Martin F. Sucralfate versus cimetidine in the treatment of reflux oesophagitis in children. Am J Med 1989; 86 (suppl 6A): 73-76.
    Active substance: SUCRALFATE
    Study summary document link (including results):
    View full study record
    Document reference: 42602
    Study title: Hermans . Primary duodenogastric reflux in children and adolescents. Eur J Pediatr 2003; 162: 598-602. Hermans . Primary duodenogastric reflux in children and adolescents. Eur J Pediatr 2003; 162: 598-602.
    Active substance: SUCRALFATE
    Study summary document link (including results):
    View full study record
    Document reference: 42604
    Study title: Bacopoulou, 2009;Netilmicin in the neonate: pharmacokinetic analysis and influence of parenteral nutrition Pharm World Sci (2009) 31:365–368 DOI 10.1007/s11096-009-9278-z
    Active substance: NETILMICIN
    Study summary document link (including results):
    View full study record
    Document reference: 32622
    Study title: 12.) Influence of Wobenzym treat- ment in children with increased sickness rate
    Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase
    Study summary document link (including results):
    View full study record
    Document reference: 40104
    Study title: Publication in CES0506 - Lavin B - 30/06/2006 Comparative efficacy, safety, and effect on quality of life of triamcinolone acetonide and fluticasone propionate aqueous nasal sprays in patients with fall seeasonal allergic rhinitis - Gross - 2002 (Annals of allergy asthma & immunology 89; 1: 56-62, 2002)
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 46833
    Study title: Publication in Rapport d'Expert sur la documentation pharmaco-toxicologique - Roquet F - 15/08/1995 A thirty day comparison of the oral toxicity of CL 30,980 : 1,4-Pregnadiene-3,20-dione, 9a-fluoro-11b-hydroxy-16a,17a-(isopropylidenedioxy)-21-(tetrahydropyran-2-yloxy)- and CL 22,353 : 1,4-Pregnadiene-3,20-dione, 9a-fluoro-11b,21-dihydroxy-16a,17a-(isopropylidenedioxy)- in rats - Kanegis LA - 26/09/1960 (Safety Evaluation.studies. PR Volume 6, 2694-2726)
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 46838
    Study title: Comparison of IM pethidine, diazepam and flunitrazepam as premedicants in children undergoing otolaryngological surgery - L Lindgren Br J. - 1979 (Anaesth 1979, 51 321-327) - Publication in expert report DOL01VOL2 -
    Active substance: PETHIDINE
    Study summary document link (including results):
    View full study record
    Document reference: 45868
    Study title: The effect of oxyphenonium bromide and oxybutynin hydrochloride on detrusor contractility and reflux in children with vesicoureteral reflux and detrusor instability. - Scholtmeijer RJ, Van Mastrigt R - J Urol - 1991; 146(2):660-662 The effect of oxyphenonium bromide and oxybutynin hydrochloride on detrusor contractility and reflux in children with vesicoureteral reflux and detrusor instability. - Scholtmeijer RJ, Van Mastrigt R - J Urol - 1991; 146(2):660-662
    Active substance: OXYBUTYNIN
    Study summary document link (including results):
    View full study record
    Document reference: 32998
    Study title: "The influence of a whole-bone preparation on the growth of dystrophic children", Gotti D. & Nicolaj P., La clinica Pediatrica, 1951, N°5, 33 "The influence of a whole-bone preparation on the growth of dystrophic children", Gotti D. & Nicolaj P., La clinica Pediatrica, 1951, N°5, 33
    Active substance: OSSEIN HYDROXYAPATITE COMPOUND
    Study summary document link (including results): Ossopan nr7.xls
    View full study record
    Document reference: 47720
    Study title: The effect of oxyphenonium bromide and oxybutynin hydrochloride on detrusor contractility and reflux in children with vesicoureteral reflux and detrusor instability. - Scholtmeijer RJ, Van Mastrigt R - J Urol - 1991; 146(2):660-662The effect of oxyphenonium bromide and oxybutynin hydrochloride on detrusor contractility and reflux in children with vesicoureteral reflux and detrusor instability. - Scholtmeijer RJ, Van Mastrigt R - J Urol - 1991; 146(2):660-662
    Active substance: OXITRIPTAN
    Study summary document link (including results):
    View full study record
    Document reference: 32926
    Study title: Influence of therapy by Woben-zym on immune and metabolic parametrs at children with chronic hepatitis B
    Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase
    Study summary document link (including results):
    View full study record
    Document reference: 40112
    Study title: The Uninhibited Bladder in Children : Effect of Treatment on Recurrence of Urinary Infection and on Vesicoureteral Reflux Resolution - Koff A S and Murtagh D S. - J of Urology - 1983 ; (130: 1138-1141) - Publication in UK registration file - The Uninhibited Bladder in Children : Effect of Treatment on Recurrence of Urinary Infection and on Vesicoureteral Reflux Resolution - Koff A S and Murtagh D S. - J of Urology - 1983 ; (130: 1138-1141) - Publication in UK registration file -
    Active substance: OXITRIPTAN
    Study summary document link (including results):
    View full study record
    Document reference: 32918
    Study title: Final Study report: Influence of intravenous, Intramuscular and oral administration of Konakion MM Paediatric on Bilirubin Binding to albumin in Full-Term Neonates (BK15055)
    Active substance: PHYTOMENADION
    Study summary document link (including results):
    View full study record
    Document reference: 34048
    Study title: Publication in CES - Ruuth E - 19/10/2001 Triamcinolone acetonide aqueous nasal inhaler and fluticasone propionate have no effect on short-term growth in children with allergic rhinitis - Skoner D - 2000 ( Allergy 2000; 55(Suppl 63): 184)
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 46832
    Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IV AND/OR PO O.S. FLUCONAZOLE IN THE TREATMENT OF PEDIATRIC PATIENTS WITH SYSTEMIC CANDIDIASIS. THIS IS A COMPASSIONATE TREATMENT.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27374
    Study title: Eur Heart J. 1990 Oct;11(10):916-24. Influence of age and sex on left ventricular volumes and ejection fraction during upright exercise in normal subjects. Younis LT, Melin JA, Robert AR, Detry JM. Eur Heart J. 1990 Oct;11(10):916-24. Influence of age and sex on left ventricular volumes and ejection fraction during upright exercise in normal subjects. Younis LT, Melin JA, Robert AR, Detry JM.
    Active substance: THALLIUM 201T1 CHLORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 44564
    Study title: MULTICENTRIC NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF FCA FOR THE TREATMENT OF SEVERE SYSTEMIC CANDIDIASIS AND CRYPTOCOCCAL MENINGITIS
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 28035
    Study title: A PROSPECTIVE RANDOMIZED TRIAL OF FCA VS. AMPHOTERICIN B FOR EMPERIC ANTI-FUNGAL THERAPY OF THE NEUTROPENIC FEBRILE PATIENTS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27986
    Study title: Tramadol iv vs nalbuphine iv, 47 children aged 1 to 10 years old. IIS on tramadol in children undergoing endoscopic surgery for reflux oesophagitis. One-year double-blind comparison of post-op tramadol (bolus of 2 mg/kg BW + infusion of 8 mg/kg BW over 24 h) vs nalbuphine.
    Active substance: TRAMADOL
    Study summary document link (including results):
    View full study record
    Document reference: 45011
    Study title: Influence of Beta Adrenergic Antagonists on Tear Secretion
    Active substance: TIMOLOL
    Study summary document link (including results): Influence of Beta Adrenergic Antagonists on Tear Secretion i.pdf
    View full study record
    Document reference: 47680
    Study title: Influences of tramadol on emergence characteristics from sevoflurane anaesthesia in pediatric ambulatory surgery - Fan KT, Lee TH, Yu KL, Tang CS, Lu DV, Chen PY, Soo LY - 2000 (Kaohsiung J Med Sci, 2000; 16: 255-260)Influences of tramadol on emergence characteristics from sevoflurane anaesthesia in pediatric ambulatory surgery - Fan KT, Lee TH, Yu KL, Tang CS, Lu DV, Chen PY, Soo LY - 2000 (Kaohsiung J Med Sci, 2000; 16: 255-260)
    Active substance: TRAMADOL
    Study summary document link (including results):
    View full study record
    Document reference: 45029
    Study title: CLINICAL EVALUATION OF DIFLUCAN ON SEVERE CANDIDEMIA
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27536
    Study title: Levocabastine eye drops and nasal spray in seasonal allergic rhino conjunctivitis: a single-blind comparison with antazolineaphazoline eye drops and flunisolide nasal spray (17-54 yrs)
    Active substance: LEVOCABASTINE
    Study summary document link (including results): LMD43871_Interventional_Levocabastine.xls
    View full study record
    Document reference: 31094
    Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN HOSPITALIZED PATIENTS IN ICU.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27877
    Study title: Wirkung und Verträglichkeit von Tussamag Hustensaft bei Kindern mit akuter Bronchitis
    Active substance: Thymi Extractum Fluidum
    Study summary document link (including results):
    View full study record
    Document reference: 40257
    Study title: Sysoeva N.A: Dynamics of selected homeostatic parameters in children suffering from thyroid gland pathology under the influence of combined treatment. Therapeutic Medico-Biological Vestnik, 2006, 9(2) [IIT-publication];
    Active substance: Thyreoidea compositum
    Study summary document link (including results):
    View full study record
    Document reference: 40258
    Study title: Anticancer Res. 2003 Jul-Aug;23(4):3513-6. Differentiating recurrent or residual nasopharyngeal carcinomas from post-radiotherapy changes with 18-fluoro-2-deoxyglucose positron emission tomography and thallium-201 single photon emission computed tomograpAnticancer Res. 2003 Jul-Aug;23(4):3513-6. Differentiating recurrent or residual nasopharyngeal carcinomas from post-radiotherapy changes with 18-fluoro-2-deoxyglucose positron emission tomography and thallium-201 single photon emission computed tomograp
    Active substance: THALLIUM 201T1 CHLORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 44518
    Study title: Eosinophil cationic protein (ECP) and tryptase in the nasal lavage fluid (NLF) of children with grass pollen rhinitis: levocabastine effect. Allergy and Asthma Proceedings 19(2), p.75-80, 1998Eosinophil cationic protein (ECP) and tryptase in the nasal lavage fluid (NLF) of children with grass pollen rhinitis: levocabastine effect. Allergy and Asthma Proceedings 19(2), p.75-80, 1998
    Active substance: LEVOCABASTINE
    Study summary document link (including results):
    View full study record
    Document reference: 31120
    Study title: Epidemiologische Begleituntersuchungen yur Gruppenprophylaxe 2000 - Gutachten (Prof. Dr. K. Pieper, im Auftrag der Deutschen Arbeitsgemeinschaft fuer Jugendzahnpflege, 2001 ISBN 3/926 228 16-4)
    Active substance: COLECALCIFEROL AND SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 24625
    Study title: EFFICACY AND SAFETY OF FLUCONAZOLE IN PATIENTS WITH OROPHARINGEAL CANDIDIASIS WITHOUT AIDS
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27404
    Study title: The influence of mucolytic treatment on patency of airways.
    Active substance: MESNA
    Study summary document link (including results): DE80H064P - Mesna.pdf
    View full study record
    Document reference: 31681
    Study title: Study of Vogalene drops in gastro-oesophageal reflux in nursing infants clinical, radiological, endoscopic and histological assessment - Ghisolfi J., Olives J.P., Rives J.J. - 09/1979
    Active substance: METOPIMAZINE
    Study summary document link (including results):
    View full study record
    Document reference: 31962
    Study title: Mecillinam in cerebrospinal fluid in childrenMecillinam in cerebrospinal fluid in children
    Active substance: PIVAMPICILLIN
    Study summary document link (including results):
    View full study record
    Document reference: 46057
    Study title: Comparative drug trials on the efficacy of Mebendazole and Flubendazole in the treatrment of Trichuris trichiura and Ascaris lumbricoides infections In children.
    Active substance: MEBENDAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 31532
    Study title: Dose Range Study of Flubendazole in Children vith Ascaris lumbricoides and/ or Trichuris trichiura infections.1979
    Active substance: MEBENDAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 31533
    Study title: Dose-range study of Flubendazole in the treatment of hookworm disease and trichuriasis. 1980
    Active substance: MEBENDAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 31540
    Study title: Single-blind comparison of flubendazole, mebendazole and placebo in the treatment of trichiuriasis ascariasis and hookworm disease. 1981
    Active substance: MEBENDAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 31531
    Study title: A randomized, double-blind, placebo-controlled trial to measure the antibody response to immunisation with diphtheria-tetanus-pertussis-inactivated poliovirus-haemophilus influenzae b and hepatitis B vaccines using
    Active substance: LIDOCAINE AND PRILOCAINE
    Study summary document link (including results): 14_DC-EMB-0002 CSR Synopsis.pdf
    View full study record
    Document reference: 47244
    Study title: Etude de l'activite therapeutique du mucofluid enquete clinique multi-centre
    Active substance: MESNA
    Study summary document link (including results): CF77F224 - Mesna.pdf
    View full study record
    Document reference: 31651
    Study title: Etude in vivo de l’activite mucolytique du mesna (mucofluid spray nasal a 2,5 %) + analyse statistique.
    Active substance: MESNA
    Study summary document link (including results): CE69L071 - Mesna.pdf
    View full study record
    Document reference: 31656
    Study title: Pharmacokinetics and Middle Ear Fluid Penetration of Levofloxacin in Children Undergoing Tympanostomy Tube Placement for Serious Otitis Media
    Active substance: Levofloxacin
    Study summary document link (including results): LOFBO-PHI-I09.pdf
    View full study record
    Document reference: 45234
    Study title: Influence of mistabron on the viscoelasticity of tracheo- bronchial secretions in children with cystic fibrosis
    Active substance: MESNA
    Study summary document link (including results):
    View full study record
    Document reference: 31665
    Study title: An exploratory unblinded trail of Levovist (SH U 508A) used in B-mode sonography in comparison with radiologically monitored voiding cystourethrography in diagnosis of vesicoureterorenal reflux in children (with subsequent blinded reading of the results)
    Active substance: MICROPARTICLES OF GALACTOSE
    Study summary document link (including results):
    View full study record
    Document reference: 31999
    Study title: de Gast-Bakker, D.A., et al., Age is of influence on midazolam requirements in a paediatric intensive care unit. Acta Paediatr, 2007. 96(3): p. 414-7. 2.de Gast-Bakker, D.A., et al., Age is of influence on midazolam requirements in a paediatric intensive care unit. Acta Paediatr, 2007. 96(3): p. 414-7. 2.
    Active substance: MIDAZOLAM
    Study summary document link (including results):
    View full study record
    Document reference: 32001
    Study title: Electrophysiological effects of fenfluramine or combined vitamin B6 and magnesium on children with autistic behaviour - J. Martineau et al. - 1989 (Developmental Medicine and Child Neurology vol 31) - Publication in MAGNE-B6 Magnesium - pyridoxine Tablet & Oral Solution -Response to questions raised during the renewal process in Estonia -Raphaëlle Pivaty- 04/2004 -Electrophysiological effects of fenfluramine or combined vitamin B6 and magnesium on children with autistic behaviour - J. Martineau et al. - 1989 (Developmental Medicine and Child Neurology vol 31) - Publication in MAGNE-B6 Magnesium - pyridoxine Tablet & Oral Solution -Response to questions raised during the renewal process in Estonia -Raphaëlle Pivaty- 04/2004 -
    Active substance: MAGNESIUM LACTATE + MAGNESIUM PIDOLATE + PYRIDOXINE (VIT B6)
    Study summary document link (including results):
    View full study record
    Document reference: 31485
    Study title: Studio comparativo tra miocamicina ed eritromicina nell'erradicazione di streptococco B-emolitico di Gruppo a ed influenza di miocamicina sulla fagocitosi dei polimorfonucleati verso streptococco autologo - M. Borzani, F. Varotto, L.Garlaschi, et al. - Riv. Inf. Ped. 1989, 1, 29-35
    Active substance: MIDECAMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 32014
    Study title: Estudio del vogalen gotas en los reflujos gastroesofagios del lactante confrontacion clinica-radiologica-endoscopia e histologica - Ghisolfi J., Olives J.P., Rives J.J. - 09/1979
    Active substance: METOPIMAZINE
    Study summary document link (including results):
    View full study record
    Document reference: 31960
    Study title: The influence of a synthetic antihistamine upon the bodyweight and height in children
    Active substance: Buclizine
    Study summary document link (including results): CE70A063-translation.pdf
    View full study record
    Document reference: 42014
    Study title: A double blind, cross-over, randomized study with 2 periods of 2 weeks with 2weeks washout. To investigate the mechanisms for the clinical effects of budesonide on LAR, by measuring inflammatory cells and markers in bronchoalveolar lavage (BAL) fluid. Mean age (range): 24.5 years (17 - 30 years)
    Active substance: BUDESONIDE
    Study summary document link (including results):
    View full study record
    Document reference: 48404
    Study title: Immunogenicity and safety study of two doses of Fluvirin (0.25 mL and 0.5 mL) with Vaxigrip (0.25 mL), in Healthy naive pediatric subjects aged 6 to 35 months.
    Active substance: INFLUENZA VACCINE
    Study summary document link (including results):
    View full study record
    Document reference: 48403
    Study title: Mecillinam in cerebrospinal fluid in children; Garborg O. 1981, Clinical Pharmacokinetics, 6:475-479 Mecillinam in cerebrospinal fluid in children; Garborg O. 1981, Clinical Pharmacokinetics, 6:475-479
    Active substance: PIVMECILLINAM
    Study summary document link (including results):
    View full study record
    Document reference: 34534
    Study title: A phase II, controlled, single-center study to assess safety and immunogenicity of a primary vaccination course with one dose of Haemophilus influenzae type b (Hib) conjugate vaccine containing Aluminum Phosphate (Hib/AlPO4 vaccine), given alone or concomitantly with Measles, Mumps and Rubella Vaccine (MMR, Morupar®, licensed by Chiron, now Novartis Vaccines and Diagnostics), in healthy children 12-15 months of age.
    Active substance: Influenza Vaccine (Split Virion, Inactivated)
    Study summary document link (including results):
    View full study record
    Document reference: 48391
    Study title: A Phase II, observer-blind, randomized, multicenter, controlled study of 3 Haemophilus influenzae type b (Hib) vaccines in infants.
    Active substance: Influenza Vaccine (Split Virion, Inactivated)
    Study summary document link (including results):
    View full study record
    Document reference: 48389
    Study title: An extension, phase III, open-label, multicenter study in healthy toddlers, of two Haemophilus influenzae type b (Hib) vaccines administered as a booster dose.
    Active substance: Influenza Vaccine (Split Virion, Inactivated)
    Study summary document link (including results):
    View full study record
    Document reference: 48392
    Study title: an observer blind, randomized, parallel groups, single-center, exploratory Phase IV study to evaluate immunogenicity of two intramuscular doses of influenza vaccine in pediatric subjects.
    Active substance: Influenza Vaccine (Split Virion, Inactivated)
    Study summary document link (including results):
    View full study record
    Document reference: 48387
    Study title: An open label, single-center, pilot study to assess the safety, tolerability and immunogenicity of three injections of the HibCRM/AlPO4 vaccine, when given at 2, 3, 4 months of age to healthy infants.
    Active substance: Influenza Vaccine (Split Virion, Inactivated)
    Study summary document link (including results):
    View full study record
    Document reference: 48390
    Study title: Clinical Testing of Influsplit SSW®93
    Active substance: Influenza Vaccine (Split Virion, Inactivated)
    Study summary document link (including results): Influsplit-1993_ synopsis.pdf
    View full study record
    Document reference: 48377
    Study title: Improved Acidosis Correction and Recovery of Mesothelial Cell Mass with Neutral-pH Bicarbonate Dialysis Solution among Children Undergoing Automated Peritoneal Dialysis, 2003 Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children, 2002 Reduced Advanced Glycation Endproduct (AGE) Levels in Children on Automated Peritoneal Dialysis (PD) with PD-Fluids Containing Less Glucose Degradation Products (GDPs), 2003
    Active substance: ISOTONIC SOLUTIONS
    Study summary document link (including results):
    View full study record
    Document reference: 30757
    Study title: Randomised trial of pivampicillin plus pivmecillinam vs pivampicillin in children and young adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzae; Johansen HK et al 1999 Curr Med Res Opin, 15: 300-309 Randomised trial of pivampicillin plus pivmecillinam vs pivampicillin in children and young adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzae; Johansen HK et al 1999 Curr Med Res Opin, 15: 300-309
    Active substance: PIVMECILLINAM
    Study summary document link (including results):
    View full study record
    Document reference: 34539
    Study title: Clinical evaluation of perphenazine, triflupromazine, and hydroxyzine for postoperative sedation in children
    Active substance: HYDROXYZINE
    Study summary document link (including results): ADPE92B0408.pdf
    View full study record
    Document reference: 29255
    Study title: Fluoxetine Versus Placebo in the Treatment of Children and Adolescents with Obsessive-Compulsive Disorder
    Active substance: FLUOXETINE
    Study summary document link (including results): fluoxetine B1Y-MC-HCJW Clinical Study Summary.pdf
    View full study record
    Document reference: 47359
    Study title: Feltman R, Kosel G: Prenatal and postnatal ingestion of fluorides – forteen years of investigation - final report. J Dent Med 1961; 16: 190-1999
    Active substance: COLECALCIFEROL AND SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 24630
    Study title: Conclusions regarding the influence of Piracetam upon the cognitive learning symptoms of children with learning disabilities.
    Active substance: PIRACETAM
    Study summary document link (including results): DE75G011 - Piracetam.pdf
    View full study record
    Document reference: 47899
    Study title: A Stratified, Randomized, Double-Blind, Parallel-Group Trial Assessing the Efficacy and Safety of Fluticasone Propionate via the Multi-Dose Powder Inhaler 50mcg BID, 100mcg QD, and Placebo in Subjects Aged 4 to 11 Years With Chronic Asthma.
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FLTA2007-ICHE3.pdf
    View full study record
    Document reference: 28376
    Study title: DTPa-HBV-IPV-103
    Active substance: diphtheria, tetanus, acellular pertussis, hepatitis b recombinant (adsorbed), inactivated poliovirus, adsorbed conjugated haemophilus influenzae type b vaccine
    Study summary document link (including results):
    View full study record
    Document reference: 41516
    Study title: One-year follow-up of young children hospitalized for wheezing: the influence of early anti-inflammatory therapy and risk factors for subsequent wheezing and asthma.
    Active substance: BUDESONIDE
    Study summary document link (including results):
    View full study record
    Document reference: 48438
    Study title: AN OPEN COMPARATIVE STUDY TO COMPARE THE EFFICACY, TOLERATION AND SAFETY OF IV AND ORAL FLUCONAZOLE WITH ORAL KETOCONAZOLE IN THE PROPHYLAXIS OF FUNGAL COLONIZATION AND INFECTION IN PATIENTS WITH ALLOGENEIC BONE MARROW TRANSPLANT.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27361
    Study title: COMPASSIONATE USE PROTOCOL FOR THE TREATMENT OF A THREE-YEAR OLD CHILD WITH SCEDOSPORIUM INFECTION
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27341
    Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE VS. ORAL KETOCONAZOLE IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL DISEASE.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 28028
    Study title: AN OPEN NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE PREVENTION OF SYSTEMIC FUNGAL INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR HAEMOTOLOGICAL DISEASE
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27847
    Study title: EFFICACY, SAFETY AND PRACTICABILITY OF FLUCONAZOLE VS. LOCAL CLOTRIMAZOLE THERAPY IN PATIENTS WITH VAGINAL CANDIDIASIS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27788
    Study title: Hiddemann W et al. Antifungal treatment by amphotericin B and 5-fluorocytosine delays the recovery of normal hematopoietic cells after intensive cytostatic therapy for acute myeloid leukemia. Cancer. 1991 Jul 1;68(1):9-14
    Active substance: FLUCOCYTOSIN
    Study summary document link (including results):
    View full study record
    Document reference: 27303
    Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSES ASSOCIATED WITH DIGESTIVE MALIGNANCY
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27925
    Study title: OPEN, NON-COMPARATIVE STUDY OF FLUCONAZOLE IN PATIENTS WITH COCCIDIOIDAL MENINGITIS
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 28052
    Study title: Legeler HJ. Bericht über die klinische Prüfung von 9alpha-Fluorhydrocortison zur Behandlung hypotoner und orthostatischer Kreislaufregulationsstörungen Arzneim Forsch (Drug Research) 1971; 21: 1144-1149
    Active substance: FLUDOCORTISONE
    Study summary document link (including results):
    View full study record
    Document reference: 28210
    Study title:
    Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT)
    Study summary document link (including results):
    View full study record
    Document reference: 41160
    Study title: Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):674-81. Epub 2005 Mar 4. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Walter MA, Melzer RA, Schindler C, Müller-Brand J, Tyndall A, Nitzsche EU.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28108
    Study title: Randomised trial of pivampicillin plus pivmecillinam vs pivampicillin in children and young adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzaeRandomised trial of pivampicillin plus pivmecillinam vs pivampicillin in children and young adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzae
    Active substance: PIVAMPICILLIN
    Study summary document link (including results):
    View full study record
    Document reference: 46067
    Study title: Sandler MS, Heyman S, Watts H. Localization of 99mTc methylene diphosphonate within synovial fluid in osteosarcoma. AJR Am J Roentgenol. 1984 Aug;143(2):349-50. No abstract available. Sandler MS, Heyman S, Watts H. Localization of 99mTc methylene diphosphonate within synovial fluid in osteosarcoma. AJR Am J Roentgenol. 1984 Aug;143(2):349-50. No abstract available.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43990
    Study title: Vander Borght T, Laloux P, Maes A, Salmon E, Goethals I, Goldman S; Belgian Society for Nuclear Medicine.. Guidelines for brain radionuclide imaging. Perfusion single photon computed tomography (SPECT) using Tc-99m radiopharmaceuticals and brain metabolism positron emission tomography (PET) using F-18 fluorodeoxyglucose. The Belgian Society for Nuclear Medicine. [vander-borght-2001]Acta Neurol Belg. 2001 Dec;101(4):196-209. Vander Borght T 2001
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48708
    Study title: Statistical report of a controlled clinical study regarding the influence of piracetam upon the symptoms presented by children with learning disabilities.
    Active substance: PIRACETAM
    Study summary document link (including results): CE75F171 - Piracetam.pdf
    View full study record
    Document reference: 45903
    Study title: Simons KS, Pickkers P, Bleeker-Rovers CP, Oyen WJ, van der Hoeven JG.. Epub 2009 Oct 22. F-18-fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection. [simons-2010]Intensive Care Med. 2010 Mar;36(3):504-11. Simons KS 2010
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48699
    Study title: Stauss J, Franzius C, Pfluger T, Juergens KU, Biassoni L, Begent J, et al..Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology. [stauss-2008]Eur J Nucl Med Mol Imaging 2008; 35:1581–1588. Stauss J 2008
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48701
    Study title: Stumpe KD, Urbinelli M, Steinert HC, Glanzmann C, Buck A, von Schulthess GK. Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography. [stumpe-1998]Eur J Nucl Med. 1998 Jul;25(7):721-8. Stumpe KD 1998
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48702
    Study title: Pulce-C, Mollon-P, Pham-E, Frantz-P, Descotes-J. Service de Pharmaco-Toxicovigilance, Hospital E. Herriot, Lyon, France. Acute poisonings with ethyle loflazepate, flunitrazepam, prazepam and triazolam in children. Veterinary and human toxicology, {Vet-Hum-Toxicol}, Apr 1992, vol. 34, no. 2, p. 141-3, ISSN: 0145-6296.Pulce-C, Mollon-P, Pham-E, Frantz-P, Descotes-J. Service de Pharmaco-Toxicovigilance, Hospital E. Herriot, Lyon, France. Acute poisonings with ethyle loflazepate, flunitrazepam, prazepam and triazolam in children. Veterinary and human toxicology, {Vet-Hum-Toxicol}, Apr 1992, vol. 34, no. 2, p. 141-3, ISSN: 0145-6296.
    Active substance: PRAZEPAM
    Study summary document link (including results):
    View full study record
    Document reference: 34637
    Study title: Safe and effective use piritramide following sevoflurane anesthesia in children. Anesthesiology 91 (3A), p.A1280. 1999 Safe and effective use piritramide following sevoflurane anesthesia in children. Anesthesiology 91 (3A), p.A1280. 1999
    Active substance: PIRITRAMIDE
    Study summary document link (including results):
    View full study record
    Document reference: 34303
    Study title: Influence of Bile Acids on Postnatal Development im Preterm Infants during the first weeks of life; A controlled study with Ursodeoxycholic acid.
    Active substance: URSODEOXYCOLIC ACID
    Study summary document link (including results): EUdraCT_reduced_datafields_paediatric data_Ursodeoxycholic acid_Ursofalk suspenion_Dr Falk Pharma GmbH.xls
    View full study record
    Document reference: 39160
    Study title: Hennon DK, Stookey GK, Beiswanger BB. Fluoride-vitamin supplements: effects on dental caries and fluorosis when used in areas with suboptimal fluoride in the water supply. JADA 1977; 95: 965-971Hennon DK, Stookey GK, Beiswanger BB. Fluoride-vitamin supplements: effects on dental caries and fluorosis when used in areas with suboptimal fluoride in the water supply. JADA 1977; 95: 965-971
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42263
    Study title: Hennon DK, Stookey GK, Beiswanger BB. Fluoride-vitamin supplements: effects on dental caries and fluorosis when used in areas with suboptimal fluoride in the water supply. JADA 1977; 95: 965-971Hennon DK, Stookey GK, Beiswanger BB. Fluoride-vitamin supplements: effects on dental caries and fluorosis when used in areas with suboptimal fluoride in the water supply. JADA 1977; 95: 965-971
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42295
    Study title: Hennon DK, Stookey GK, Beiswanger BB. Fluoride-vitamin supplements: effects on dental caries and fluorosis when used in areas with suboptimal fluoride in the water supply. JADA 1977; 95: 965-971Hennon DK, Stookey GK, Beiswanger BB. Fluoride-vitamin supplements: effects on dental caries and fluorosis when used in areas with suboptimal fluoride in the water supply. JADA 1977; 95: 965-971
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42327
    Study title: In vitro fluoride uptake, distribution and retention by human enamel after 1- and 24-hour application of various topical fluoride agents.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42404
    Study title: In vitro fluoride uptake, distribution and retention by human enamel after 1- and 24-hour application of various topical fluoride agents.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42517
    Study title: Influence of F--releasing varnishes on the acid resistance of enamel.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42337
    Study title: "Safety of inactivated split-virion influenza vaccine administered by the intradermal route in healthy children"
    Active substance: Virus de la gripe fraccionados
    Study summary document link (including results):
    View full study record
    Document reference: 45261
    Study title: "Evaluation of safety and immunogenicity of inactivated flu vaccine in children with underlying disease"
    Active substance: Virus de la gripe fraccionados, inactivados que contienen antígenos equivalentes a las cepas recomendadas por la OMS (hemisferio Norte) y la decisión de la Unión Europea para cada campaña de vacunación [inactivated influenza split virion vaccine (Triton X 100)]
    Study summary document link (including results):
    View full study record
    Document reference: 41459
    Study title: Evaluation of safety and immunogenicity of inactivated flu vaccine in children with underlying disease
    Active substance: Virus de la gripe fraccionados, inactivados que contienen antígenos equivalentes a las cepas recomendadas por la OMS (hemisferio Norte) y la decisión de la Unión Europea para cada campaña de vacunación [inactivated influenza split virion vaccine (Triton X 100)]
    Study summary document link (including results):
    View full study record
    Document reference: 41460
    Study title: Fanning EA, Cellier KM, Leadbeater MM, Somerville CM. South Australian kindergarten children: fluoride tablet supplements and dental caries. Aust Dent J 1975: 20: 7-9Fanning EA, Cellier KM, Leadbeater MM, Somerville CM. South Australian kindergarten children: fluoride tablet supplements and dental caries. Aust Dent J 1975: 20: 7-9
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42276
    Study title: Fanning EA, Cellier KM, Leadbeater MM, Somerville CM. South Australian kindergarten children: fluoride tablet supplements and dental caries. Aust Dent J 1975: 20: 7-9Fanning EA, Cellier KM, Leadbeater MM, Somerville CM. South Australian kindergarten children: fluoride tablet supplements and dental caries. Aust Dent J 1975: 20: 7-9
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42308
    Study title: Feltman R, Kosel G: Prenatal and postnatal ingestion of fluorides – forteen years of investigation - final report. J Dent Med 1961; 16: 190-1999Feltman R, Kosel G: Prenatal and postnatal ingestion of fluorides – forteen years of investigation - final report. J Dent Med 1961; 16: 190-1999
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42245
    Study title: Feltman R, Kosel G: Prenatal and postnatal ingestion of fluorides – forteen years of investigation - final report. J Dent Med 1961; 16: 190-1999Feltman R, Kosel G: Prenatal and postnatal ingestion of fluorides – forteen years of investigation - final report. J Dent Med 1961; 16: 190-1999
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42277
    Study title: Feltman R, Kosel G: Prenatal and postnatal ingestion of fluorides – forteen years of investigation - final report. J Dent Med 1961; 16: 190-1999Feltman R, Kosel G: Prenatal and postnatal ingestion of fluorides – forteen years of investigation - final report. J Dent Med 1961; 16: 190-1999
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42309
    Study title: Fissure sealants versus fluorine varnish on the first permanent molars: economic assessment
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42348
    Study title: Fissure sealants versus fluorine varnish on the first permanent molars: economic assessment
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42461
    Study title: Fissure sealing of permanent first molars in children receiving a high standard of prophylactic care.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42400
    Study title: Fissure sealing of permanent first molars in children receiving a high standard of prophylactic care.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42513
    Study title: Fluoride clearance of whole saliva in young school children after topical application.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42397
    Study title: Fluoride clearance of whole saliva in young school children after topical application.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42510
    Study title: Fluoride concentration in plaque in adolescents after topical application of different fluoride varnishes.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42537
    Study title: Fluoride concentration in whole saliva and separate gland secretions after topical treatment with three different fluoride varnishes
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42434
    Study title: Fluoride concentration in whole saliva and separate gland secretions after topical treatment with three different fluoride varnishes
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42547
    Study title: Fluoride content of enamel during treatment and 2 years after discontinuation of treatment with fluoride varnishes.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42415
    Study title: Fluoride content of enamel during treatment and 2 years after discontinuation of treatment with fluoride varnishes.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42528
    Study title: Fluoride deposited topical applications in enamel. KOH-soluble and acquired fluoride.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42355
    Study title: Influence of F--releasing varnishes on the acid resistance of enamel.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42450
    Study title: Intensive fluoride varnish program in Swedish adolescents: economic assessment of a 7-year follow-up study on proximal caries incidence.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42398
    Study title: Intensive fluoride varnish program in Swedish adolescents: economic assessment of a 7-year follow-up study on proximal caries incidence.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42511
    Study title: Kinetics of fluorine in deciduous enamel after application of fluoride-containing varnish (Duraphat).
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42375
    Study title: Kinetics of fluorine in deciduous enamel after application of fluoride-containing varnish (Duraphat).
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42488
    Study title: Leverett DH, Adair SM, Vaughan BW et al. Randomized clinical trail of the effect of prenatal fluoride supplements in preventing dental caries. Caries res 1997; 31: 174-179.Leverett DH, Adair SM, Vaughan BW et al. Randomized clinical trail of the effect of prenatal fluoride supplements in preventing dental caries. Caries res 1997; 31: 174-179.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42247
    Study title: Leverett DH, Adair SM, Vaughan BW et al. Randomized clinical trail of the effect of prenatal fluoride supplements in preventing dental caries. Caries res 1997; 31: 174-179.Leverett DH, Adair SM, Vaughan BW et al. Randomized clinical trail of the effect of prenatal fluoride supplements in preventing dental caries. Caries res 1997; 31: 174-179.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42279
    Study title: Leverett DH, Adair SM, Vaughan BW et al. Randomized clinical trail of the effect of prenatal fluoride supplements in preventing dental caries. Caries res 1997; 31: 174-179.Leverett DH, Adair SM, Vaughan BW et al. Randomized clinical trail of the effect of prenatal fluoride supplements in preventing dental caries. Caries res 1997; 31: 174-179.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42311
    Study title: Long-term use of fluoride lacquer in preventive care of school children in area of basic care.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42384
    Study title: Long-term use of fluoride lacquer in preventive care of school children in area of basic care.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42497
    Study title: Margolis FJ, Rheames HR, Freshman E et al. Fluoride: ten year prospective study of deciduous teeth and permanent dentition. Am J Dis Child 1975; 129: 794-800.Margolis FJ, Rheames HR, Freshman E et al. Fluoride: ten year prospective study of deciduous teeth and permanent dentition. Am J Dis Child 1975; 129: 794-800.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42248
    Study title: Margolis FJ, Rheames HR, Freshman E et al. Fluoride: ten year prospective study of deciduous teeth and permanent dentition. Am J Dis Child 1975; 129: 794-800.Margolis FJ, Rheames HR, Freshman E et al. Fluoride: ten year prospective study of deciduous teeth and permanent dentition. Am J Dis Child 1975; 129: 794-800.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42280
    Study title: Margolis FJ, Rheames HR, Freshman E et al. Fluoride: ten year prospective study of deciduous teeth and permanent dentition. Am J Dis Child 1975; 129: 794-800.Margolis FJ, Rheames HR, Freshman E et al. Fluoride: ten year prospective study of deciduous teeth and permanent dentition. Am J Dis Child 1975; 129: 794-800.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42312
    Study title: Marthaler TM, König KG. Der Einfluß von Fluoridtablettengaben in der Schule auf den Kariesbefall 6- bis 15-Jähriger Kinder. Schweiz Monatsschr Zahnmed 1967; 77: 539-554Marthaler TM, König KG. Der Einfluß von Fluoridtablettengaben in der Schule auf den Kariesbefall 6- bis 15-Jähriger Kinder. Schweiz Monatsschr Zahnmed 1967; 77: 539-554
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42264
    Study title: A randomized, open label, comparative multicenter study of voriconazole versus conventional amphotericin B → fluconazole in the treatment of candidemia in non neutropenic subjects
    Active substance: VORICONAZOLE
    Study summary document link (including results): 150-608 PhRMA Web Synopsis.pdf
    View full study record
    Document reference: 48051
    Study title: Armstrong KL, Fraser DKB, Faoagali JL. Gastrointestinal bleeding with influenza virus. Med J Aust. March 11, 1991, 180-2) Armstrong KL, Fraser DKB, Faoagali JL. Gastrointestinal bleeding with influenza virus. Med J Aust. March 11, 1991, 180-2)
    Active substance: SIMETICONE
    Study summary document link (including results):
    View full study record
    Document reference: 42197
    Study title: Driscoll WS, Heifetz SB, Korts DC. Effect of chewable fluoride tablets on dental caries in schoolchildren: results after six years of use. J Am Dent Assoc. 1978 Nov;97(5):820-4.Driscoll WS, Heifetz SB, Korts DC. Effect of chewable fluoride tablets on dental caries in schoolchildren: results after six years of use. J Am Dent Assoc. 1978 Nov;97(5):820-4.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42255
    Study title: Driscoll WS, Heifetz SB, Korts DC. Effect of chewable fluoride tablets on dental caries in schoolchildren: results after six years of use. J Am Dent Assoc. 1978 Nov;97(5):820-4.Driscoll WS, Heifetz SB, Korts DC. Effect of chewable fluoride tablets on dental caries in schoolchildren: results after six years of use. J Am Dent Assoc. 1978 Nov;97(5):820-4.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42287
    Study title: Driscoll WS, Heifetz SB, Korts DC. Effect of chewable fluoride tablets on dental caries in schoolchildren: results after six years of use. J Am Dent Assoc. 1978 Nov;97(5):820-4.Driscoll WS, Heifetz SB, Korts DC. Effect of chewable fluoride tablets on dental caries in schoolchildren: results after six years of use. J Am Dent Assoc. 1978 Nov;97(5):820-4.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42319
    Study title: Driscoll WS, Nowjack-Raymer R, Heifetz SB, Li SH, Selwitz RH. Evaluation of the comparative effectiveness of fluoride mouthrinsing, fluoride tablets, and both procedures in combination: interim findings after five years. J Public Health Dent. 1990 Winter;50(1):13-7.Driscoll WS, Nowjack-Raymer R, Heifetz SB, Li SH, Selwitz RH. Evaluation of the comparative effectiveness of fluoride mouthrinsing, fluoride tablets, and both procedures in combination: interim findings after five years. J Public Health Dent. 1990 Winter;50(1):13-7.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42256
    Study title: Driscoll WS, Nowjack-Raymer R, Heifetz SB, Li SH, Selwitz RH. Evaluation of the comparative effectiveness of fluoride mouthrinsing, fluoride tablets, and both procedures in combination: interim findings after five years. J Public Health Dent. 1990 Winter;50(1):13-7.Driscoll WS, Nowjack-Raymer R, Heifetz SB, Li SH, Selwitz RH. Evaluation of the comparative effectiveness of fluoride mouthrinsing, fluoride tablets, and both procedures in combination: interim findings after five years. J Public Health Dent. 1990 Winter;50(1):13-7.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42288
    Study title: Driscoll WS, Nowjack-Raymer R, Heifetz SB, Li SH, Selwitz RH. Evaluation of the comparative effectiveness of fluoride mouthrinsing, fluoride tablets, and both procedures in combination: interim findings after five years. J Public Health Dent. 1990 Winter;50(1):13-7.Driscoll WS, Nowjack-Raymer R, Heifetz SB, Li SH, Selwitz RH. Evaluation of the comparative effectiveness of fluoride mouthrinsing, fluoride tablets, and both procedures in combination: interim findings after five years. J Public Health Dent. 1990 Winter;50(1):13-7.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42320
    Study title: Fluoride deposited topical applications in enamel. KOH-soluble and acquired fluoride.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42468
    Study title: Fluoride retention in sound and demineralized enamel in vivo after treatment with a fluoride varnish (Duraphat).
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42390
    Study title: Fluoride retention in sound and demineralized enamel in vivo after treatment with a fluoride varnish (Duraphat).
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42503
    Study title: Fluoride uptake in plaque-covered enamel after treatment with the fluoride lacquer Duraphat.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42368
    Study title: Fluoride uptake in plaque-covered enamel after treatment with the fluoride lacquer Duraphat.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42481
    Study title: Fluoride varnish versus acidulated phosphate fluoride for schoolchildren in Manipal.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42426
    Study title: Fluoride varnish versus acidulated phosphate fluoride for schoolchildren in Manipal.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42539
    Study title: Fluoride varnishes (Duraphat): a meta-analysis.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42367
    Study title: Fluoride varnishes (Duraphat): a meta-analysis.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42480
    Study title: Fluoride varnishes in caries prevention.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42533
    Study title: Tsou VM et al. Multicenter, randomized, double-blind study comparing 20 and 40 mg of pantoprazole for symptom relief in adolescents (12 to 16 years of age) with gastroesophageal reflux disease (GERD). Clin Pediatr (Phila). 2006 Oct;45(8):741-9Tsou VM et al. Multicenter, randomized, double-blind study comparing 20 and 40 mg of pantoprazole for symptom relief in adolescents (12 to 16 years of age) with gastroesophageal reflux disease (GERD). Clin Pediatr (Phila). 2006 Oct;45(8):741-9
    Active substance: SIMETICONE
    Study summary document link (including results):
    View full study record
    Document reference: 42203
    Study title: Driscoll WS, Nowjack-Raymer R, Selwitz RH, Li SH, Heifetz SB. A comparison of the caries-preventive effects of fluoride mouthrinsing, fluoride tablets, and both procedures combined: final results after eight years. J Public Health Dent. 1992 Winter;52(2):111-6.Driscoll WS, Nowjack-Raymer R, Selwitz RH, Li SH, Heifetz SB. A comparison of the caries-preventive effects of fluoride mouthrinsing, fluoride tablets, and both procedures combined: final results after eight years. J Public Health Dent. 1992 Winter;52(2):111-6.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42257
    Study title: Driscoll WS, Nowjack-Raymer R, Selwitz RH, Li SH, Heifetz SB. A comparison of the caries-preventive effects of fluoride mouthrinsing, fluoride tablets, and both procedures combined: final results after eight years. J Public Health Dent. 1992 Winter;52(2):111-6.Driscoll WS, Nowjack-Raymer R, Selwitz RH, Li SH, Heifetz SB. A comparison of the caries-preventive effects of fluoride mouthrinsing, fluoride tablets, and both procedures combined: final results after eight years. J Public Health Dent. 1992 Winter;52(2):111-6.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42289
    Study title: Fluoride varnishes in caries prevention].
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42416
    Study title: Fluoride varnishes in caries prevention].
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42529
    Study title: Fluoride varnishes--a review.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42349
    Study title: Fluoride varnishes--a review.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42462
    Study title: Fluorine gradients in outermost surface enamel after various forms of topical application of fluorides in vivo.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42395
    Study title: Fluorine gradients in outermost surface enamel after various forms of topical application of fluorides in vivo.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42508
    Study title: Friis-Hasché E, Bergamnn J, Wenzel A, Thylstrup A et al. Dental health status and attitudes to dental care in families participating in a Danish fluoride tablet program. Community Dent Oral Epidemiol 1984; 12: 303-307Friis-Hasché E, Bergamnn J, Wenzel A, Thylstrup A et al. Dental health status and attitudes to dental care in families participating in a Danish fluoride tablet program. Community Dent Oral Epidemiol 1984; 12: 303-307
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42246
    Study title: Friis-Hasché E, Bergamnn J, Wenzel A, Thylstrup A et al. Dental health status and attitudes to dental care in families participating in a Danish fluoride tablet program. Community Dent Oral Epidemiol 1984; 12: 303-307Friis-Hasché E, Bergamnn J, Wenzel A, Thylstrup A et al. Dental health status and attitudes to dental care in families participating in a Danish fluoride tablet program. Community Dent Oral Epidemiol 1984; 12: 303-307
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42278
    Study title: A 2-week, randomized, double-blind, parallel-group study in pediatric subjects with asthma aged 4 to11 years to examine the pharmacokinetics of fluticasone propionate (FP) and salmeterol (SALM) from the FP/SALM combination product administered twice daily via the Diskus (FP 100mcg/SALM 50mcg) and the FP Diskus (FP 100mcg). Report No. RM2004/00114/00
    Active substance: SALMETEROL
    Study summary document link (including results):
    View full study record
    Document reference: 35602
    Study title: A Multicentre, Randomised, Double-blind, Double-dummy, Parallel Group Comparison of Three Treatments: 1) Seretide (50/100 mcg Strength)bd via Diskus/Accuhaler Inhaler, 2) Fluticasone Propionate 200 mcg bd via Diskus Inhaler, 3) Fluticasone Propionate 100mcg bd via Diskus/Accuhaler Inhaler in Children Aged 4-11 Years with Asthma. Report No. BP1999/00102/00
    Active substance: SALMETEROL
    Study summary document link (including results):
    View full study record
    Document reference: 35594
    Study title: A pilot single centre, randomised, double-blind crossover study to demonstrate the superiority of Salmeterol/fluticasone propionate combination product 50/100mcg bd versus fluticasone propionate 100mcg bd when treated for two weeks with respect to activity levels in children aged 7 15 years. Report No. GM2003/00237/00;
    Active substance: SALMETEROL
    Study summary document link (including results):
    View full study record
    Document reference: 35591
    Study title: A Randomized, Double-Blind, 12-Week Trial Evaluating the Safety of the Fluticasone Propionate/Sameterol DISKUS Combination Product 100/50mcg BID Versus Fluticasone Propionate DISKUS 100mcg BID in Sympotmatic Pediatric Subjects (4-11 Years) With Asthma. Report No. RM2002/00268/00;
    Active substance: SALMETEROL
    Study summary document link (including results):
    View full study record
    Document reference: 35596
    Study title: A Stratified, Multicenter, Randomized, Double-Blind, Parallel Group, 4-Week Comparison of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID versus Fluticasone Propionate DISKUS 100/50mcg BID in Pediatric and Adolescent Subjects with Activity-Induced Bronchospasm. Report No. RM2005/00343/00
    Active substance: SALMETEROL
    Study summary document link (including results):
    View full study record
    Document reference: 35592
    Study title: A Stratified, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Trial Evaluating the Safety and Efficacy of the Fluticasone Propionate/Salmeterol Diskus Combination Product 100/50mcg Once Daily Versus Fluticasone Propionate Diskus 100mcg Once Daily and Placebo in Symptomatic Pediatric Subjects (4-11 Years) With Asthma. Report No. RM2001/00010/07
    Active substance: SALMETEROL
    Study summary document link (including results):
    View full study record
    Document reference: 35595
    Study title: Marthaler TM, König KG. Der Einfluß von Fluoridtablettengaben in der Schule auf den Kariesbefall 6- bis 15-Jähriger Kinder. Schweiz Monatsschr Zahnmed 1967; 77: 539-554Marthaler TM, König KG. Der Einfluß von Fluoridtablettengaben in der Schule auf den Kariesbefall 6- bis 15-Jähriger Kinder. Schweiz Monatsschr Zahnmed 1967; 77: 539-554
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42296
    Study title: Marthaler TM, König KG. Der Einfluß von Fluoridtablettengaben in der Schule auf den Kariesbefall 6- bis 15-Jähriger Kinder. Schweiz Monatsschr Zahnmed 1967; 77: 539-554Marthaler TM, König KG. Der Einfluß von Fluoridtablettengaben in der Schule auf den Kariesbefall 6- bis 15-Jähriger Kinder. Schweiz Monatsschr Zahnmed 1967; 77: 539-554
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42328
    Study title: On topical application of fluorides and its inhibiting effect on caries.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42394
    Study title: On topical application of fluorides and its inhibiting effect on caries.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42507
    Study title: Paediatric dentistry discussion paper and case report. Management of small carious lesions in primary teeth: caries removal versus fluoride application and periodic 'observation' until exfoliation.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42360
    Study title: Paediatric dentistry discussion paper and case report. Management of small carious lesions in primary teeth: caries removal versus fluoride application and periodic 'observation' until exfoliation.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42473
    Study title: Petersson LG, Koch G, Rasmusson CG, Stanke H. Effect on caries of different fluoride prophylactic programs in preschool children. A two year clinical study. Swed Dent J. 1985;9(3):97-104.Petersson LG, Koch G, Rasmusson CG, Stanke H. Effect on caries of different fluoride prophylactic programs in preschool children. A two year clinical study. Swed Dent J. 1985;9(3):97-104.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42265
    Study title: Comparison of stepwise treatment of asthmatic children with salmeterol/fluticasone propionate (FP) combination product (Seretide) and/or fluticasone propionate (Flixotide) based on PD20 methacholine plus symptoms or based on symptoms only (Children Asthma Therapy Optimal”
    Active substance: SALMETEROL
    Study summary document link (including results):
    View full study record
    Document reference: 35599
    Study title: Summary of the efficacy and safety and safety of salmeterol 50mcg and fluticasone propionate 100mcg administered in Diskus Dry Powder Inhaler twice daily in steroid experienced children with reversible airways obstruction
    Active substance: SALMETEROL
    Study summary document link (including results):
    View full study record
    Document reference: 35601
    Study title: Petersson LG, Koch G, Rasmusson CG, Stanke H. Effect on caries of different fluoride prophylactic programs in preschool children. A two year clinical study. Swed Dent J. 1985;9(3):97-104.Petersson LG, Koch G, Rasmusson CG, Stanke H. Effect on caries of different fluoride prophylactic programs in preschool children. A two year clinical study. Swed Dent J. 1985;9(3):97-104.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42297
    Study title: Petersson LG, Koch G, Rasmusson CG, Stanke H. Effect on caries of different fluoride prophylactic programs in preschool children. A two year clinical study. Swed Dent J. 1985;9(3):97-104.Petersson LG, Koch G, Rasmusson CG, Stanke H. Effect on caries of different fluoride prophylactic programs in preschool children. A two year clinical study. Swed Dent J. 1985;9(3):97-104.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42329
    Study title: Pharmacokinetics of fluoride gels in children and adults.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42357
    Study title: Pharmacokinetics of fluoride gels in children and adults.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42470
    Study title: Plasschaert AJM, König KG: Die Wirkung von Zahngesundheitsinformation und von Fluoridtabletten auf den Karieszuwachs bei Schulkindern. I Experimentelle Ergebnisse nach 2 Jahren Versuchsdauer. Schweiz Mschr zahnkeilk 1973; 83: 421-445Plasschaert AJM, König KG: Die Wirkung von Zahngesundheitsinformation und von Fluoridtabletten auf den Karieszuwachs bei Schulkindern. I Experimentelle Ergebnisse nach 2 Jahren Versuchsdauer. Schweiz Mschr zahnkeilk 1973; 83: 421-445
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42266
    Study title: Plasschaert AJM, König KG: Die Wirkung von Zahngesundheitsinformation und von Fluoridtabletten auf den Karieszuwachs bei Schulkindern. I Experimentelle Ergebnisse nach 2 Jahren Versuchsdauer. Schweiz Mschr zahnkeilk 1973; 83: 421-445Plasschaert AJM, König KG: Die Wirkung von Zahngesundheitsinformation und von Fluoridtabletten auf den Karieszuwachs bei Schulkindern. I Experimentelle Ergebnisse nach 2 Jahren Versuchsdauer. Schweiz Mschr zahnkeilk 1973; 83: 421-445
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42298
    Study title: A Phase II, Randomized, Open-Label Study to Compare the Safety and Efficacy of Sevoflurane Versus Halothane Administered with Nitrous Oxide and Oxygen in ASA Class I and II Pediatric Patients
    Active substance: SEVOFLURANE
    Study summary document link (including results): Sevoflurane-P92-124.pdf
    View full study record
    Document reference: 42160
    Study title: A Phase III, Multicenter, Open-Label Study Evaluating the Effect of Multiple Exposure to Sevoflurane for the Maintenance of Anesthesia in Pediatric ASA Class I, II, and III Inpatients
    Active substance: SEVOFLURANE
    Study summary document link (including results): Sevoflurane-P92-098.pdf
    View full study record
    Document reference: 42158
    Study title: A Phase III, Multicenter, Open-Label, Randomized, Comparative Study Evaluating the Effect of Sevoflurane Versus Halothane in the Induction and Maintenance of Anesthesia in Pediatric ASA Class I and II Outpatients
    Active substance: SEVOFLURANE
    Study summary document link (including results): Sevoflurane-P92-090.pdf
    View full study record
    Document reference: 42156
    Study title: A Phase III, Multicenter, Open-Label, Randomized, Comparative Study Evaluating the Effect of Sevoflurane Versus Halothane in the Induction and Maintenance of Anesthesia in Pediatric ASA Class I and II Inpatients
    Active substance: SEVOFLURANE
    Study summary document link (including results): Sevoflurane-P92-091.pdf
    View full study record
    Document reference: 42157
    Study title: A Phase III, Randomized, Open-Label Study to Compare the Safety, Tolerability and Recovery Characteristics of Sevoflurane Versus Halothane Administered with Nitrous Oxide and Oxygen in ASA Class I and II Pediatric Patients Undergoing Ambulatory Surgery
    Active substance: SEVOFLURANE
    Study summary document link (including results): Sevoflurane-P92-125.pdf
    View full study record
    Document reference: 42161
    Study title: A Phase III, Single Center, Open-Label Study Evaluating the Production of Compound A When Sevoflurane is Administered for the Induction and Maintenance of Anesthesia in Pediatric ASA Class I, II, and III Patients
    Active substance: SEVOFLURANE
    Study summary document link (including results):
    View full study record
    Document reference: 42162
    Study title: Driscoll WS, Nowjack-Raymer R, Selwitz RH, Li SH, Heifetz SB. A comparison of the caries-preventive effects of fluoride mouthrinsing, fluoride tablets, and both procedures combined: final results after eight years. J Public Health Dent. 1992 Winter;52(2):111-6.Driscoll WS, Nowjack-Raymer R, Selwitz RH, Li SH, Heifetz SB. A comparison of the caries-preventive effects of fluoride mouthrinsing, fluoride tablets, and both procedures combined: final results after eight years. J Public Health Dent. 1992 Winter;52(2):111-6.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42321
    Study title: Effect of a fluoride varnish on primary dentition. Dental research in Finland 1982.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42392
    Study title: Effect of a fluoride varnish on primary dentition. Dental research in Finland 1982.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42505
    Study title: Effect of a fluoride-containinglacquer on dental caries.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42362
    Study title: Effect of a fluoride-containinglacquer on dental caries.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42475
    Study title: Effect of a preventive program based on professional toothcleaning and fluoride application on caries and gingivitis.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42374
    Study title: Effect of a preventive program based on professional toothcleaning and fluoride application on caries and gingivitis.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42487
    Study title: Effect of annual application of polyurethane lacquer containing silane-fluoride.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42436
    Study title: Effect of annual application of polyurethane lacquer containing silane-fluoride.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42549
    Study title: Effect of different carriers preventive measures in children highly infected with mutans streptococci.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42381
    Study title: Effect of different carriers preventive measures in children highly infected with mutans streptococci.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42494
    Study title: Effect of Fluor-Protector varnish on the inhibition of the carious process in milk teeth
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42437
    Study title: Friis-Hasché E, Bergamnn J, Wenzel A, Thylstrup A et al. Dental health status and attitudes to dental care in families participating in a Danish fluoride tablet program. Community Dent Oral Epidemiol 1984; 12: 303-307Friis-Hasché E, Bergamnn J, Wenzel A, Thylstrup A et al. Dental health status and attitudes to dental care in families participating in a Danish fluoride tablet program. Community Dent Oral Epidemiol 1984; 12: 303-307
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42310
    Study title: Füchte W. Ergebnisse einer Kariesprophylaxe mit Fluor-Kalktabletten. ZM 3/1971, 1-5Füchte W. Ergebnisse einer Kariesprophylaxe mit Fluor-Kalktabletten. ZM 3/1971, 1-5
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42258
    Study title: Füchte W. Ergebnisse einer Kariesprophylaxe mit Fluor-Kalktabletten. ZM 3/1971, 1-5Füchte W. Ergebnisse einer Kariesprophylaxe mit Fluor-Kalktabletten. ZM 3/1971, 1-5
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42290
    Study title: Füchte W. Ergebnisse einer Kariesprophylaxe mit Fluor-Kalktabletten. ZM 3/1971, 1-5Füchte W. Ergebnisse einer Kariesprophylaxe mit Fluor-Kalktabletten. ZM 3/1971, 1-5
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42322
    Study title: Hamberg L. Controlled trial of fluoride vitamin drops for prevention of caries in children. The Lancet 1971; Feb 27; 441-442Hamberg L. Controlled trial of fluoride vitamin drops for prevention of caries in children. The Lancet 1971; Feb 27; 441-442
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42259
    Study title: Hamberg L. Controlled trial of fluoride vitamin drops for prevention of caries in children. The Lancet 1971; Feb 27; 441-442Hamberg L. Controlled trial of fluoride vitamin drops for prevention of caries in children. The Lancet 1971; Feb 27; 441-442
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42291
    Study title: Effect of Fluor-Protector varnish on the inhibition of the carious process in milk teeth
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42550
    Study title: Effect of fluoride brushing on the dental treatment requirement in a group of junior elementary school students.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42413
    Study title: Effect of fluoride brushing on the dental treatment requirement in a group of junior elementary school students.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42526
    Study title: Effect of fortnightly rinsing with a 0.2% NaF solution and a fluoride varnish with 5% NaF in dental caries prevention: comparative study in students of the northern region of Sao Paulo city, Brazil, 1992-1993
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42402
    Study title: Effect of fortnightly rinsing with a 0.2% NaF solution and a fluoride varnish with 5% NaF in dental caries prevention: comparative study in students of the northern region of Sao Paulo city, Brazil, 1992-1993
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42515
    Study title: Effect of schoolbased fluoride varnish programmeson approximal caries in adolescents from different caries risk areas.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42425
    Study title: Effect of schoolbased fluoride varnish programmeson approximal caries in adolescents from different caries risk areas.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42538
    Study title: Effect on caries of different fluoride prophylactic programs in preschool children. A two year clinical study.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42396
    Study title: Effect on caries of different fluoride prophylactic programs in preschool children. A two year clinical study.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42509
    Study title: Hamberg L. Controlled trial of fluoride vitamin drops for prevention of caries in children. The Lancet 1971; Feb 27; 441-442Hamberg L. Controlled trial of fluoride vitamin drops for prevention of caries in children. The Lancet 1971; Feb 27; 441-442
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42323
    Study title: Haugejorgen O, Birkeland JM. Analysis of the ups and downs of caries experience among Norwegian children aged five years between 1997 and 2003. Acta Odonttol Scand 2005; 63 (2): 115-122.Haugejorgen O, Birkeland JM. Analysis of the ups and downs of caries experience among Norwegian children aged five years between 1997 and 2003. Acta Odonttol Scand 2005; 63 (2): 115-122.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42260
    Study title: Haugejorgen O, Birkeland JM. Analysis of the ups and downs of caries experience among Norwegian children aged five years between 1997 and 2003. Acta Odonttol Scand 2005; 63 (2): 115-122.Haugejorgen O, Birkeland JM. Analysis of the ups and downs of caries experience among Norwegian children aged five years between 1997 and 2003. Acta Odonttol Scand 2005; 63 (2): 115-122.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42292
    Study title: Haugejorgen O, Birkeland JM. Analysis of the ups and downs of caries experience among Norwegian children aged five years between 1997 and 2003. Acta Odonttol Scand 2005; 63 (2): 115-122.Haugejorgen O, Birkeland JM. Analysis of the ups and downs of caries experience among Norwegian children aged five years between 1997 and 2003. Acta Odonttol Scand 2005; 63 (2): 115-122.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42324
    Study title: Haugejorgen O, Birkeland JM. Evidence of reversal of the caries decline among Norwegian children. Int J Paediatr Dent 2002; 12 (5): 306-315.Haugejorgen O, Birkeland JM. Evidence of reversal of the caries decline among Norwegian children. Int J Paediatr Dent 2002; 12 (5): 306-315.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42261
    Study title: Plasschaert AJM, König KG: Die Wirkung von Zahngesundheitsinformation und von Fluoridtabletten auf den Karieszuwachs bei Schulkindern. I Experimentelle Ergebnisse nach 2 Jahren Versuchsdauer. Schweiz Mschr zahnkeilk 1973; 83: 421-445Plasschaert AJM, König KG: Die Wirkung von Zahngesundheitsinformation und von Fluoridtabletten auf den Karieszuwachs bei Schulkindern. I Experimentelle Ergebnisse nach 2 Jahren Versuchsdauer. Schweiz Mschr zahnkeilk 1973; 83: 421-445
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42330
    Study title: Post-treatment effect of fluoride varnishes in children with a high prevalence of dental caries in a community with fluoridated water.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42534
    Study title: Poulsen S, Gadegaard E, Mortensen B. Cariostatic effect of daily use of a fluoride-containing lozenge compared to forthnightly rinses with 0,2% sodium fluoride. Caries Res 1981; 15: 236-242.Poulsen S, Gadegaard E, Mortensen B. Cariostatic effect of daily use of a fluoride-containing lozenge compared to forthnightly rinses with 0,2% sodium fluoride. Caries Res 1981; 15: 236-242.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42267
    Study title: A multi-centre, double-blind, randomised, parallel group study comparing the addition of inhaled salmeterol with an increase in the dose of inhaled fluticasone propionate in asthmatic patients on a low or intermediate dose of inhaled steroid.
    Active substance: SALMETEROL (XINAFOATE)
    Study summary document link (including results): Salmeterol-Xinafoate-SMS30073-ICHE3.pdf
    View full study record
    Document reference: 42056
    Study title: Poulsen S, Gadegaard E, Mortensen B. Cariostatic effect of daily use of a fluoride-containing lozenge compared to forthnightly rinses with 0,2% sodium fluoride. Caries Res 1981; 15: 236-242.Poulsen S, Gadegaard E, Mortensen B. Cariostatic effect of daily use of a fluoride-containing lozenge compared to forthnightly rinses with 0,2% sodium fluoride. Caries Res 1981; 15: 236-242.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42299
    Study title: Poulsen S, Gadegaard E, Mortensen B. Cariostatic effect of daily use of a fluoride-containing lozenge compared to forthnightly rinses with 0,2% sodium fluoride. Caries Res 1981; 15: 236-242.Poulsen S, Gadegaard E, Mortensen B. Cariostatic effect of daily use of a fluoride-containing lozenge compared to forthnightly rinses with 0,2% sodium fluoride. Caries Res 1981; 15: 236-242.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42331
    Study title: Prediction of root caries in periodontally treated patients maintained with different fluoride programmes.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42403
    Study title: Prediction of root caries in periodontally treated patients maintained with different fluoride programmes.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42516
    Study title: Prevention. Part 7: professionally applied topical fluorides for caries prevention.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42366
    Study title: Prevention. Part 7: professionally applied topical fluorides for caries prevention.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42479
    Study title: Preventive measures and caries progression: an in vitro study on fissures and smooth surfaces of human molars.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42435
    Study title: Preventive measures and caries progression: an in vitro study on fissures and smooth surfaces of human molars.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42548
    Study title: Professional topical fluoride applications--clinical efficacy and mechanism of action.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42391
    Study title: Professional topical fluoride applications--clinical efficacy and mechanism of action.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42504
    Study title: Progression of approximal caries in primary molars and the effect of Duraphat treatment.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42399
    Study title: Progression of approximal caries in primary molars and the effect of Duraphat treatment.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42512
    Study title: Progression of proximal caries in primary teeth in relation to radiographic scoring codes
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42427
    Study title: Progression of proximal caries in primary teeth in relation to radiographic scoring codes
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42540
    Study title: A Phase III, Single Center, Open-Label, Randomized, Comparative Study Evaluating the Effect of Sevoflurane Versus Halothane on Hepatic Metabolism in the Induction and Maintenance of Anesthesia in Pediatric Inpatients
    Active substance: SEVOFLURANE
    Study summary document link (including results): Sevoflurane-P92-084.pdf
    View full study record
    Document reference: 42155
    Study title: An open-label, multi-center, phase IV study to evaluate the efficacy and safety profiles of sevoflurane in pediatric subjects of different ages undergoing inpatient surgery with general anesthesia
    Active substance: SEVOFLURANE
    Study summary document link (including results): Sevoflurane-CHIN-05-001.pdf
    View full study record
    Document reference: 42152
    Study title: Drug Metabolism Report No. 8 - The Minimum Alveolar Concentration (MAC), and Maintenance and Recovery Characteristics of Sevoflurane in Pediatric Patients
    Active substance: SEVOFLURANE
    Study summary document link (including results):
    View full study record
    Document reference: 42159
    Study title: Evaluation of the Clinical and Consumption Differences between Sevoflurane Innovative Drug and Sevoflurane Similar Drug - Pilot Study
    Active substance: SEVOFLURANE
    Study summary document link (including results):
    View full study record
    Document reference: 42154
    Study title: Sevoflurane versus Halothane in the induction and maintenance of anesthesia in pediatric patients (Abbott Affiliate sponsored study - drug administered)
    Active substance: SEVOFLURANE
    Study summary document link (including results):
    View full study record
    Document reference: 42153
    Study title: The Minimum Alveolar Concentration (MAC), and Maintenance and Recovery Characteristics of Sevoflurane in Pediatric Patients
    Active substance: SEVOFLURANE
    Study summary document link (including results): sevoflurane-ghba532.pdf
    View full study record
    Document reference: 48115
    Study title: Korman MG et al. Influence of smoking on healing rate of duodenal ulcer in response to cimetidine or high-dose antacid. Gastroenterology. 1981 Jun;80(6):1451-3Korman MG et al. Influence of smoking on healing rate of duodenal ulcer in response to cimetidine or high-dose antacid. Gastroenterology. 1981 Jun;80(6):1451-3
    Active substance: SIMETICONE
    Study summary document link (including results):
    View full study record
    Document reference: 42220
    Study title: Effect on the primary dentition of mouthrinsing with a 0.2 percent neutral NaF solution: results from a demonstration program after four school years.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42406
    Study title: Effect on the primary dentition of mouthrinsing with a 0.2 percent neutral NaF solution: results from a demonstration program after four school years.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42519
    Study title: Effectiveness of silver diamine fluoride and sodium fluoride varnish in arresting dentin caries in Chinese pre-school children
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42351
    Study title: Effectiveness of silver diamine fluoride and sodium fluoride varnish in arresting dentin caries in Chinese pre-school children
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42464
    Study title: Effects of fluoride and chlorhexidine on the microflora of dental root surfaces and progression of root-surface caries.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42410
    Study title: Effects of fluoride and chlorhexidine on the microflora of dental root surfaces and progression of root-surface caries.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42523
    Study title: Effects of self-applied topical fluoride preparations in orthodontic patients.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42448
    Study title: Efficacy of preventive agents for dental caries. Systemic fluorides: water fluoridation.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42388
    Study title: Efficacy of preventive agents for dental caries. Systemic fluorides: water fluoridation.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42501
    Study title: Enamel fluoride uptake, distribution and retention from topical fluoride agents.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42405
    Study title: Enamel fluoride uptake, distribution and retention from topical fluoride agents.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42518
    Study title: Erosion caused by gastric reflux in childen. Discussion of etiology, clinical appearance and therapy in two cases.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42382
    Study title: Orenstein SR et al. Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: An open-label, multiple-dose, randomized, multicenter clinical trial in 210 children. Clin Ther. April 1, 2005, 472-83Orenstein SR et al. Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: An open-label, multiple-dose, randomized, multicenter clinical trial in 210 children. Clin Ther. April 1, 2005, 472-83
    Active substance: SIMETICONE
    Study summary document link (including results):
    View full study record
    Document reference: 42181
    Study title: Haugejorgen O, Birkeland JM. Evidence of reversal of the caries decline among Norwegian children. Int J Paediatr Dent 2002; 12 (5): 306-315.Haugejorgen O, Birkeland JM. Evidence of reversal of the caries decline among Norwegian children. Int J Paediatr Dent 2002; 12 (5): 306-315.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42293
    Study title: Haugejorgen O, Birkeland JM. Evidence of reversal of the caries decline among Norwegian children. Int J Paediatr Dent 2002; 12 (5): 306-315.Haugejorgen O, Birkeland JM. Evidence of reversal of the caries decline among Norwegian children. Int J Paediatr Dent 2002; 12 (5): 306-315.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42325
    Study title: Heifetz SB, Horowitz HS, Meyers RJ, Li SH. Evaluation of the comparative effectiveness of fluoride mouth rinsing, fluoride tablets, and both procedures in combination: interim findings after zwo years. Pediatric Dentistry 1987; 9: 121-125.Heifetz SB, Horowitz HS, Meyers RJ, Li SH. Evaluation of the comparative effectiveness of fluoride mouth rinsing, fluoride tablets, and both procedures in combination: interim findings after zwo years. Pediatric Dentistry 1987; 9: 121-125.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42262
    Study title: Heifetz SB, Horowitz HS, Meyers RJ, Li SH. Evaluation of the comparative effectiveness of fluoride mouth rinsing, fluoride tablets, and both procedures in combination: interim findings after zwo years. Pediatric Dentistry 1987; 9: 121-125.Heifetz SB, Horowitz HS, Meyers RJ, Li SH. Evaluation of the comparative effectiveness of fluoride mouth rinsing, fluoride tablets, and both procedures in combination: interim findings after zwo years. Pediatric Dentistry 1987; 9: 121-125.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42294
    Study title: Heifetz SB, Horowitz HS, Meyers RJ, Li SH. Evaluation of the comparative effectiveness of fluoride mouth rinsing, fluoride tablets, and both procedures in combination: interim findings after zwo years. Pediatric Dentistry 1987; 9: 121-125.Heifetz SB, Horowitz HS, Meyers RJ, Li SH. Evaluation of the comparative effectiveness of fluoride mouth rinsing, fluoride tablets, and both procedures in combination: interim findings after zwo years. Pediatric Dentistry 1987; 9: 121-125.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42326
    Study title: Verapamil versus flunarizina nella terapia preventiva dell'emicrania. (Verapamil versus flunarizine in the preventive therapy of hemicrania).Lastilla M, Achille P, Savarese MA, Frascella G. La Clinica terapeutica, 31 Mar 1990, vol. 132, no. 6, p. 401−4, Verapamil versus flunarizina nella terapia preventiva dell'emicrania. (Verapamil versus flunarizine in the preventive therapy of hemicrania).Lastilla M, Achille P, Savarese MA, Frascella G. La Clinica terapeutica, 31 Mar 1990, vol. 132, no. 6, p. 401−4,
    Active substance: VERAPAMIL
    Study summary document link (including results):
    View full study record
    Document reference: 45559
    Study title: Erosion caused by gastric reflux in childen. Discussion of etiology, clinical appearance and therapy in two cases.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42495
    Study title: Evaluation of a fluoride-containing varnish in children with low caries incidence.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42377
    Study title: Evaluation of a fluoride-containing varnish in children with low caries incidence.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42490
    Study title: Evaluation of a routine for prevention and treatment of fissure caries in permanent first molars.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42401
    Study title: Evaluation of a routine for prevention and treatment of fissure caries in permanent first molars.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42514
    Study title: Evaluation of non-invasive treatment applied to occlusal surfaces.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42358
    Study title: Evaluation of non-invasive treatment applied to occlusal surfaces.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42471
    Study title: Factors governing the use of topical fluorides: time and patient acceptability.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42338
    Study title: Factors governing the use of topical fluorides: time and patient acceptability.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42451
    Study title: Fanning EA, Cellier KM, Leadbeater MM, Somerville CM. South Australian kindergarten children: fluoride tablet supplements and dental caries. Aust Dent J 1975: 20: 7-9Fanning EA, Cellier KM, Leadbeater MM, Somerville CM. South Australian kindergarten children: fluoride tablet supplements and dental caries. Aust Dent J 1975: 20: 7-9
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42244
    Study title: A 2-year report on caries prevention by fluoride varnishes in a community with fluoridated water.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42417
    Study title: A 2-year report on caries prevention by fluoride varnishes in a community with fluoridated water.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42419
    Study title: A 2-year report on caries prevention by fluoride varnishes in a community with fluoridated water.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42530
    Study title: A 2-year report on caries prevention by fluoride varnishes in a community with fluoridated water.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42532
    Study title: A 24-month study comparing sealant and fluoride varnish in caries reduction on different permanent first molar surfaces.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42346
    Study title: A 24-month study comparing sealant and fluoride varnish in caries reduction on different permanent first molar surfaces.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42459
    Study title: A clinical estimation of the fluoride used during application of a fluoride varnish.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42408
    Study title: A clinical estimation of the fluoride used during application of a fluoride varnish.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42521
    Study title: A cluster randomised controlled trial to evaluate the effectiveness of fluoride varnish as a public health measure to reduce caries in children.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42363
    Study title: A cluster randomised controlled trial to evaluate the effectiveness of fluoride varnish as a public health measure to reduce caries in children.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42476
    Study title: A combined application of ART-fluoride varnish for immigrant junior field-workers: 12-months follow-up field trial in rural Anatolia.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42356
    Study title: Relationship between caries and fluoride uptake by enamel from two fluoride varnishes in a community with fluoridated water.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42531
    Study title: Results of a 32-month fluoride varnish study in Sherbrooke and Lac-Megantic, Canada.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42353
    Study title: Results of a 32-month fluoride varnish study in Sherbrooke and Lac-Megantic, Canada.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42466
    Study title: Results of a promising open trial to prevent baby bottle tooth decay: a fluoride varnish study.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42439
    Study title: Results of a promising open trial to prevent baby bottle tooth decay: a fluoride varnish study.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42552
    Study title: Results of the combined use of remodent and fluorine lacquer for dental caries prevention in preschoolers]
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42433
    Study title: Results of the combined use of remodent and fluorine lacquer for dental caries prevention in preschoolers]
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42546
    Study title: Review of the anticaries effectiveness of professionally applied and self-applied topical fluoride gels.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42407
    Study title: A combined application of ART-fluoride varnish for immigrant junior field-workers: 12-months follow-up field trial in rural Anatolia.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42469
    Study title: A polarized light and scanning electron microscope study of the effect of Duraphat treatment on in vivo caries.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42370
    Study title: A polarized light and scanning electron microscope study of the effect of Duraphat treatment on in vivo caries.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42483
    Study title: A review on fluoride varnishes: an alternative topical fluoride treatment.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42352
    Study title: A review on fluoride varnishes: an alternative topical fluoride treatment.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42465
    Study title: Review of the anticaries effectiveness of professionally applied and self-applied topical fluoride gels.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42520
    Study title: Relationship between caries and fluoride uptake by enamel from two fluoride varnishes in a community with fluoridated water.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42418
    Study title: Sealant and fluoride varnish in caries: a randomized trial.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42347
    Study title: Sealant and fluoride varnish in caries: a randomized trial.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42460
    Study title: Stephen KW, Campbell D. Caries reduction and cost benefit after 3 years of sucking fluoride tablets daily at school: a double-blind trail. Br Dent J 1978; 144: 202-206.Stephen KW, Campbell D. Caries reduction and cost benefit after 3 years of sucking fluoride tablets daily at school: a double-blind trail. Br Dent J 1978; 144: 202-206.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42268
    Study title: Stephen KW, Campbell D. Caries reduction and cost benefit after 3 years of sucking fluoride tablets daily at school: a double-blind trail. Br Dent J 1978; 144: 202-206.Stephen KW, Campbell D. Caries reduction and cost benefit after 3 years of sucking fluoride tablets daily at school: a double-blind trail. Br Dent J 1978; 144: 202-206.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42300
    Study title: Stephen KW, Campbell D. Caries reduction and cost benefit after 3 years of sucking fluoride tablets daily at school: a double-blind trail. Br Dent J 1978; 144: 202-206.Stephen KW, Campbell D. Caries reduction and cost benefit after 3 years of sucking fluoride tablets daily at school: a double-blind trail. Br Dent J 1978; 144: 202-206.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42332
    Study title: Strübig W, Aeckerle-Witten B, Lange-v.d. Burchard G. Karies-statische Ergebnisse nach 2-jähriger Tabletten­fluoridierung. Öff Gesundheitswesen 1982; 44: 462-.Strübig W, Aeckerle-Witten B, Lange-v.d. Burchard G. Karies-statische Ergebnisse nach 2-jähriger Tabletten­fluoridierung. Öff Gesundheitswesen 1982; 44: 462-.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42269
    Study title: Strübig W, Aeckerle-Witten B, Lange-v.d. Burchard G. Karies-statische Ergebnisse nach 2-jähriger Tabletten­fluoridierung. Öff Gesundheitswesen 1982; 44: 462-.Strübig W, Aeckerle-Witten B, Lange-v.d. Burchard G. Karies-statische Ergebnisse nach 2-jähriger Tabletten­fluoridierung. Öff Gesundheitswesen 1982; 44: 462-.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42301
    Study title: Widenheim J, Birkhed D, Granath L et al. Pre-eruptive effect of NaF tablets on caries in children from 12 to 17 years of age. Community Dent Oral Epidemiolog 1986, 14: 1-4.Widenheim J, Birkhed D, Granath L et al. Pre-eruptive effect of NaF tablets on caries in children from 12 to 17 years of age. Community Dent Oral Epidemiolog 1986, 14: 1-4.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42303
    Study title: Widenheim J, Birkhed D, Granath L et al. Pre-eruptive effect of NaF tablets on caries in children from 12 to 17 years of age. Community Dent Oral Epidemiolog 1986, 14: 1-4.Widenheim J, Birkhed D, Granath L et al. Pre-eruptive effect of NaF tablets on caries in children from 12 to 17 years of age. Community Dent Oral Epidemiolog 1986, 14: 1-4.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42335
    Study title: Widenheim J, Petersson LG, Koch G. Fluorine concentration in primary tooth enamel in 6-year-olds after 3 years of daily intake of fluoride-containing tablets (Fludent). Swed Dent J. 1984;8(4):203-7.Widenheim J, Petersson LG, Koch G. Fluorine concentration in primary tooth enamel in 6-year-olds after 3 years of daily intake of fluoride-containing tablets (Fludent). Swed Dent J. 1984;8(4):203-7.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42240
    Study title: Aasenden R, Peebles TC. Effects of fluoride supplementation from birth on human deciduous and permanent teeth. Arch Oral Biol 1974; 19: 321-326.Aasenden R, Peebles TC. Effects of fluoride supplementation from birth on human deciduous and permanent teeth. Arch Oral Biol 1974; 19: 321-326.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42241
    Study title: Aasenden R, Peebles TC. Effects of fluoride supplementation from birth on human deciduous and permanent teeth. Arch Oral Biol 1974; 19: 321-326.Aasenden R, Peebles TC. Effects of fluoride supplementation from birth on human deciduous and permanent teeth. Arch Oral Biol 1974; 19: 321-326.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42273
    Study title: Aasenden R, Peebles TC. Effects of fluoride supplementation from birth on human deciduous and permanent teeth. Arch Oral Biol 1974; 19: 321-326.Aasenden R, Peebles TC. Effects of fluoride supplementation from birth on human deciduous and permanent teeth. Arch Oral Biol 1974; 19: 321-326.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42305
    Study title: Allmark C, Green HP, Linney et al. A community study of fluoride tablets for schoolchildren in Portsmouth. Results after six years. Br Dent J 1982; 153: 426-430.Allmark C, Green HP, Linney et al. A community study of fluoride tablets for schoolchildren in Portsmouth. Results after six years. Br Dent J 1982; 153: 426-430.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42249
    Study title: Allmark C, Green HP, Linney et al. A community study of fluoride tablets for schoolchildren in Portsmouth. Results after six years. Br Dent J 1982; 153: 426-430.Allmark C, Green HP, Linney et al. A community study of fluoride tablets for schoolchildren in Portsmouth. Results after six years. Br Dent J 1982; 153: 426-430.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42281
    Study title: Allmark C, Green HP, Linney et al. A community study of fluoride tablets for schoolchildren in Portsmouth. Results after six years. Br Dent J 1982; 153: 426-430.Allmark C, Green HP, Linney et al. A community study of fluoride tablets for schoolchildren in Portsmouth. Results after six years. Br Dent J 1982; 153: 426-430.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42313
    Study title: Andersson R, Grahnen H. Fluoride tablets in pre-school age – effect on primary and permanet teeth. Swed Dent J 1976; 69: 137-143.Andersson R, Grahnen H. Fluoride tablets in pre-school age – effect on primary and permanet teeth. Swed Dent J 1976; 69: 137-143.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42242
    Study title: Andersson R, Grahnen H. Fluoride tablets in pre-school age – effect on primary and permanet teeth. Swed Dent J 1976; 69: 137-143.Andersson R, Grahnen H. Fluoride tablets in pre-school age – effect on primary and permanet teeth. Swed Dent J 1976; 69: 137-143.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42274
    Study title: Andersson R, Grahnen H. Fluoride tablets in pre-school age – effect on primary and permanet teeth. Swed Dent J 1976; 69: 137-143.Andersson R, Grahnen H. Fluoride tablets in pre-school age – effect on primary and permanet teeth. Swed Dent J 1976; 69: 137-143.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42306
    Study title: Strübig W, Aeckerle-Witten B, Lange-v.d. Burchard G. Karies-statische Ergebnisse nach 2-jähriger Tabletten­fluoridierung. Öff Gesundheitswesen 1982; 44: 462-.Strübig W, Aeckerle-Witten B, Lange-v.d. Burchard G. Karies-statische Ergebnisse nach 2-jähriger Tabletten­fluoridierung. Öff Gesundheitswesen 1982; 44: 462-.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42333
    Study title: Strübig W, Gülzow HJ. Die Abhängigkeit des Fluoridgehaltes im Zahnschmelz von regelmäßiger oder unkontrollierter Fluoridaufnahme. Dtsch zahnärztl Z 1979; 34: 172-175Strübig W, Gülzow HJ. Die Abhängigkeit des Fluoridgehaltes im Zahnschmelz von regelmäßiger oder unkontrollierter Fluoridaufnahme. Dtsch zahnärztl Z 1979; 34: 172-175
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42270
    Study title: De Liefde B, Herbison GP. Prevalence of developmental defects of enamel and denatl caries in New Zealand children receiving differing fluoride supplementation. Community Dent Oral Epidemiol 1985; 13: 164-167De Liefde B, Herbison GP. Prevalence of developmental defects of enamel and denatl caries in New Zealand children receiving differing fluoride supplementation. Community Dent Oral Epidemiol 1985; 13: 164-167
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42243
    Study title: De Liefde B, Herbison GP. Prevalence of developmental defects of enamel and denatl caries in New Zealand children receiving differing fluoride supplementation. Community Dent Oral Epidemiol 1985; 13: 164-167De Liefde B, Herbison GP. Prevalence of developmental defects of enamel and denatl caries in New Zealand children receiving differing fluoride supplementation. Community Dent Oral Epidemiol 1985; 13: 164-167
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42275
    Study title: De Liefde B, Herbison GP. Prevalence of developmental defects of enamel and denatl caries in New Zealand children receiving differing fluoride supplementation. Community Dent Oral Epidemiol 1985; 13: 164-167De Liefde B, Herbison GP. Prevalence of developmental defects of enamel and denatl caries in New Zealand children receiving differing fluoride supplementation. Community Dent Oral Epidemiol 1985; 13: 164-167
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42307
    Study title: DePaola PF, Lax M. the caries-inhibiting effect of acidulated phosphate-fluoride chewable tablets: a two-year double-blind study. J Dent Assoc 1968; 76: 554-557.DePaola PF, Lax M. the caries-inhibiting effect of acidulated phosphate-fluoride chewable tablets: a two-year double-blind study. J Dent Assoc 1968; 76: 554-557.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42253
    Study title: DePaola PF, Lax M. the caries-inhibiting effect of acidulated phosphate-fluoride chewable tablets: a two-year double-blind study. J Dent Assoc 1968; 76: 554-557.DePaola PF, Lax M. the caries-inhibiting effect of acidulated phosphate-fluoride chewable tablets: a two-year double-blind study. J Dent Assoc 1968; 76: 554-557.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42285
    Study title: DePaola PF, Lax M. the caries-inhibiting effect of acidulated phosphate-fluoride chewable tablets: a two-year double-blind study. J Dent Assoc 1968; 76: 554-557.DePaola PF, Lax M. the caries-inhibiting effect of acidulated phosphate-fluoride chewable tablets: a two-year double-blind study. J Dent Assoc 1968; 76: 554-557.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42317
    Study title: Discroll WS, Heifetz SB, Brunelle JA. Caries-preventive effects of fluoride tablets in schoolchildren four years after discontinuation of treatments. J Am Dent Assoc 1981; 103: 878-881.Discroll WS, Heifetz SB, Brunelle JA. Caries-preventive effects of fluoride tablets in schoolchildren four years after discontinuation of treatments. J Am Dent Assoc 1981; 103: 878-881.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42254
    Study title: Widenheim J, Petersson LG, Koch G. Fluorine concentration in primary tooth enamel in 6-year-olds after 3 years of daily intake of fluoride-containing tablets (Fludent). Swed Dent J. 1984;8(4):203-7.Widenheim J, Petersson LG, Koch G. Fluorine concentration in primary tooth enamel in 6-year-olds after 3 years of daily intake of fluoride-containing tablets (Fludent). Swed Dent J. 1984;8(4):203-7.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42272
    Study title: Widenheim J, Petersson LG, Koch G. Fluorine concentration in primary tooth enamel in 6-year-olds after 3 years of daily intake of fluoride-containing tablets (Fludent). Swed Dent J. 1984;8(4):203-7.Widenheim J, Petersson LG, Koch G. Fluorine concentration in primary tooth enamel in 6-year-olds after 3 years of daily intake of fluoride-containing tablets (Fludent). Swed Dent J. 1984;8(4):203-7.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42304
    Study title: Strübig W, Gülzow HJ. Die Abhängigkeit des Fluoridgehaltes im Zahnschmelz von regelmäßiger oder unkontrollierter Fluoridaufnahme. Dtsch zahnärztl Z 1979; 34: 172-175Strübig W, Gülzow HJ. Die Abhängigkeit des Fluoridgehaltes im Zahnschmelz von regelmäßiger oder unkontrollierter Fluoridaufnahme. Dtsch zahnärztl Z 1979; 34: 172-175
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42302
    Study title: Strübig W, Gülzow HJ. Die Abhängigkeit des Fluoridgehaltes im Zahnschmelz von regelmäßiger oder unkontrollierter Fluoridaufnahme. Dtsch zahnärztl Z 1979; 34: 172-175Strübig W, Gülzow HJ. Die Abhängigkeit des Fluoridgehaltes im Zahnschmelz von regelmäßiger oder unkontrollierter Fluoridaufnahme. Dtsch zahnärztl Z 1979; 34: 172-175
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42334
    Study title: Studies of fluoride varnishes in Finland.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42422
    Study title: Studies of fluoride varnishes in Finland.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42535
    Study title: The caries-preventive effect of a fluoride varnish in the fissures of the first permanent molar.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42482
    Study title: The caries-protective efficacy of 2 fluoride varnishes in a 2-year controlled clinical trial
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42343
    Study title: The caries-protective efficacy of 2 fluoride varnishes in a 2-year controlled clinical trial
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42456
    Study title: The clinical effect of application of a urethane lacquer containing silane fluorine. A one-year study.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42376
    Study title: The clinical effect of application of a urethane lacquer containing silane fluorine. A one-year study.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42489
    Study title: The clinical effect of application of fluoride varnish.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42438
    Study title: The clinical effect of application of fluoride varnish.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42551
    Study title: The comparative efficacy of local anticaries agents][Article in Russian
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42371
    Study title: The comparative efficacy of local anticaries agents][Article in Russian
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42484
    Study title: The effect of Duraphat lacquer on the condition of the permanent teeth in children consuming fluoridated table salt.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42386
    Study title: The effect of Duraphat lacquer on the condition of the permanent teeth in children consuming fluoridated table salt.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42499
    Study title: The effect of five years' implementation of caries-preventive methods in Swedish high-risk adolescents.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42372
    Study title: The effect of five years' implementation of caries-preventive methods in Swedish high-risk adolescents.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42485
    Study title: The effect of prophylactic measures on the gingival health of school children.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42345
    Study title: Discroll WS, Heifetz SB, Brunelle JA. Caries-preventive effects of fluoride tablets in schoolchildren four years after discontinuation of treatments. J Am Dent Assoc 1981; 103: 878-881.Discroll WS, Heifetz SB, Brunelle JA. Caries-preventive effects of fluoride tablets in schoolchildren four years after discontinuation of treatments. J Am Dent Assoc 1981; 103: 878-881.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42286
    Study title: Discroll WS, Heifetz SB, Brunelle JA. Caries-preventive effects of fluoride tablets in schoolchildren four years after discontinuation of treatments. J Am Dent Assoc 1981; 103: 878-881.Discroll WS, Heifetz SB, Brunelle JA. Caries-preventive effects of fluoride tablets in schoolchildren four years after discontinuation of treatments. J Am Dent Assoc 1981; 103: 878-881.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42318
    Study title: Comparison of intra-examiner reproducibility in scoring caries in primary teeth of two scoring systems used to monitor caries progression.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42541
    Study title: 19. Influence of oral intake of Saccharomyces boulardii on Escherichia coli in enteric flora.; Pediatric Nephrology 2006 ; 21 (6) : 807-810
    Active substance: Saccharomyces boulardii
    Study summary document link (including results):
    View full study record
    Document reference: 40173
    Study title: Post-treatment effect of fluoride varnishes in children with a high prevalence of dental caries in a community with fluoridated water.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42421
    Study title: Application of fluoride varnish Duraphat with a cotton carrier respectively a syringe for cartridges--a comparison study.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42472
    Study title: Assessing the effect of fluoride varnish on early enamel carious lesions in the primary dentition
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42336
    Study title: Assessing the effect of fluoride varnish on early enamel carious lesions in the primary dentition
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42449
    Study title: Bibby BG, Wilkins E, Witol E. A preliminary study of the effects of fluoride lozenges and pills on dental caries. Oral Surg Oral Med Oral Pathol 1955; 8 : 213-216.Bibby BG, Wilkins E, Witol E. A preliminary study of the effects of fluoride lozenges and pills on dental caries. Oral Surg Oral Med Oral Pathol 1955; 8 : 213-216.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42250
    Study title: Bibby BG, Wilkins E, Witol E. A preliminary study of the effects of fluoride lozenges and pills on dental caries. Oral Surg Oral Med Oral Pathol 1955; 8 : 213-216.Bibby BG, Wilkins E, Witol E. A preliminary study of the effects of fluoride lozenges and pills on dental caries. Oral Surg Oral Med Oral Pathol 1955; 8 : 213-216.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42282
    Study title: Bibby BG, Wilkins E, Witol E. A preliminary study of the effects of fluoride lozenges and pills on dental caries. Oral Surg Oral Med Oral Pathol 1955; 8 : 213-216.Bibby BG, Wilkins E, Witol E. A preliminary study of the effects of fluoride lozenges and pills on dental caries. Oral Surg Oral Med Oral Pathol 1955; 8 : 213-216.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42314
    Study title: Busse H, Geiger L. Fluoridierungsmaßnahmen und Kariesprävalenz bei Schülern in der ehemaligen DDR. Oralprophylaxe 1990; 12: 145-153Busse H, Geiger L. Fluoridierungsmaßnahmen und Kariesprävalenz bei Schülern in der ehemaligen DDR. Oralprophylaxe 1990; 12: 145-153
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42251
    Study title: Busse H, Geiger L. Fluoridierungsmaßnahmen und Kariesprävalenz bei Schülern in der ehemaligen DDR. Oralprophylaxe 1990; 12: 145-153Busse H, Geiger L. Fluoridierungsmaßnahmen und Kariesprävalenz bei Schülern in der ehemaligen DDR. Oralprophylaxe 1990; 12: 145-153
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42283
    Study title: Application of fluoride varnish Duraphat with a cotton carrier respectively a syringe for cartridges--a comparison study.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42359
    Study title: Busse H, Geiger L. Fluoridierungsmaßnahmen und Kariesprävalenz bei Schülern in der ehemaligen DDR. Oralprophylaxe 1990; 12: 145-153Busse H, Geiger L. Fluoridierungsmaßnahmen und Kariesprävalenz bei Schülern in der ehemaligen DDR. Oralprophylaxe 1990; 12: 145-153
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42315
    Study title: Caries incidence after topical application of varnishes containing different concentrations of sodium fluoride: 3-year results
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42365
    Study title: Caries incidence after topical application of varnishes containing different concentrations of sodium fluoride: 3-year results
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42478
    Study title: Caries increment in primary teeth after application of Duraphat fluoride varnish.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42361
    Study title: Caries increment in primary teeth after application of Duraphat fluoride varnish.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42474
    Study title: Caries prevention by means of deep impregnation of the dental enamel with fluoride lacquer] [Article in German]
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42414
    Study title: Caries prevention by means of deep impregnation of the dental enamel with fluoride lacquer] [Article in German]
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42527
    Study title: Caries prevention with Duraphat in a new application form].
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42412
    Study title: The effect of prophylactic measures on the gingival health of school children.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42458
    Study title: Comparative evaluation of the role of NaF, APF & Duraphat topical fluoride applications in the prevention of dental caries--a 2 1/2 years study.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42431
    Study title: The effect of topical fluoride treatment on enamel fluoride uptake and the tensile bond strength of an orthodontic bonding resin.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42350
    Study title: The effect of topical fluoride treatment on enamel fluoride uptake and the tensile bond strength of an orthodontic bonding resin.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42463
    Study title: The trace efficacy of dental caries prevention in children
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42429
    Study title: The trace efficacy of dental caries prevention in children
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42542
    Study title: The use of a fluoride varnish and helium-neon laser light in preventing caries of the deciduous teeth] [Article in Russian
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42378
    Study title: The use of a fluoride varnish and helium-neon laser light in preventing caries of the deciduous teeth] [Article in Russian
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42491
    Study title: Three-year study of the effect of fluoride varnish (Duraphat) on proximal caries progression in teenagers.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42387
    Study title: Three-year study of the effect of fluoride varnish (Duraphat) on proximal caries progression in teenagers.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42500
    Study title: Topical application of fluoride varnish for dental caries prevention in ollectives following a 3-year testing period][Article in German
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42385
    Study title: Topical application of fluoride varnish for dental caries prevention in ollectives following a 3-year testing period][Article in German
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42498
    Study title: Trials - results - conclusions. Duraphat - Fluor Protector
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42340
    Study title: Trials - results - conclusions. Duraphat - Fluor Protector
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42453
    Study title: Two-year trial of the fluoride-containing varnishes Duraphat and Carex].
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42389
    Study title: Two-year trial of the fluoride-containing varnishes Duraphat and Carex].
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42502
    Study title: Uptake of KOH-soluble and KOH-insoluble fluoride in sound human enamel after topical application of a fluoride varnish (Duraphat) or a neutral 2% NaF solution in vitro.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42354
    Study title: Uptake of KOH-soluble and KOH-insoluble fluoride in sound human enamel after topical application of a fluoride varnish (Duraphat) or a neutral 2% NaF solution in vitro.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42467
    Study title: use of a fluoride varnish in caries prevention.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42383
    Study title: use of a fluoride varnish in caries prevention.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42496
    Study title: use of fluoride varnish in the prevention of caries.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42379
    Study title: use of fluoride varnish in the prevention of caries.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42492
    Study title: Widenheim J, Birkhed D, Granath L et al. Pre-eruptive effect of NaF tablets on caries in children from 12 to 17 years of age. Community Dent Oral Epidemiolog 1986, 14: 1-4.Widenheim J, Birkhed D, Granath L et al. Pre-eruptive effect of NaF tablets on caries in children from 12 to 17 years of age. Community Dent Oral Epidemiolog 1986, 14: 1-4.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42271
    Study title: Influence of age on quantitative sacro-iliac joint imaging. Dodig D, Popović S, Domljan Z. Eur J Nucl Med. 1984;9(4):177-9.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 44016
    Study title: Caries prevention with fluoride varnish in a socially deprived community
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42444
    Study title: Caries prevention with fluoride varnish in a socially deprived community
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42557
    Study title: Caries prevention with fluoride varnishes among preschool children.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42344
    Study title: Caries prevention with fluoride varnishes among preschool children.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42457
    Study title: Caries prophylaxis by local application of sodium fluoride lacquer
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42441
    Study title: Caries prophylaxis by local application of sodium fluoride lacquer
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42554
    Study title: Caries prophylaxis by means of local application of sodium fluoride lacquer
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42442
    Study title: Caries prophylaxis by means of local application of sodium fluoride lacquer
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42555
    Study title: Caries prevention with Duraphat in a new application form].
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42525
    Study title: Caries prevention with Duraphat in a new applications form].
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42411
    Study title: Caries prophylaxis by topical application of sodium fluoride varnish
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42440
    Study title: Caries prophylaxis by topical application of sodium fluoride varnish
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42553
    Study title: Caries-preventive effect of a fluoride-containing lacquer, Duraphat, evaluated in a clinical study
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42373
    Study title: Caries-preventive effect of a fluoride-containing lacquer, Duraphat, evaluated in a clinical study
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42486
    Study title: Caries-preventive effect of fluoride varnish with different fluoride concentrations.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42423
    Study title: Caries-preventive effect of fluoride varnish with different fluoride concentrations.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42536
    Study title: Caries-preventive effects of fluoride products when used in conjunction with fluoride dentifrice.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42445
    Study title: Caries-preventive effects of fluoride products when used in conjunction with fluoride dentifrice.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42558
    Study title: Chemical changes and surface morphology of acid-etching of human enamel treated with topical fluoride agents in vitro.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42364
    Study title: Chemical changes and surface morphology of acid-etching of human enamel treated with topical fluoride agents in vitro.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42477
    Study title: Christen F, Hotz P. [Long-term effect of fluoride prophylaxis: a follow-up study of 151 subjects 13 to 15 years after tablet fluoridation] SSO Schweiz Monatsschr Zahnheilkd. 1981 Nov;91(11):932-9. German.Christen F, Hotz P. [Long-term effect of fluoride prophylaxis: a follow-up study of 151 subjects 13 to 15 years after tablet fluoridation] SSO Schweiz Monatsschr Zahnheilkd. 1981 Nov;91(11):932-9. German.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42252
    Study title: Christen F, Hotz P. [Long-term effect of fluoride prophylaxis: a follow-up study of 151 subjects 13 to 15 years after tablet fluoridation] SSO Schweiz Monatsschr Zahnheilkd. 1981 Nov;91(11):932-9. German.Christen F, Hotz P. [Long-term effect of fluoride prophylaxis: a follow-up study of 151 subjects 13 to 15 years after tablet fluoridation] SSO Schweiz Monatsschr Zahnheilkd. 1981 Nov;91(11):932-9. German.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42284
    Study title: Even-Sapir E, Flusser G, Lerman H, Lievshitz G, Metser U. SPECT/multislice low-dose CT: a clinically relevant constituent in the imaging algorithm of nononcologic patients referred for bone scintigraphy. J Nucl Med. 2007 Feb;48(2):319-24. Even-Sapir E, Flusser G, Lerman H, Lievshitz G, Metser U. SPECT/multislice low-dose CT: a clinically relevant constituent in the imaging algorithm of nononcologic patients referred for bone scintigraphy. J Nucl Med. 2007 Feb;48(2):319-24.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43365
    Study title: Christen F, Hotz P. [Long-term effect of fluoride prophylaxis: a follow-up study of 151 subjects 13 to 15 years after tablet fluoridation] SSO Schweiz Monatsschr Zahnheilkd. 1981 Nov;91(11):932-9. German.Christen F, Hotz P. [Long-term effect of fluoride prophylaxis: a follow-up study of 151 subjects 13 to 15 years after tablet fluoridation] SSO Schweiz Monatsschr Zahnheilkd. 1981 Nov;91(11):932-9. German.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42316
    Study title: Clinical evaluation of Duraphat and Fluor-Protector preparations in caries prevention
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42339
    Study title: Clinical evaluation of Duraphat and Fluor-Protector preparations in caries prevention
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42452
    Study title: Clinical evaluation of Duraphat varnish in the prevention of dental caries in children and in the control of cervical hypersensitivity in adults.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42443
    Study title: Clinical evaluation of Duraphat varnish in the prevention of dental caries in children and in the control of cervical hypersensitivity in adults.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42556
    Study title: Clinical evaluation of home fluoride-containing varnish.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42380
    Study title: Clinical evaluation of home fluoride-containing varnish.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42493
    Study title: Clinical experience with the use of Duraphat lacquer.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42341
    Study title: Clinical experience with the use of Duraphat lacquer.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42454
    Study title: Clinical experience with the use of Duraphat shellac.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42446
    Study title: Clinical experimental field studies of the caries-preventive effect of a fluoride lacquer]
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42432
    Study title: Clinical experimental field studies of the caries-preventive effect of a fluoride lacquer]
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42545
    Study title: Collective preschool caries prevention using a fluoride-containing varnish] [Article in German]
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42430
    Study title: Comparative assessment of the caries prevention effectiveness of different fluorine preparations] [Article in Russian]
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42393
    Study title: Comparative assessment of the caries prevention effectiveness of different fluorine preparations] [Article in Russian]
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42506
    Study title: Comparative clinical and radiological studies on Fluor ProtectorR and DuraphatR.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42342
    Study title: Comparative clinical and radiological studies on Fluor ProtectorR and DuraphatR.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42455
    Study title: Comparative evaluation of the role of NaF, APF & Duraphat topical fluoride applications in the prevention of dental caries--a 2 1/2 years study.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42544
    Study title: Comparative study of the increase in acid solubility resistance of enamel using different fluoride treatments].
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42409
    Study title: Comparative study of the increase in acid solubility resistance of enamel using different fluoride treatments].
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42522
    Study title: Comparison of intra-examiner reproducibility in scoring caries in primary teeth of two scoring systems used to monitor caries progression.
    Active substance: SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 42428
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu Aug 07 08:24:28 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA